CLCN2, TYR26ASN	CLCN2	Hyperaldosteronism, familial, type II	Pathogenic(Last reviewed: Aug 10, 2018)	no assertion criteria provided					559515	550238
NM_001204.6(BMPR2):c.1414-?_2866+?del	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided					425941	414068
NM_001204.6(BMPR2):c.1277-?_1413+?dup	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided					425920	414067
NM_001204.6(BMPR2):c.1277-?_1413+?del	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided					425919	414066
NM_001204.6(BMPR2):c.968-?_1413+?dup	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided					425857	414065
NM_001204.6(BMPR2):c.968-?_1276+?del	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided					425856	414064
NM_001204.6(BMPR2):c.968-?_1128+?del	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided					425855	414063
NM_001204.6(BMPR2):c.853-?_967+?dup	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided					425835	414062
NM_001204.6(BMPR2):c.622-?_967+?del	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided					425809	414061
NM_001204.6(BMPR2):c.622-?_852+?del	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided					425808	414060
NM_001204.6(BMPR2):c.530-?_967+?del	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided					425802	414059
NM_001204.6(BMPR2):c.530-?_621+?del	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided					425801	414058
NM_001204.6(BMPR2):c.419-?_1413+?del	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided					425788	414057
NM_001204.6(BMPR2):c.419-?_1128+?dup	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided					425787	414056
NM_001204.6(BMPR2):c.419-?_967+?del	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided					425786	414055
NM_001204.6(BMPR2):c.419-?_621+?del	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided					425785	414054
NM_001204.6(BMPR2):c.419-?_529+?del	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided					425784	414053
NM_001204.6(BMPR2):c.248-?_418+?dup	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided					425740	414052
NM_001204.6(BMPR2):c.248-?_418+?del	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided					425739	414051
NM_001204.6(BMPR2):c.77-?_1276+?del	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided					425697	414050
NM_001204.6(BMPR2):c.77-?_967+?dup	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided					425696	414049
NM_001204.6(BMPR2):c.77-?_621+?del	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided					425695	414048
NM_001204.6(BMPR2):c.77-?_418+?dup	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided					425694	414047
NM_001204.6(BMPR2):c.77-?_247+?dup	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided					425693	414046
PRDM16, 1-BP DUP, 1573C	PRDM16	Left ventricular noncompaction 8	Pathogenic(Last reviewed: Jul 11, 2013)	no assertion criteria provided					60725	75285
KLHL3, ASN529LYS	KLHL3	Pseudohypoaldosteronism type 2D	Pathogenic(Last reviewed: Mar 11, 2012)	no assertion criteria provided					31545	40223
AGT, -6A HAPLOTYPE	AGT	Hypertension, essential, susceptibility to|Crohn disease, association with	Pathogenic, risk factor(Last reviewed: Dec 24, 2010)	no assertion criteria provided					18069	33108
CD46, 6-BP DEL	CD46	Atypical hemolytic-uremic syndrome 2	risk factor(Last reviewed: Oct 28, 2003)	no assertion criteria provided					17045	32084
EPOR, 5968_5975DUP	EPOR	Familial erythrocytosis, 1	Affects(Last reviewed: Oct 1, 1999)	no assertion criteria provided					16601	31640
ESR1, IVS1, T-C, -401	ESR1	Myocardial infarction|Atherosclerosis, susceptibility to|Hdl cholesterol, augmented response of, to hormone replacement	drug response, risk factor(Last reviewed: Nov 5, 2003)	no assertion criteria provided					16594	31633
GNB3, 825C-T	GNB3	Hypertension, essential, susceptibility to|GNB3 POLYMORPHISM	Benign, risk factor(Last reviewed: Apr 1, 2003)	no assertion criteria provided					16004	31043
ECE1, -839T-G	ECE1	Hypertension, essential, susceptibility to	risk factor(Last reviewed: Feb 15, 2003)	no assertion criteria provided					9135	24174
ECE1, -338C-A	ECE1	Hypertension, essential, susceptibility to	risk factor(Last reviewed: Feb 15, 2003)	no assertion criteria provided					9134	24173
SCNN1B, 32-BP DEL	SCNN1B	Pseudoprimary hyperaldosteronism	Pathogenic(Last reviewed: Oct 1, 1997)	no assertion criteria provided					8835	23874
SCNN1B, 1-BP INS, 592C	SCNN1B	Pseudoprimary hyperaldosteronism	Pathogenic(Last reviewed: Apr 1, 1997)	no assertion criteria provided					8834	23873
BMPR2, EX1-13DEL	BMPR2	Primary pulmonary hypertension	Pathogenic(Last reviewed: Feb 1, 2006)	no assertion criteria provided					8818	23857
BMPR2, EX10DEL	BMPR2	Primary pulmonary hypertension	Pathogenic(Last reviewed: Feb 1, 2006)	no assertion criteria provided					8817	23856
BMPR2, 2-BP DEL, 1-BP INS, NT690	BMPR2	Primary pulmonary hypertension	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided					8807	23846
BMPR2, 5-BP DEL, NT1099	BMPR2	Primary pulmonary hypertension	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided					8803	23842
PPARG, 3-BP DEL/1-BP INS, NT553	PPARG	Diabetes Mellitus, Noninsulin-Dependent, with Acanthosis Nigricans and Hypertension|Diabetes mellitus, type II, digenic	Pathogenic(Last reviewed: Aug 1, 2002)	no assertion criteria provided					8140	23179
PPARG, 161C-T	PPARG	PPARG POLYMORPHISM C/T	Benign(Last reviewed: Dec 1, 2003)	no assertion criteria provided					8138	23177
PTGIS, IVS9, T-C, +2	PTGIS	Essential hypertension	Pathogenic(Last reviewed: Oct 11, 2002)	no assertion criteria provided					7864	22903
CYP3A5, 6986A-G	CYP3A5	Hypertension, salt-sensitive essential, susceptibility to	risk factor(Last reviewed: Dec 1, 2004)	no assertion criteria provided					5066	20105
RETN, +62G-A	RETN	Diabetes mellitus type 2|HYPERTENSION, INSULIN RESISTANCE-RELATED, SUSCEPTIBILITY TO	risk factor(Last reviewed: Mar 1, 2003)	no assertion criteria provided					4884	19923
CYP17A1, 7-BP DUP, EX2	CYP17A1	Complete combined 17-alpha-hydroxylase/17,20-lyase deficiency	Pathogenic(Last reviewed: May 1, 1990)	no assertion criteria provided					1779	16818
CYP11B1, CYP11B1/CYP11B2 CHIMERA	CYP11B1	Deficiency of steroid 11-beta-monooxygenase	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided					1184	16223
CYP11B1, 954G-A	CYP11B1	Deficiency of steroid 11-beta-monooxygenase	Pathogenic(Last reviewed: Nov 1, 2000)	no assertion criteria provided					1180	16219
CYP11B1, 2-BP INS	CYP11B1	Deficiency of steroid 11-beta-monooxygenase	Pathogenic(Last reviewed: Nov 1, 1992)	no assertion criteria provided					1175	16214
CYP11B1, CYP11B1/CYP11B2 ANTI-LEPORE-LIKE CHIMERA	CYP11B1	Hyperaldosteronism, familial, type I	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided					1172	16211
NM_022114.3(PRDM16):c.1573dupC (p.Arg525Profs)	PRDM16	not provided	Pathogenic(Last reviewed: Feb 8, 2016)	criteria provided, single submitter	1	3328334	1	3411770	280120	264033
NM_005957.4(MTHFR):c.665C>T (p.Ala222Val)	MTHFR	Gastrointestinal stroma tumor|Neural tube defects, folate-sensitive|MTHFR deficiency, thermolabile type|Neoplasm of stomach|not specified|not provided|carboplatin response - Efficacy|cyclophosphamide response - Toxicity/ADR|methotrexate response - Dosage, Efficacy, Toxicity/ADR	drug response(Last reviewed: May 14, 2018)	reviewed by expert panel	1	11856378	1	11796321	3520	18559
NM_003000.2(SDHB):c.424-19_424-14dupTTCTTC	SDHB	Pheochromocytoma|not specified	Benign/Likely benign(Last reviewed: Aug 22, 2017)	criteria provided, multiple submitters, no conflicts	1	17354374 - 17354379	1	17027879 - 17027884	36770	45431
NC_000001.11:g.17048754_17064432del15679	SDHB	Paragangliomas 4	Pathogenic(Last reviewed: Apr 1, 2009)	no assertion criteria provided	1	17375249 - 17390927	1	17048754 - 17064432	18455	33494
NM_005216.4(DDOST):c.1325T>A (p.Phe442Tyr)	DDOST	Congenital disorder of glycosylation type Ir	not provided	no assertion provided	1	20978918	1	20652425	585026	576081
NM_005216.4(DDOST):c.20C>G (p.Ala7Gly)	DDOST	Congenital disorder of glycosylation type Ir	not provided	no assertion provided	1	20987875	1	20661382	585027	576082
NM_005857.4(ZMPSTE24):c.1085dupT (p.Leu362Phefs)	ZMPSTE24	Lethal tight skin contracture syndrome|Mandibuloacral dysplasia with type B lipodystrophy|not provided|ZMPSTE24-Related Disorders	Pathogenic(Last reviewed: Jul 31, 2016)	criteria provided, multiple submitters, no conflicts	1	40756551	1	40290879	4271	19310
NM_148960.2(CLDN19):c.388G>T (p.Gly130Cys)	CLDN19	Hypomagnesemia 5, renal, with ocular involvement	Pathogenic	no assertion criteria provided	1	43204092	1	42738421	560599	551674
NM_015506.2(MMACHC):c.276G>A (p.Glu92=)	MMACHC	Methylmalonic acidemia with homocystinuria	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	1	45973222	1	45507550	161118	170962
NM_015506.2(MMACHC):c.276G>T (p.Glu92Asp)	MMACHC	Methylmalonic acidemia with homocystinuria	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	1	45973222	1	45507550	161117	170961
NM_015506.2(MMACHC):c.464G>A (p.Gly155Glu)	MMACHC	Methylmalonic acidemia with homocystinuria	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	1	45974502	1	45508830	161119	170963
NM_174936.3(PCSK9):c.1069C>T (p.Arg357Cys)	PCSK9	Hypercholesterolemia, autosomal dominant, 3	Uncertain significance(Last reviewed: Feb 1, 2018)	criteria provided, single submitter	1	55523076	1	55057403	575758	557107
NM_001127328.2(ACADM):c.997A>G (p.Lys333Glu)	ACADM	Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, multiple submitters, no conflicts	1	76226846	1	75761161	3586	18625
NM_000969.5(RPL5):c.74-1G>C	RPL5|DIPK1A	Aplastic anemia|Atrial septal defect|Pulmonary arterial hypertension|Hypotelorism|Hemangioma|Hepatomegaly|Abnormality of the pinna|Downslanted palpebral fissures|Wide anterior fontanel|Low-set, posteriorly rotated ears|Dry skin|Relative macrocephaly|Dilation of lateral ventricles|Intracerebral periventricular calcifications|Aplasia of the ovary|Erythroid hypoplasia|Vaginal hydrocele	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	1	93299101	1	92833544	523383	513904
NM_013386.4(SLC25A24):c.650G>A (p.Arg217His)	SLC25A24	Fontaine progeroid syndrome	Pathogenic(Last reviewed: Oct 4, 2016)	criteria provided, single submitter	1	108700103	1	108157481	370032	354272
NM_001232.3(CASQ2):c.1194_1196delTGA (p.Asp398del)	CASQ2	not specified	Likely benign(Last reviewed: Nov 14, 2016)	criteria provided, single submitter	1	116243866 - 116243868	1	115701245 - 115701247	190752	188301
NM_002016.1(FLG):c.2282_2285delCAGT (p.Ser761Cysfs)	FLG	Dermatitis, atopic, 2|Ichthyosis vulgaris|Dermatitis, atopic, 2, susceptibility to|not provided|FLG-Related Disorder	Conflicting interpretations of pathogenicity, risk factor(Last reviewed: May 3, 2018)	criteria provided, conflicting interpretations	1	152285077 - 152285080	1	152312601 - 152312604	16320	31359
NM_001005741.2(GBA):c.1093G>A (p.Glu365Lys)	GBA|LOC106627981	Gaucher's disease, type 1|not specified|not provided|Hypertension|Parkinsonism|Tremor|Rigidity|Neurological speech impairment|Cogwheel rigidity|Hyperlipidemia|Lower limb muscle weakness|Dementia|Hypertension	Conflicting interpretations of pathogenicity, risk factor(Last reviewed: Oct 31, 2017)	criteria provided, conflicting interpretations	1	155206167	1	155236376	199044	38432
NM_001005741.2(GBA):c.[535G>C;c.1093G>A]	GBA|LOC106627981	Gaucher's disease, type 1	Pathogenic(Last reviewed: Jun 1, 2004)	no assertion criteria provided	1|1	155208361	1|1	155238570	4299	19338|38432
NM_001198903.1(YY1AP1):c.724C>T (p.Gln242Ter)	YY1AP1	Grange syndrome	Pathogenic(Last reviewed: Feb 14, 2017)	no assertion criteria provided	1	155646353	1	155676562	375638	362479
NM_005572.3(LMNA):c.1488+5G>C	LMNA	Familial partial lipodystrophy 2|not provided	Pathogenic(Last reviewed: Oct 3, 2016)	criteria provided, single submitter	1	156106824	1	156137033	66833	77730
NM_003005.3(SELP):c.775+1G>A	SELP	Premature coronary artery disease	Likely pathogenic(Last reviewed: Nov 22, 2013)	no assertion criteria provided	1	169582166	1	169612928	180693	178858
NM_006894.5(FMO3):c.913G>T (p.Glu305Ter)	FMO3	Trimethylaminuria	Pathogenic(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	171083232	1	171114092	16304	31343
NM_000261.1(MYOC):c.1102C>T (p.Gln368Ter)	MYOC	Primary open angle glaucoma|Primary open angle glaucoma juvenile onset 1	Likely pathogenic(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	171605478	1	171636338	7949	22988
NM_000261.1(MYOC):c.734G>A (p.Cys245Tyr)	MYOC	Primary open angle glaucoma juvenile onset 1	Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	1	171605846	1	171636706	7959	22998
NM_018122.5(DARS2):c.228-21_228-20delTTinsC	DARS2	Leukoencephalopathy with Brainstem and Spinal Cord Involvement and Lactate Elevation|Talipes equinovarus|Abnormality of the foot|Hypertension|Dysmetria|Talipes equinovarus|Gait ataxia|Cerebral cortical atrophy|Gait imbalance|Impaired vibration sensation in the lower limbs|Difficulty walking|EMG: axonal abnormality|Sensorimotor neuropathy|CNS demyelination|Hypertension|Gout	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	1	173797450 - 173797451	1	173828312 - 173828313	1057	16096
NM_018122.5(DARS2):c.492+2T>C	DARS2	Leukoencephalopathy with Brainstem and Spinal Cord Involvement and Lactate Elevation|Talipes equinovarus|Abnormality of the foot|not provided|Hypertension|Dysmetria|Talipes equinovarus|Gait ataxia|Cerebral cortical atrophy|Gait imbalance|Impaired vibration sensation in the lower limbs|Difficulty walking|EMG: axonal abnormality|Sensorimotor neuropathy|CNS demyelination|Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation|Hypertension|Gout	Pathogenic(Last reviewed: Aug 16, 2017)	criteria provided, multiple submitters, no conflicts	1	173800770	1	173831632	1062	16101
NM_014625.3(NPHS2):c.686G>A (p.Arg229Gln)	NPHS2	Nephrotic syndrome, idiopathic, steroid-resistant|Nephrotic syndrome, type 2, susceptibility to|not provided|Proteinuria	Conflicting interpretations of pathogenicity, risk factor(Last reviewed: Sep 16, 2018)	criteria provided, conflicting interpretations	1	179526214	1	179557079	5370	20409
NM_018713.2(SLC30A10):c.507delG (p.Pro170Leufs)	SLC30A10	Hypermanganesemia with dystonia 1	Pathogenic(Last reviewed: Aug 30, 2012)	no assertion criteria provided	1	220101276	1	219927934	30888	39845
NM_020435.3(GJC2):c.1254_1258delGCCCAinsCG (p.Lys418_Arg420delinsAsnGly)	GJC2	Spastic paraplegia 44, autosomal recessive	not provided	no assertion provided	1	228346713 - 228346717	1	228159012 - 228159016	441072	434566
NM_000029.3(AGT):c.803T>C (p.Met268Thr)	AGT	Hypertension, essential, susceptibility to|Preeclampsia, susceptibility to|Susceptibility to progression to renal failure in IgA nephropathy|not specified|Renal dysplasia	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	230845794	1	230710048	18068	33107
NM_022051.2(EGLN1):c.1121A>G (p.His374Arg)	EGLN1	Erythrocytosis, familial, 3	Pathogenic(Last reviewed: Dec 18, 2008)	no assertion criteria provided	1	231506335	1	231370589	4357	19396
NM_014801.3(PCNX2):c.4125_4126delAA (p.Asp1377Serfs)	PCNX2	not specified	Uncertain significance(Last reviewed: Sep 11, 2015)	criteria provided, single submitter	1	233192987 - 233192988	1	233057241 - 233057242	212725	209340
NM_014801.3(PCNX2):c.3526C>T (p.His1176Tyr)	PCNX2	not specified	Uncertain significance(Last reviewed: Sep 11, 2015)	criteria provided, single submitter	1	233275593	1	233139847	212726	209341
NM_001103.3(ACTN2):c.1691C>T (p.Thr564Met)	ACTN2	not specified|Cardiovascular phenotype	Uncertain significance(Last reviewed: Oct 5, 2012)	criteria provided, single submitter	1	236914804	1	236751504	234977	236741
NM_001103.3(ACTN2):c.1748A>G (p.Glu583Gly)	ACTN2	Dilated cardiomyopathy 1AA|Primary familial hypertrophic cardiomyopathy|not specified|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Feb 13, 2018)	criteria provided, conflicting interpretations	1	236914861	1	236751561	201642	198058
NM_001103.3(ACTN2):c.2659G>A (p.Ala887Thr)	ACTN2	Dilated cardiomyopathy 1AA|Primary familial hypertrophic cardiomyopathy|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 12, 2017)	criteria provided, conflicting interpretations	1	236925893	1	236762593	191601	189403
NM_001035.2(RYR2):c.4198A>G (p.Ser1400Gly)	RYR2	Arrhythmogenic right ventricular cardiomyopathy|not specified|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia	Benign/Likely benign(Last reviewed: Aug 17, 2017)	criteria provided, multiple submitters, no conflicts	1	237755076	1	237591776	43782	52951
NM_001035.2(RYR2):c.9655G>A (p.Val3219Met)	RYR2	not specified|not provided|Inborn genetic diseases|Catecholaminergic polymorphic ventricular tachycardia	Conflicting interpretations of pathogenicity(Last reviewed: May 31, 2018)	criteria provided, conflicting interpretations	1	237870323	1	237707023	201179	196661
NM_001035.2(RYR2):c.13291G>A (p.Glu4431Lys)	RYR2	Arrhythmogenic right ventricular dysplasia, familial, 2|Catecholaminergic polymorphic ventricular tachycardia type 1|Left ventricular noncompaction|not specified|Inborn genetic diseases|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia	Uncertain significance(Last reviewed: Jun 25, 2018)	criteria provided, multiple submitters, no conflicts	1	237949299	1	237785999	165128	172435
NM_001035.2(RYR2):c.14173T>A (p.Tyr4725Asn)	RYR2	not specified|not provided	Likely pathogenic(Last reviewed: Jan 5, 2015)	criteria provided, single submitter	1	237969458	1	237806158	235053	236748
NM_001243133.1(NLRP3):c.592G>A (p.Val198Met)	NLRP3	Chronic infantile neurological, cutaneous and articular syndrome|Familial amyloid nephropathy with urticaria AND deafness|Familial cold urticaria|not specified|not provided|Familial cold autoinflammatory syndrome|Cryopyrin associated periodic syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 5, 2018)	criteria provided, conflicting interpretations	1	247587343	1	247424041	4371	19410
NC_000001.10:g.(?_15764961)_(16063358_?)del	CASP9|RSC1A1|CTRC|PLEKHM2|DNAJC16|CELA2B|CELA2A|AGMAT|DDI2|SLC25A34	Hereditary pancreatitis	Pathogenic(Last reviewed: May 31, 2018)	criteria provided, single submitter	1	15764961 - 16063358			584380	556485
NC_000001.10:g.(?_15764955)_(15773090_?)del	CTRC	Hereditary pancreatitis	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, single submitter	1	15764955 - 15773090			528777	514864
GRCh37/hg19 1p36.33-36.32(chr1:849466-5352492)x1	CDK11B|DFFB|DVL1|MEGF6|GABRD|GNB1|PEX10|PRKCZ|SCNN1D|SKI|TP73|TNFRSF4|MMP23B|TNFRSF14|TNFRSF18|ISG15|PLCH2|CEP104|SLC35E2A|RER1|NOC2L|ARHGEF16|SSU72|WRAP73|SDF4|MXRA8|INTS11|C1orf159|AURKAIP1|MRPL20|ATAD3A|PANK4|AJAP1|LRRC47|HES4|PRDM16|VWA1|NADK|MMEL1|MORN1|CPTP|CCNL2|TAS1R3|ATAD3B|PLEKHN1|CFAP74|ACAP3|UBE2J2|PUSL1|B3GALT6|TPRG1L|PRXL2B|ACTRT2|MIB2|SAMD11|CCDC27|CALML6|FAAP20|ATAD3C|TTLL10|C1orf174|KLHL17|TMEM240|TMEM52|AGRN|C1QTNF12|HES5|SMIM1|RNF223|MIR200A|MIR200B|ANKRD65|MIR429|TMEM88B|FNDC10|MIR551A|CDK11A|SLC35E2B|TTC34	See cases	Pathogenic(Last reviewed: Mar 31, 2015)	no assertion criteria provided	1	849466 - 5352492			443250	436912
GRCh37/hg19 1q43(chr1:239569530-241526991)x3	CHRM3|RGS7|FMN2|GREM2	See cases	Uncertain significance(Last reviewed: Mar 31, 2015)	no assertion criteria provided	1	239569530 - 241526991			443027	436689
GRCh37/hg19 1q44(chr1:244281222-247789907)x3	ADSS|HNRNPU|ZNF124|AHCTF1|DESI2|SCCPDH|KIF26B|ZNF695|TFB2M|SMYD3|ZNF669|OR2G3|OR2G2|OR2C3|EFCAB2|ZNF496|ZNF670|NLRP3|COX20|OR2B11|GCSAML|CNST|C1orf100|CATSPERE|VN1R5|C1orf229|OR2W5	See cases	Uncertain significance(Last reviewed: Mar 31, 2015)	no assertion criteria provided	1	244281222 - 247789907			442983	436645
GRCh37/hg19 1q44(chr1:248572727-249224684)x3	ZNF692|ZNF672|SH3BP5L|OR2T34|OR2T10|OR2T11|PGBD2|OR2T3|OR2T29|OR2G6|OR2T2|OR2T5|OR14I1|OR2T27|OR2T35|LYPD8	See cases	Uncertain significance(Last reviewed: Mar 31, 2015)	no assertion criteria provided	1	248572727 - 249224684			442141	435803
GRCh37/hg19 1q24.3-25.3(chr1:172742952-181814496)x1	ABL2|ASTN1|SERPINC1|CACNA1E|MR1|QSOX1|SOAT1|TNR|TNFSF4|NPHS2|TNFSF18|ANGPTL1|XPR1|GPR52|RASAL2|PRDX6|KIAA0040|CEP350|RABGAP1L|FAM20B|STX6|TOR1AIP1|CACYBP|KLHL20|IER5|RALGPS2|DARS2|KIAA1614|BRINP2|GAS5|PAPPA2|TNN|MRPS14|TOR3A|COP1|TEX35|ACBD6|ZBTB37|SEC16B|LHX4|CENPL|AXDND1|FAM163A|RC3H1|TDRD5|TOR1AIP2|SLC9C2|ANKRD45	See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	1	172742952 - 181814496			253471	247919
GRCh38/hg38 1q21.1-21.2(chr1:146987841-148355961)x1	BCL9|FMO5|GJA5|GJA8|PRKAB2|CHD1L|RNVU1-7|ACP6|GPR89B|NBPF12|NBPF11|TRQ-CTG7-1|TRQ-CTG4-1|TRQ-CTG3-2|TRH-GTG1-4|TRN-GTT9-2|TRN-GTT9-1|TRH-GTG1-3|TRH-GTG1-2|TRQ-CTG3-1|LINC00624|LOC100505824|MIR5087|RNVU1-8|LOC101927468|LINC01731|LOC110121261|LOC111556113	See cases	Pathogenic(Last reviewed: Jan 9, 2013)	no assertion criteria provided	1	145626237 - 147828089	1	146987841 - 148355961	154731	164485
NM_002246.2(KCNK3):c.17T>C (p.Val6Ala)	KCNK3	Primary pulmonary hypertension 4	Uncertain significance(Last reviewed: May 16, 2017)	criteria provided, single submitter	2	26915760	2	26692892	474319	450686
NM_002246.2(KCNK3):c.23C>A (p.Thr8Lys)	KCNK3	Primary pulmonary hypertension 4	Pathogenic	no assertion criteria provided	2	26915766	2	26692898	426049	414373
NM_002246.2(KCNK3):c.100G>A (p.Glu34Lys)	KCNK3	Primary pulmonary hypertension 4	Uncertain significance(Last reviewed: Jun 22, 2017)	criteria provided, single submitter	2	26915843	2	26692975	474316	450959
NM_002246.2(KCNK3):c.172G>A (p.Gly58Ser)	KCNK3	Primary pulmonary hypertension 4	Uncertain significance(Last reviewed: May 7, 2018)	criteria provided, single submitter	2	26915915	2	26693047	474318	450694
NM_002246.2(KCNK3):c.289G>A (p.Gly97Arg)	KCNK3	Primary pulmonary hypertension 4	Pathogenic(Last reviewed: Jul 25, 2013)	no assertion criteria provided	2	26950540	2	26727672	60480	75075
NM_002246.2(KCNK3):c.365T>C (p.Leu122Pro)	KCNK3	Primary pulmonary hypertension 4	Likely pathogenic(Last reviewed: Sep 21, 2017)	criteria provided, single submitter	2	26950616	2	26727748	548009	538347
NM_002246.2(KCNK3):c.366C>T (p.Leu122=)	KCNK3	Primary pulmonary hypertension 4	Likely benign(Last reviewed: Jul 27, 2017)	criteria provided, single submitter	2	26950617	2	26727749	474320	450786
NM_002246.2(KCNK3):c.423C>A (p.His141Gln)	KCNK3	Primary pulmonary hypertension 4	Likely benign(Last reviewed: Jun 27, 2017)	criteria provided, single submitter	2	26950674	2	26727806	474321	450788
NM_002246.2(KCNK3):c.544G>A (p.Glu182Lys)	KCNK3	Primary pulmonary hypertension 4	Pathogenic(Last reviewed: Jul 25, 2013)	no assertion criteria provided	2	26950795	2	26727927	60482	75077
NM_002246.2(KCNK3):c.547C>T (p.His183Tyr)	KCNK3	Primary pulmonary hypertension 4	Uncertain significance(Last reviewed: May 21, 2018)	criteria provided, single submitter	2	26950798	2	26727930	578932	560559
NM_002246.2(KCNK3):c.575A>G (p.Tyr192Cys)	KCNK3	Primary pulmonary hypertension 4	Pathogenic(Last reviewed: Jul 25, 2013)	no assertion criteria provided	2	26950826	2	26727958	60483	75078
NM_002246.2(KCNK3):c.608G>A (p.Gly203Asp)	KCNK3	Primary pulmonary hypertension|Primary pulmonary hypertension 4	Pathogenic(Last reviewed: Jul 11, 2016)	no assertion criteria provided	2	26950859	2	26727991	60479	75074
NM_002246.2(KCNK3):c.646_651dup (p.Gln217_Pro218insThrGln)	KCNK3	Primary pulmonary hypertension 4	Uncertain significance(Last reviewed: May 4, 2018)	criteria provided, single submitter	2	26950897 - 26950902	2	26728029 - 26728034	580894	560561
NM_002246.2(KCNK3):c.654G>T (p.Pro218=)	KCNK3	Primary pulmonary hypertension 4	Benign(Last reviewed: Nov 13, 2017)	criteria provided, single submitter	2	26950905	2	26728037	474322	450696
NM_002246.2(KCNK3):c.661G>C (p.Val221Leu)	KCNK3	Primary pulmonary hypertension 4	Pathogenic(Last reviewed: Jul 25, 2013)	no assertion criteria provided	2	26950912	2	26728044	60481	75076
NM_002246.2(KCNK3):c.832A>T (p.Ser278Cys)	KCNK3	Primary pulmonary hypertension 4	Uncertain significance(Last reviewed: Sep 28, 2017)	criteria provided, single submitter	2	26951083	2	26728215	541325	518067
NM_002246.2(KCNK3):c.834C>A (p.Ser278Arg)	KCNK3	Primary pulmonary hypertension 4	Uncertain significance(Last reviewed: Jun 25, 2018)	criteria provided, single submitter	2	26951085	2	26728217	580390	557992
NM_002246.2(KCNK3):c.844A>G (p.Thr282Ala)	KCNK3	Primary pulmonary hypertension 4	Uncertain significance(Last reviewed: Mar 14, 2018)	criteria provided, single submitter	2	26951095	2	26728227	575685	560563
NM_002246.2(KCNK3):c.953G>A (p.Arg318His)	KCNK3	Primary pulmonary hypertension 4	Uncertain significance(Last reviewed: Mar 15, 2018)	criteria provided, single submitter	2	26951204	2	26728336	569441	558342
NM_002246.2(KCNK3):c.1014G>A (p.Thr338=)	KCNK3	Primary pulmonary hypertension 4	Likely benign(Last reviewed: Sep 27, 2017)	criteria provided, single submitter	2	26951265	2	26728397	541326	518148
NM_002246.2(KCNK3):c.1169G>A (p.Arg390His)	KCNK3	Primary pulmonary hypertension 4	Uncertain significance(Last reviewed: Jun 27, 2018)	criteria provided, single submitter	2	26951420	2	26728552	576185	560565
NM_002246.2(KCNK3):c.1180G>A (p.Val394Met)	KCNK3	Primary pulmonary hypertension 4	Uncertain significance(Last reviewed: Jul 28, 2017)	criteria provided, single submitter	2	26951431	2	26728563	474317	450789
NM_001002755.2(NFU1):c.622G>T (p.Gly208Cys)	NFU1	Multiple mitochondrial dysfunctions syndrome 1|not provided	Pathogenic(Last reviewed: Feb 16, 2016)	criteria provided, single submitter	2	69627594	2	69400462	30700	39657
NM_080916.2(DGUOK):c.137A>G (p.Asn46Ser)	DGUOK	Portal hypertension, noncirrhotic|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4|MITOCHONDRIAL DNA DEPLETION SYNDROME 3	Pathogenic/Likely pathogenic(Last reviewed: Aug 18, 2016)	no assertion criteria provided	2	74154174	2	73927047	253062	247473
NM_198843.2(SFTPB):c.501G>T (p.Gly167=)	SFTPB	Surfactant metabolism dysfunction, pulmonary, 1	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	2	85892846	2	85665723	13205	28244
NM_015929.3(LIPT1):c.212C>T (p.Ser71Phe)	LIPT1|MITD1	Lipoyltransferase 1 deficiency	Pathogenic(Last reviewed: Apr 1, 2014)	no assertion criteria provided	2	99778632	2	99162169	189835	187695
NM_173841.2(IL1RN):c.180T>C (p.Ala60=)	IL1RN	Osteomyelitis, sterile multifocal, with periostitis and pustulosis|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	113887207	2	113129630	330825	282295
NR_023343.1(RNU4ATAC):n.50G>A	CLASP1|RNU4ATAC	Osteodysplastic primordial dwarfism, type 1	Pathogenic(Last reviewed: Apr 8, 2011)	no assertion criteria provided	2	122288505	2	121530929	30184	39140
NM_003937.2(KYNU):c.563G>A (p.Arg188Gln)	KYNU	not provided	Uncertain significance(Last reviewed: Dec 1, 2011)	no assertion criteria provided	2	143715265	2	142957696	160356	170199
NM_016953.3(PDE11A):c.171delT (p.Thr58Profs)	PDE11A	Pigmented nodular adrenocortical disease, primary, 2|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jul 12, 2016)	criteria provided, conflicting interpretations	2	178936994	2	178072267	208602	205134
NM_001267550.2(TTN):c.57331C>T (p.Arg19111Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 22, 2015)	criteria provided, conflicting interpretations	2	179462478	2	178597751	47121	56286
NM_001256850.1(TTN):c.49243C>T (p.Arg16415Ter)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 7, 2017)	criteria provided, conflicting interpretations	2	179469738	2	178605011	202509	199221
NM_001256850.1(TTN):c.12991G>A (p.Glu4331Lys)	TTN	not specified|TTN-Related Disorders	Uncertain significance(Last reviewed: Sep 7, 2017)	criteria provided, single submitter	2	179604018	2	178739291	451528	443093
NM_001256850.1(TTN):c.9443G>A (p.Arg3148His)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|Familial hypertrophic cardiomyopathy 9|not specified|not provided	Uncertain significance(Last reviewed: Apr 2, 2018)	criteria provided, multiple submitters, no conflicts	2	179632514	2	178767787	96325	102219
NM_000090.3(COL3A1):c.203A>G (p.Asp68Gly)	COL3A1	Ehlers-Danlos syndrome, type 4|not specified|not provided	Uncertain significance(Last reviewed: Sep 22, 2017)	criteria provided, multiple submitters, no conflicts	2	189849609	2	188984883	199708	196764
NM_000393.4(COL5A2):c.315_316delCAinsCG (p.Asn106Asp)	COL5A2	Ehlers-Danlos syndrome, type 2|Ehlers-Danlos syndrome, classic type	not provided	no assertion provided	2	189974957 - 189974958	2	189110231 - 189110232	441116	434575
NM_007315.3(STAT1):c.979A>G (p.Thr327Ala)	STAT1	STAT1-Related Disorder	not provided	no assertion provided	2	191856012	2	190991286	440946	434576
NM_015265.3(SATB2):c.19dup (p.Ser7Lysfs)	SATB2	not provided|SATB2-Related Disorder	Pathogenic(Last reviewed: Sep 13, 2017)	criteria provided, single submitter	2	200320742	2	199456019	451780	443137
NC_000002.12:g.202249539_202474756del225218	BMPR2|NOP58|SNORD11|SNORD70|SNORD11B|SNORD70B	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203114262 - 203339479	2	202249539 - 202474756	425667	414069
NM_001204.6(BMPR2):c.-1114A>C	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203241084	2	202376361	333616	286645
NM_001204.6(BMPR2):c.-947_-946delGCinsAT	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203241251 - 203241252	2	202376528 - 202376529	425668	414070
NM_001204.6(BMPR2):c.-933G>A	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203241265	2	202376542	333619	283987
NM_001204.6(BMPR2):c.-930_-928delGGC	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203241268 - 203241270	2	202376545 - 202376547	333618	284756
NM_001204.6(BMPR2):c.-930_-928dupGGC	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203241268 - 203241270	2	202376545 - 202376547	333617	286646
NM_001204.6(BMPR2):c.-927A>G	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203241271	2	202376548	333622	284758
NM_001204.6(BMPR2):c.-927_-924delAGCAinsGGCGGCGGCGGCG	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203241271 - 203241274	2	202376548 - 202376551	333621	284761
NM_001204.6(BMPR2):c.-922C>T	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203241276	2	202376553	333623	284773
NM_001204.6(BMPR2):c.-921_-919dupAGC	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203241277 - 203241279	2	202376554 - 202376556	333620	284776
NM_001204.6(BMPR2):c.-871G>A	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203241327	2	202376604	333624	283993
NM_001204.6(BMPR2):c.-837G>T	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203241361	2	202376638	333625	287129
NM_001204.6(BMPR2):c.-753C>T	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203241445	2	202376722	333626	286647
NM_001204.6(BMPR2):c.-704C>G	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203241494	2	202376771	333627	286649
NM_001204.6(BMPR2):c.-702C>T	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203241496	2	202376773	333628	284780
NM_001204.6(BMPR2):c.-669G>A	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203241529	2	202376806	333629	286657
NM_001204.6(BMPR2):c.-594A>G	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203241604	2	202376881	333630	284000
NM_001204.6(BMPR2):c.-575A>T	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203241623	2	202376900	333631	284001
NM_001204.6(BMPR2):c.-407G>T	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203241791	2	202377068	333632	286658
NM_001204.6(BMPR2):c.-310A>G	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203241888	2	202377165	333633	286662
NM_001204.6(BMPR2):c.-301G>A	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203241897	2	202377174	333634	286663
NM_001204.6(BMPR2):c.-212dupC	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203241986	2	202377263	333635	286664
NM_001204.6(BMPR2):c.-93A>G	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203242105	2	202377382	333636	286666
NM_001204.6(BMPR2):c.-70G>T	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203242128	2	202377405	333637	284783
NM_001204.6(BMPR2):c.9dup (p.Ser4Leufs)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203242206	2	202377483	425676	414071
NM_001204.6(BMPR2):c.16_20delCAGCG (p.Q6Afs*30)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203242213 - 203242217	2	202377490 - 202377494	425677	414072
NM_001204.6(BMPR2):c.16C>T (p.Gln6Ter)	BMPR2	Primary pulmonary hypertension	Pathogenic(Last reviewed: Jul 11, 2016)	no assertion criteria provided	2	203242213	2	202377490	264650	259244
NM_001204.6(BMPR2):c.21_29delGCCCTGGCGinsA (p.Pro8Glyfs)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203242218 - 203242226	2	202377495 - 202377503	425679	414073
NM_001204.6(BMPR2):c.21delG (p.W9Gfs*38)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203242218	2	202377495	425678	414074
NM_001204.6(BMPR2):c.27G>A (p.W9*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203242224	2	202377501	425680	414075
NM_001204.6(BMPR2):c.28C>T (p.Arg10Trp)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203242225	2	202377502	425681	414076
NM_001204.6(BMPR2):c.38G>A (p.W13*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203242235	2	202377512	425682	414077
NM_001204.6(BMPR2):c.39G>A (p.W13*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203242236	2	202377513	425683	414078
NM_001204.6(BMPR2):c.44delC (p.Pro15Hisfs)	BMPR2	Primary pulmonary hypertension|Pulmonary venoocclusive disease 1	Pathogenic(Last reviewed: Mar 15, 2003)	no assertion criteria provided	2	203242241	2	202377518	8814	23853
NM_001204.6(BMPR2):c.47G>A (p.W16*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203242244	2	202377521	425684	414079
NM_001204.6(BMPR2):c.48G>A (p.W16*)	BMPR2	Primary pulmonary hypertension	Pathogenic(Last reviewed: Jun 27, 2017)	criteria provided, single submitter	2	203242245	2	202377522	425685	414080
NM_001204.6(BMPR2):c.51_814del (p.I18Hfs*25)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203242248 - 203383737	2	202377525 - 202519014	425686	414372
NM_001204.6(BMPR2):c.71C>A (p.Ala24Glu)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203242268	2	202377545	425687	414081
NM_001204.6(BMPR2):c.76+1G>T	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203242274	2	202377551	425688	414082
NM_001204.6(BMPR2):c.76+2T>C	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203242275	2	202377552	425689	414083
NM_001204.6(BMPR2):c.76+5G>A	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203242278	2	202377555	425690	414084
NM_001204.6(BMPR2):c.77-35_86del	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203329497 - 203329541	2	202464774 - 202464818	425691	414085
NM_001204.6(BMPR2):c.77-1G>A (p.A26Efs*9)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203329531	2	202464808	425692	414086
NM_001204.6(BMPR2):c.82C>T (p.Q28*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203329537	2	202464814	425699	414087
NM_001204.6(BMPR2):c.86A>G (p.Asn29Ser)	BMPR2	Primary pulmonary hypertension	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	203329541	2	202464818	333638	287145
NM_001204.6(BMPR2):c.88C>T (p.Q30*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203329543	2	202464820	425700	414088
NM_001204.6(BMPR2):c.91G>T (p.E31*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203329546	2	202464823	425701	414089
NM_001204.6(BMPR2):c.100T>C (p.Cys34Arg)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203329555	2	202464832	425702	414090
NM_001204.6(BMPR2):c.103delG (p.A35Rfs*12)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203329558	2	202464835	425703	414091
NM_001204.6(BMPR2):c.116delC (p.P39Rfs*8)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203329571	2	202464848	425704	414092
NM_001204.6(BMPR2):c.120T>G (p.Tyr40Ter)	BMPR2	Pulmonary venoocclusive disease 1	Pathogenic(Last reviewed: Feb 1, 2006)	no assertion criteria provided	2	203329575	2	202464852	8815	23854
NM_001204.6(BMPR2):c.124C>T (p.Q42*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203329579	2	202464856	425705	414093
NM_001204.6(BMPR2):c.125A>G (p.Gln42Arg)	BMPR2	Pulmonary arterial hypertension associated with congenital heart disease	Pathogenic	no assertion criteria provided	2	203329580	2	202464857	425706	414094
NM_001204.6(BMPR2):c.140G>A (p.Gly47Asp)	BMPR2	Pulmonary arterial hypertension associated with congenital heart disease	Pathogenic	no assertion criteria provided	2	203329595	2	202464872	425707	414095
NM_001204.6(BMPR2):c.156_157delTC (p.H53*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203329611 - 203329612	2	202464888 - 202464889	425708	414096
NM_001204.6(BMPR2):c.168delG (p.T57Qfs*21)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203329623	2	202464900	425709	414097
NM_001204.6(BMPR2):c.174_175dup (p.Leu59Tyrfs)	BMPR2	Primary pulmonary hypertension	Pathogenic(Last reviewed: Jul 11, 2016)	no assertion criteria provided	2	203329629 - 203329630	2	202464906 - 202464907	264655	259245
NM_001204.6(BMPR2):c.178T>G (p.Cys60Gly)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203329633	2	202464910	425711	414099
NM_001204.6(BMPR2):c.178T>C (p.Cys60Arg)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203329633	2	202464910	425710	414098
NM_001204.6(BMPR2):c.179G>A (p.Cys60Tyr)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203329634	2	202464911	425712	414100
NM_001204.6(BMPR2):c.186_187insTACC (p.G63Yfs*3)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203329641 - 203329642	2	202464918 - 202464919	425713	414101
NM_001204.6(BMPR2):c.189_209del21 (p.Ser64_Trp70del)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203329644 - 203329664	2	202464921 - 202464941	425715	414103
NM_001204.6(BMPR2):c.189_207del19insGGAGCATAATCAAA (p.Ser64Glufs)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203329644 - 203329662	2	202464921 - 202464939	425714	414102
NM_001204.6(BMPR2):c.196T>G (p.Cys66Gly)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203329651	2	202464928	425717	414105
NM_001204.6(BMPR2):c.196T>C (p.Cys66Arg)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203329651	2	202464928	425716	414104
NM_001204.6(BMPR2):c.197G>A (p.Cys66Tyr)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203329652	2	202464929	425718	414106
NM_001204.6(BMPR2):c.200dup (p.Tyr67Terfs)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203329655	2	202464932	425720	414108
NM_001204.6(BMPR2):c.200A>G (p.Tyr67Cys)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203329655	2	202464932	425719	414107
NM_001204.6(BMPR2):c.201T>G (p.Y67*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203329656	2	202464933	425721	414109
NM_001204.6(BMPR2):c.203G>A (p.Gly68Asp)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203329658	2	202464935	425722	414110
NM_001204.6(BMPR2):c.211G>A (p.Glu71Lys)	BMPR2	Pulmonary arterial hypertension associated with congenital heart disease	Uncertain significance(Last reviewed: Jun 27, 2018)	criteria provided, single submitter	2	203329666	2	202464943	548688	539168
NM_001204.6(BMPR2):c.218C>G (p.Ser73Ter)	BMPR2	Primary pulmonary hypertension	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	2	203329673	2	202464950	8797	23836
NM_001204.6(BMPR2):c.236_238delTTGinsAAAAGGGGACA (p.Leu79Glnfs)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203329691 - 203329693	2	202464968 - 202464970	425723	414111
NM_001204.6(BMPR2):c.237delT (p.V80*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203329692	2	202464969	425724	414112
NM_001204.6(BMPR2):c.240_241insT (p.Lys81Terfs)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203329695 - 203329696	2	202464972 - 202464973	425725	414428
NM_001204.6(BMPR2):c.244C>T (p.Q82*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203329699	2	202464976	425726	414113
NM_001204.6(BMPR2):c.246dup (p.Gly83Argfs)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203329701	2	202464978	425728	414115
NM_001204.6(BMPR2):c.246A>C (p.Gln82His)	BMPR2	Pulmonary hypertension, primary, dexfenfluramine-associated	Pathogenic	no assertion criteria provided	2	203329701	2	202464978	425727	414114
NM_001204.6(BMPR2):c.247G>A (p.Gly83Arg)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203329702	2	202464979	425729	414116
NM_001204.6(BMPR2):c.247+1_247+7delGCAAGTG	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203329703 - 203329709	2	202464980 - 202464986	425731	414118
NM_001204.6(BMPR2):c.247+1G>A	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203329703	2	202464980	425730	414117
NM_001204.6(BMPR2):c.247+2delC (p.G47_Q82del,G63_Q82del)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203329704	2	202464981	425732	414119
NM_001204.6(BMPR2):c.247+6T>G (p.G47_Q82del,G63_Q82del)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203329708	2	202464985	425733	414120
NM_001204.6(BMPR2):c.248-592_413delinsGTAAAGTA	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203331650 - 203332407	2	202466927 - 202467684	425734	414121
NM_001204.6(BMPR2):c.248-5_248delinsAC	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203332237 - 203332242	2	202467514 - 202467519	425735	414122
NM_001204.6(BMPR2):c.248-3T>G	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203332239	2	202467516	425736	414123
NM_001204.6(BMPR2):c.248-2A>G	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203332240	2	202467517	425737	414124
NM_001204.6(BMPR2):c.248-1G>A	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203332241	2	202467518	425738	414125
NM_001204.6(BMPR2):c.248G>A (p.Gly83Glu)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203332242	2	202467519	425741	414126
NM_001204.6(BMPR2):c.250T>G (p.Cys84Gly)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203332244	2	202467521	425743	414128
NM_001204.6(BMPR2):c.250T>C (p.Cys84Arg)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203332244	2	202467521	425742	414127
NM_001204.6(BMPR2):c.251G>T (p.Cys84Phe)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203332245	2	202467522	425744	414129
NM_001204.6(BMPR2):c.255G>A (p.W85*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203332249	2	202467526	425745	414130
NM_001204.6(BMPR2):c.260dup (p.His87Glnfs)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203332254	2	202467531	425746	414131
NM_001204.6(BMPR2):c.266G>C (p.Gly89Ala)	BMPR2	Primary pulmonary hypertension	Uncertain significance	no assertion criteria provided	2	203332260	2	202467537	425747	414132
NM_001204.6(BMPR2):c.274C>T (p.Q92*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203332268	2	202467545	425748	414133
NM_001204.6(BMPR2):c.276A>C (p.Gln92His)	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Mar 18, 2016)	criteria provided, single submitter	2	203332270	2	202467547	225305	227232
NM_001204.6(BMPR2):c.277dup (p.Glu93Glyfs)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203332271	2	202467548	425749	414134
NM_001204.6(BMPR2):c.280T>G (p.Cys94Gly)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203332274	2	202467551	425751	414136
NM_001204.6(BMPR2):c.280T>C (p.Cys94Arg)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203332274	2	202467551	425750	414135
NM_001204.6(BMPR2):c.292G>T (p.E98*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203332286	2	202467563	425753	414138
NM_001204.6(BMPR2):c.292G>A (p.Glu98Lys)	BMPR2	Primary pulmonary hypertension	Uncertain significance	no assertion criteria provided	2	203332286	2	202467563	425752	414137
NM_001204.6(BMPR2):c.295T>C (p.Cys99Arg)	BMPR2	Primary pulmonary hypertension|not provided	Pathogenic(Last reviewed: Oct 9, 2014)	criteria provided, single submitter	2	203332289	2	202467566	212816	209584
NM_001204.6(BMPR2):c.296G>T (p.Cys99Phe)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203332290	2	202467567	425755	414140
NM_001204.6(BMPR2):c.296G>A (p.Cys99Tyr)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203332290	2	202467567	425754	414139
NM_001204.6(BMPR2):c.304A>G (p.Thr102Ala)	BMPR2	Pulmonary arterial hypertension associated with congenital heart disease	Pathogenic	no assertion criteria provided	2	203332298	2	202467575	425756	414141
NM_001204.6(BMPR2):c.319T>C (p.Ser107Pro)	BMPR2	Pulmonary arterial hypertension associated with congenital heart disease	Pathogenic	no assertion criteria provided	2	203332313	2	202467590	425757	414142
NM_001204.6(BMPR2):c.320C>G (p.S107*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203332314	2	202467591	425758	414143
NM_001204.6(BMPR2):c.338dup (p.Tyr113Terfs)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203332332	2	202467609	425760	414145
NM_001204.6(BMPR2):c.338A>G (p.Tyr113Cys)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203332332	2	202467609	425759	414144
NM_001204.6(BMPR2):c.339_340insAA (p.R114Nfs*39)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203332333 - 203332334	2	202467610 - 202467611	425763	414148
NM_001204.6(BMPR2):c.339C>G (p.Y113*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203332333	2	202467610	425762	414147
NM_001204.6(BMPR2):c.339C>A (p.Y113*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203332333	2	202467610	425761	414146
NM_001204.6(BMPR2):c.340C>T (p.Arg114Cys)	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jul 19, 2017)	criteria provided, single submitter	2	203332334	2	202467611	458627	450514
NM_001204.6(BMPR2):c.345_346delCT (p.F115Lfs*4)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203332339 - 203332340	2	202467616 - 202467617	425764	414149
NM_001204.6(BMPR2):c.349T>C (p.Cys117Arg)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203332343	2	202467620	425765	414150
NM_001204.6(BMPR2):c.350G>C (p.Cys117Ser)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203332344	2	202467621	425767	414152
NM_001204.6(BMPR2):c.350G>A (p.Cys117Tyr)	BMPR2	Primary pulmonary hypertension|not specified	Pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, single submitter	2	203332344	2	202467621	425766	414151
NM_001204.6(BMPR2):c.353delG (p.C118Lfs*34)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203332347	2	202467624	425769	414154
NM_001204.6(BMPR2):c.353G>A (p.Cys118Tyr)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203332347	2	202467624	425768	414153
NM_001204.6(BMPR2):c.354_355delTAinsAG (p.Cys118Ter)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203332348 - 203332349	2	202467625 - 202467626	425770	414429
NM_001204.6(BMPR2):c.354T>G (p.Cys118Trp)	BMPR2	Primary pulmonary hypertension	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	2	203332348	2	202467625	8799	23838
NM_001204.6(BMPR2):c.355delA (p.S119Afs*33)	BMPR2	Primary pulmonary hypertension	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	2	203332349	2	202467626	425771	414155
NM_001204.6(BMPR2):c.359_360delCA (p.T120Rfs*4)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203332353 - 203332354	2	202467630 - 202467631	425772	414156
NM_001204.6(BMPR2):c.367T>A (p.Cys123Ser)	BMPR2	Primary pulmonary hypertension	Pathogenic(Last reviewed: Jan 1, 2001)	no assertion criteria provided	2	203332361	2	202467638	8809	23848
NM_001204.6(BMPR2):c.367T>C (p.Cys123Arg)	BMPR2	Primary pulmonary hypertension	Pathogenic(Last reviewed: Jan 1, 2001)	no assertion criteria provided	2	203332361	2	202467638	8808	23847
NM_001204.6(BMPR2):c.370A>G (p.Asn124Asp)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203332364	2	202467641	425773	414157
NM_001204.6(BMPR2):c.371dup (p.Asn124Lysfs)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203332365	2	202467642	425774	414158
NM_001204.6(BMPR2):c.377A>G (p.Asn126Ser)	BMPR2	Primary pulmonary hypertension|not provided	Pathogenic(Last reviewed: Sep 3, 2014)	criteria provided, single submitter	2	203332371	2	202467648	212817	209585
NM_001204.6(BMPR2):c.399delT (p.P134Lfs*18)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203332393	2	202467670	425775	414159
NM_001204.6(BMPR2):c.407_408delCA (p.T136Nfs*10)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203332401 - 203332402	2	202467678 - 202467679	425776	414160
NM_001204.6(BMPR2):c.408_412delAACAC (p.P138Qfs*7)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203332402 - 203332406	2	202467679 - 202467683	425777	414161
NM_001204.6(BMPR2):c.418+1G>C	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203332413	2	202467690	425778	414162
NM_001204.6(BMPR2):c.418+2_418+4delinsGAG	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203332414 - 203332416	2	202467691 - 202467693	425779	414163
NM_001204.6(BMPR2):c.418+3A>T	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203332415	2	202467692	425780	414164
NM_001204.6(BMPR2):c.418+5_418+8delGTAA (p.C84_S140del)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203332417 - 203332420	2	202467694 - 202467697	425782	414166
NM_001204.6(BMPR2):c.418+5G>A	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203332417	2	202467694	425781	414165
NM_001204.6(BMPR2):c.419-43delT	BMPR2	Pulmonary arterial hypertension associated with congenital heart disease	Uncertain significance(Last reviewed: Jun 27, 2018)	criteria provided, single submitter	2	203378399	2	202513676	548685	539169
NM_001204.6(BMPR2):c.419-10T>C	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203378432	2	202513709	425783	414167
NM_001204.6(BMPR2):c.420_421insG (p.P141Afs*6)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203378443 - 203378444	2	202513720 - 202513721	425790	414168
NM_001204.6(BMPR2):c.435delT (p.F145Lfs*7)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203378458	2	202513735	425791	414169
NM_001204.6(BMPR2):c.439C>T (p.Arg147Ter)	BMPR2	Primary pulmonary hypertension|not provided	Pathogenic(Last reviewed: Aug 31, 2015)	criteria provided, multiple submitters, no conflicts	2	203378462	2	202513739	222513	224249
NM_001204.6(BMPR2):c.449dup (p.Ile151Asnfs)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203378472	2	202513749	425792	414170
NM_001204.6(BMPR2):c.461C>G (p.Ala154Gly)	BMPR2	Primary pulmonary hypertension	Uncertain significance	no assertion criteria provided	2	203378484	2	202513761	425793	414171
NM_001204.6(BMPR2):c.482T>A (p.L161*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203378505	2	202513782	425794	414172
NM_001204.6(BMPR2):c.498delT (p.A167Pfs*9)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203378521	2	202513798	425795	414173
NM_001204.6(BMPR2):c.503dup (p.Leu168Phefs)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203378526	2	202513803	425796	414174
NM_001204.6(BMPR2):c.507_510delCTTTinsAAA (p.Cys169Terfs)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203378530 - 203378533	2	202513807 - 202513810	425797	414430
NM_001204.6(BMPR2):c.507C>A (p.Cys169Ter)	BMPR2	Primary pulmonary hypertension	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	2	203378530	2	202513807	8804	23843
NM_001204.6(BMPR2):c.516C>G (p.Y172*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203378539	2	202513816	425798	414175
NM_001204.6(BMPR2):c.528delA (p.G177Efs*10)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203378551	2	202513828	425799	414176
NM_001204.6(BMPR2):c.529+1G>A	BMPR2	Pulmonary arterial hypertension associated with congenital heart disease	Likely pathogenic(Last reviewed: Jun 27, 2018)	criteria provided, single submitter	2	203378553	2	202513830	548686	539170
NM_001204.6(BMPR2):c.529+2T>C	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203378554	2	202513831	425800	414177
NM_001204.6(BMPR2):c.541C>T (p.Q181*)	BMPR2	Primary pulmonary hypertension|not provided	Pathogenic(Last reviewed: Aug 31, 2015)	criteria provided, single submitter	2	203379622	2	202514899	425803	414178
NM_001204.6(BMPR2):c.545G>A (p.Gly182Asp)	BMPR2	Pulmonary hypertension, primary, fenfluramine-associated|not specified	Uncertain significance(Last reviewed: Sep 29, 2016)	criteria provided, single submitter	2	203379626	2	202514903	8813	23852
NM_001204.6(BMPR2):c.551_573del23 (p.His184Argfs)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203379632 - 203379654	2	202514909 - 202514931	425804	414179
NM_001204.6(BMPR2):c.556A>G (p.Met186Val)	BMPR2	Pulmonary arterial hypertension associated with congenital heart disease	Pathogenic	no assertion criteria provided	2	203379637	2	202514914	425805	414180
NM_001204.6(BMPR2):c.583G>T (p.Glu195Ter)	BMPR2	Pulmonary venoocclusive disease 1	Pathogenic(Last reviewed: Jul 1, 2008)	no assertion criteria provided	2	203379664	2	202514941	39423	48022
NM_001204.6(BMPR2):c.600A>C (p.Leu200=)	BMPR2	Primary pulmonary hypertension|not specified	Benign/Likely benign(Last reviewed: Aug 7, 2017)	criteria provided, multiple submitters, no conflicts	2	203379681	2	202514958	162791	173629
NM_001204.6(BMPR2):c.604A>T (p.Asn202Tyr)	BMPR2	Pulmonary venoocclusive disease 1	Pathogenic(Last reviewed: Jul 1, 2008)	no assertion criteria provided	2	203379685	2	202514962	39422	48021
NM_001204.6(BMPR2):c.608_609delTG (p.L203Qfs*16)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203379689 - 203379690	2	202514966 - 202514967	425806	414181
NM_001204.6(BMPR2):c.612delA (p.K204Nfs*5)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203379693	2	202514970	425807	414182
NM_001204.6(BMPR2):c.621+1G>T	BMPR2	Primary pulmonary hypertension	Likely pathogenic(Last reviewed: May 27, 2017)	criteria provided, single submitter	2	203379703	2	202514980	458628	450397
NM_001204.6(BMPR2):c.621+8T>C	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203379710	2	202514987	333639	284784
NM_001204.6(BMPR2):c.631C>T (p.Arg211Ter)	BMPR2	Primary pulmonary hypertension|Pulmonary hypertension, primary, dexfenfluramine-associated|not provided	Pathogenic(Last reviewed: Mar 3, 2017)	criteria provided, multiple submitters, no conflicts	2	203383554	2	202518831	8812	23851
NM_001204.6(BMPR2):c.637C>T (p.Arg213Ter)	BMPR2	Primary pulmonary hypertension|not provided	Pathogenic(Last reviewed: Jun 7, 2016)	criteria provided, single submitter	2	203383560	2	202518837	280019	264058
NM_001204.6(BMPR2):c.642T>G (p.Y214*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203383565	2	202518842	425810	414183
NM_001204.6(BMPR2):c.659dup (p.Ser221Leufs)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203383582	2	202518859	425811	414184
NM_001204.6(BMPR2):c.664_665delTTinsAAGG (p.Leu222Lysfs)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203383587 - 203383588	2	202518864 - 202518865	425812	414185
NM_001204.6(BMPR2):c.673C>T (p.Arg225Cys)	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	2	203383596	2	202518873	528332	517635
NM_001204.6(BMPR2):c.673_679delCGTCCAG (p.R225Lfs*3)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203383596 - 203383602	2	202518873 - 202518879	425813	414186
NM_001204.6(BMPR2):c.674G>A (p.Arg225His)	BMPR2	Primary pulmonary hypertension	Benign/Likely benign(Last reviewed: Jun 30, 2017)	criteria provided, multiple submitters, no conflicts	2	203383597	2	202518874	333640	284788
NM_001204.6(BMPR2):c.689_690delAA (p.K230Sfs*25)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203383612 - 203383613	2	202518889 - 202518890	425814	414187
NM_001204.6(BMPR2):c.690_691delAGinsT (p.Lys230Asnfs)	BMPR2	Primary pulmonary hypertension	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	2	203383613 - 203383614	2	202518890 - 202518891	425816	414189
NM_001204.6(BMPR2):c.690A>T (p.Lys230Asn)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203383613	2	202518890	425815	414188
NM_001204.6(BMPR2):c.708C>T (p.Asn236=)	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203383631	2	202518908	333641	287146
NM_001204.6(BMPR2):c.727G>T (p.E243*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203383650	2	202518927	425819	414192
NM_001204.6(BMPR2):c.727G>C (p.Glu243Gln)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203383650	2	202518927	425818	414191
NM_001204.6(BMPR2):c.727G>A (p.Glu243Lys)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203383650	2	202518927	425817	414190
NM_001204.6(BMPR2):c.775delC (p.R259Afs*3)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203383698	2	202518975	425820	414193
NM_001204.6(BMPR2):c.782_783delTA (p.I261Sfs*4)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203383705 - 203383706	2	202518982 - 202518983	425821	414194
NM_001204.6(BMPR2):c.786dup (p.Gly263Trpfs)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203383709	2	202518986	425822	414195
NM_001204.6(BMPR2):c.790delG (p.D264Mfs*15)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203383713	2	202518990	425823	414196
NM_001204.6(BMPR2):c.794A>G (p.Glu265Gly)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203383717	2	202518994	425824	414197
NM_001204.6(BMPR2):c.795_796delGAinsTT (p.Glu265_Arg266delinsAspTer)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203383718 - 203383719	2	202518995 - 202518996	425825	414198
NM_001204.6(BMPR2):c.796_799delAGAG (p.R266Sfs*12)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203383719 - 203383722	2	202518996 - 202518999	425826	414199
NM_001204.6(BMPR2):c.797G>C (p.Arg266Thr)	BMPR2	Primary pulmonary hypertension|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 16, 2017)	criteria provided, conflicting interpretations	2	203383720	2	202518997	212810	209586
NM_001204.6(BMPR2):c.802dup (p.Thr268Asnfs)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203383725	2	202519002	425827	414200
NM_001204.6(BMPR2):c.804delT (p.A269Qfs*10)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203383727	2	202519004	425828	414201
NM_001204.6(BMPR2):c.818T>G (p.Met273Arg)	BMPR2	Primary pulmonary hypertension	Uncertain significance	no assertion criteria provided	2	203383741	2	202519018	425829	414202
NM_001204.6(BMPR2):c.830T>C (p.Leu277Pro)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203383753	2	202519030	425830	414203
NM_001204.6(BMPR2):c.852+1G>C	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203383776	2	202519053	425832	414205
NM_001204.6(BMPR2):c.852+1G>A	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203383776	2	202519053	425831	414204
NM_001204.6(BMPR2):c.853-2A>G	BMPR2	Primary pulmonary hypertension|not provided	Pathogenic(Last reviewed: Jun 4, 2015)	criteria provided, single submitter	2	203384808	2	202520085	212815	209588
NM_001204.6(BMPR2):c.853-1G>C	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203384809	2	202520086	425834	414207
NM_001204.6(BMPR2):c.853-1G>A	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203384809	2	202520086	425833	414206
NM_001204.6(BMPR2):c.855delA (p.S286Lfs*6)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203384812	2	202520089	425836	414208
NM_001204.6(BMPR2):c.860T>A (p.L287*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203384817	2	202520094	425837	414209
NM_001204.6(BMPR2):c.872delT (p.L291*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203384829	2	202520106	425839	414211
NM_001204.6(BMPR2):c.872T>G (p.L291*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203384829	2	202520106	425838	414210
NM_001204.6(BMPR2):c.893G>A (p.W298*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203384850	2	202520127	425840	414212
NM_001204.6(BMPR2):c.894_895dup (p.Val299Glyfs)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203384851 - 203384852	2	202520128 - 202520129	425841	414213
NM_001204.6(BMPR2):c.901T>C (p.Ser301Pro)	BMPR2	Primary pulmonary hypertension|not specified	Uncertain significance(Last reviewed: Sep 30, 2015)	criteria provided, single submitter	2	203384858	2	202520135	228460	228911
NM_001204.6(BMPR2):c.908G>A (p.Arg303His)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203384865	2	202520142	425842	414214
NM_001204.6(BMPR2):c.928A>T (p.R310*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203384885	2	202520162	425843	414215
NM_001204.6(BMPR2):c.932G>A (p.Gly311Glu)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203384889	2	202520166	425844	414216
NM_001204.6(BMPR2):c.937G>C (p.Ala313Pro)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203384894	2	202520171	425845	414217
NM_001204.6(BMPR2):c.954A>C (p.Glu318Asp)	BMPR2	Primary pulmonary hypertension	Uncertain significance	no assertion criteria provided	2	203384911	2	202520188	425846	414218
NM_001204.6(BMPR2):c.961delC (p.R321Efs*14)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203384918	2	202520195	425847	414219
NM_001204.6(BMPR2):c.961C>T (p.Arg321Ter)	BMPR2	Primary pulmonary hypertension	Pathogenic(Last reviewed: Aug 30, 2016)	criteria provided, single submitter	2	203384918	2	202520195	409826	392462
NM_001204.6(BMPR2):c.967+2T>C	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203384926	2	202520203	425848	414220
NM_001204.6(BMPR2):c.967+4delA (p.G285Ifs*12)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203384928	2	202520205	425849	414221
NM_001204.6(BMPR2):c.967+5G>T	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203384929	2	202520206	425851	414223
NM_001204.6(BMPR2):c.967+5G>C	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203384929	2	202520206	425850	414222
NM_001204.6(BMPR2):c.968-5A>G	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Apr 17, 2016)	criteria provided, single submitter	2	203395512	2	202530789	409829	392465
NM_001204.6(BMPR2):c.968-3C>G	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203395514	2	202530791	425852	414224
NM_001204.6(BMPR2):c.968-2A>C	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203395515	2	202530792	425853	414225
NM_001204.6(BMPR2):c.968-1G>T	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203395516	2	202530793	425854	414226
NM_001204.6(BMPR2):c.969dup (p.His324Serfs)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203395518	2	202530795	425858	414227
NM_001204.6(BMPR2):c.980delC (p.P327Lfs*8)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203395529	2	202530806	425859	414228
NM_001204.6(BMPR2):c.992A>G (p.His331Arg)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203395541	2	202530818	425860	414229
NM_001204.6(BMPR2):c.994C>T (p.Arg332Ter)	BMPR2	Primary pulmonary hypertension|not provided	Pathogenic(Last reviewed: May 24, 2017)	criteria provided, single submitter	2	203395543	2	202530820	8810	23849
NM_001204.6(BMPR2):c.1001T>G (p.L334*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203395550	2	202530827	425861	414230
NM_001204.6(BMPR2):c.1011_1015delAAATG (p.R337Sfs*6)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203395560 - 203395564	2	202530837 - 202530841	425862	414231
NM_001204.6(BMPR2):c.1016T>A (p.Val339Asp)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203395565	2	202530842	425863	414232
NM_001204.6(BMPR2):c.1019T>C (p.Leu340Pro)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203395568	2	202530845	425864	414233
NM_001204.6(BMPR2):c.1039T>C (p.Cys347Arg)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203395588	2	202530865	425865	414234
NM_001204.6(BMPR2):c.1040G>A (p.Cys347Tyr)	BMPR2	Primary pulmonary hypertension	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	2	203395589	2	202530866	8800	23839
NM_001204.6(BMPR2):c.1042G>A (p.Val348Ile)	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203395591	2	202530868	333642	284004
NM_001204.6(BMPR2):c.1044delT (p.I349Lfs*8)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203395593	2	202530870	425866	414235
NM_001204.6(BMPR2):c.1060delC (p.L354Cfs*3)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203395609	2	202530886	425867	414236
NM_001204.6(BMPR2):c.1066A>T (p.Met356Leu)	BMPR2	Primary pulmonary hypertension	Uncertain significance	no assertion criteria provided	2	203395615	2	202530892	425868	414237
NM_001204.6(BMPR2):c.1076delC (p.T359Mfs*16)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203395625	2	202530902	425869	414238
NM_001204.6(BMPR2):c.1093_1098delCGCCCAinsG (p.Arg365Glyfs)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203395642 - 203395647	2	202530919 - 202530924	425870	414239
NM_001204.6(BMPR2):c.1097delC (p.P366Qfs*9)	BMPR2	Primary pulmonary hypertension|not provided	Pathogenic(Last reviewed: Sep 1, 2015)	criteria provided, single submitter	2	203395646	2	202530923	425871	414240
NM_001204.6(BMPR2):c.1101_1105delGGAGG (p.E368Rfs*2)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203395650 - 203395654	2	202530927 - 202530931	425872	414241
NM_001204.6(BMPR2):c.1113dup (p.Ala372Cysfs)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203395662	2	202530939	425873	414242
NM_001204.6(BMPR2):c.1117G>C (p.Ala373Pro)	BMPR2	Primary pulmonary hypertension	Uncertain significance	no assertion criteria provided	2	203395666	2	202530943	425874	414243
NM_001204.6(BMPR2):c.1125_1128+16del	BMPR2	Primary pulmonary hypertension	Pathogenic(Last reviewed: Nov 19, 2015)	criteria provided, single submitter	2	203395674 - 203395693	2	202530951 - 202530970	238628	238597
NM_001204.6(BMPR2):c.1126G>T (p.E376*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203395675	2	202530952	425876	414245
NM_001204.6(BMPR2):c.1128+1G>T	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203395678	2	202530955	425877	414246
NM_001204.6(BMPR2):c.1128+1G>A	BMPR2	Primary pulmonary hypertension|not provided	Pathogenic(Last reviewed: May 18, 2018)	criteria provided, multiple submitters, no conflicts	2	203395678	2	202530955	212811	209589
NM_001204.6(BMPR2):c.1129-3C>G	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203397305	2	202532582	425878	414247
NM_001204.6(BMPR2):c.1129-1_1129dupGG (p.V377Gfs*13)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203397307 - 203397308	2	202532584 - 202532585	425879	414431
NM_001204.6(BMPR2):c.1141dup (p.Arg381Lysfs)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203397320	2	202532597	425880	414248
NM_001204.6(BMPR2):c.1142_1143dup (p.Tyr382Aspfs)	BMPR2	Primary pulmonary hypertension	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	2	203397321 - 203397322	2	202532598 - 202532599	528331	517786
NM_001204.6(BMPR2):c.1146T>G (p.Y382*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203397325	2	202532602	425881	414249
NM_001204.6(BMPR2):c.1148delT (p.Met383Argfs)	BMPR2	Primary pulmonary hypertension	Pathogenic(Last reviewed: Feb 4, 2017)	criteria provided, single submitter	2	203397327	2	202532604	458623	450259
NM_001204.6(BMPR2):c.1151C>T (p.Ala384Val)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203397330	2	202532607	425882	414250
NM_001204.6(BMPR2):c.1156G>C (p.Glu386Gln)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203397335	2	202532612	425884	414252
NM_001204.6(BMPR2):c.1156G>A (p.Glu386Lys)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203397335	2	202532612	425883	414251
NM_001204.6(BMPR2):c.1157A>T (p.Glu386Val)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203397336	2	202532613	425887	414255
NM_001204.6(BMPR2):c.1157A>G (p.Glu386Gly)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203397336	2	202532613	425886	414254
NM_001204.6(BMPR2):c.1157A>C (p.Glu386Ala)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203397336	2	202532613	425885	414253
NM_001204.6(BMPR2):c.1171G>A (p.Ala391Thr)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203397350	2	202532627	425888	414256
NM_001204.6(BMPR2):c.1175T>C (p.Val392Ala)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203397354	2	202532631	425889	414257
NM_001204.6(BMPR2):c.1191_1192delTG (p.Cys397Terfs)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203397370 - 203397371	2	202532647 - 202532648	425890	414432
NM_001204.6(BMPR2):c.1196C>G (p.S399*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203397375	2	202532652	425891	414258
NM_001204.6(BMPR2):c.1202T>C (p.Leu401Ser)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203397381	2	202532658	425892	414259
NM_001204.6(BMPR2):c.1207C>T (p.Q403*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203397386	2	202532663	425893	414260
NM_001204.6(BMPR2):c.1214delA (p.D405Afs*7)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203397393	2	202532670	425894	414261
NM_001204.6(BMPR2):c.1220A>C (p.Tyr407Ser)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203397399	2	202532676	425895	414262
NM_001204.6(BMPR2):c.1221T>G (p.Y407*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203397400	2	202532677	425896	414263
NM_001204.6(BMPR2):c.1228G>A (p.Gly410Arg)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203397407	2	202532684	425897	414264
NM_001204.6(BMPR2):c.1241G>A (p.W414*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203397420	2	202532697	425898	414265
NM_001204.6(BMPR2):c.1243G>T (p.E415*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203397422	2	202532699	425899	414266
NM_001204.6(BMPR2):c.1245_1246dup (p.Ile416Argfs)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203397424 - 203397425	2	202532701 - 202532702	425900	414267
NM_001204.6(BMPR2):c.1246_1247insG (p.I416Sfs*32)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203397425 - 203397426	2	202532702 - 202532703	425901	414268
NM_001204.6(BMPR2):c.1247_1250delTATTinsGA (p.Ile416Argfs)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203397426 - 203397429	2	202532703 - 202532706	425902	414269
NM_001204.6(BMPR2):c.1248delA (p.F417Lfs*2)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203397427	2	202532704	425903	414270
NM_001204.6(BMPR2):c.1250_1253delTTAT (p.F417*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203397429 - 203397432	2	202532706 - 202532709	425904	414271
NM_001204.6(BMPR2):c.1257A>T (p.Arg419Ser)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203397436	2	202532713	425905	414272
NM_001204.6(BMPR2):c.1258T>C (p.Cys420Arg)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203397437	2	202532714	425906	414273
NM_001204.6(BMPR2):c.1259G>A (p.Cys420Tyr)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203397438	2	202532715	425907	414274
NM_001204.6(BMPR2):c.1268dup (p.Phe424Leufs)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203397447	2	202532724	425908	414275
NG_009363.1:g.161401_170985del9585insAGA	BMPR2	Pulmonary arterial hypertension associated with congenital heart disease	Likely pathogenic(Last reviewed: Jun 27, 2018)	criteria provided, single submitter	2	203397450 - 203407034	2	202532727 - 202542311	548926	539413
NM_001204.6(BMPR2):c.1271_1276delTCCCAGinsCGGAGA (p.Phe424_Gly426delinsSerGluArg)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203397450 - 203397455	2	202532727 - 202532732	425909	414276
NM_001204.6(BMPR2):c.1274dup (p.Gly426Argfs)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203397453	2	202532730	425910	414277
NM_001204.6(BMPR2):c.1276G>A (p.Gly426Arg)	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: May 10, 2017)	criteria provided, single submitter	2	203397455	2	202532732	458625	450264
NM_001204.6(BMPR2):c.1276G>C (p.Gly426Arg)	BMPR2	Primary pulmonary hypertension	Likely pathogenic(Last reviewed: Sep 8, 2015)	criteria provided, single submitter	2	203397455	2	202532732	222514	224250
NM_001204.6(BMPR2):c.1276+1G>A	BMPR2	Primary pulmonary hypertension|Pulmonary arterial hypertension associated with congenital heart disease	Likely pathogenic(Last reviewed: Jun 27, 2018)	criteria provided, single submitter	2	203397456	2	202532733	425911	414278
NM_001204.6(BMPR2):c.1276+3A>T	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203397458	2	202532735	425913	414280
NM_001204.6(BMPR2):c.1276+3A>G	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203397458	2	202532735	425912	414279
NM_001204.6(BMPR2):c.1276+4A>G	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203397459	2	202532736	425914	414281
NM_001204.6(BMPR2):c.1277-289_1413+4737del	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203406745 - 203411907	2	202542022 - 202547184	425915	414282
NM_001204.6(BMPR2):c.1277-10_1277-9insGGG	BMPR2	Primary pulmonary hypertension	Pathogenic(Last reviewed: Jul 11, 2016)	no assertion criteria provided	2	203407024 - 203407025	2	202542301 - 202542302	264651	259246
NM_001204.6(BMPR2):c.1277-9A>G	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203407025	2	202542302	425917	414284
NM_001204.6(BMPR2):c.1277-9A>C	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203407025	2	202542302	425916	414283
NM_001204.6(BMPR2):c.1277-8A>G	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203407026	2	202542303	425918	414285
NM_001204.6(BMPR2):c.1279delG (p.E427Nfs*47)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203407036	2	202542313	425921	414286
NM_001204.6(BMPR2):c.1284C>G (p.Ser428=)	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Oct 6, 2017)	criteria provided, single submitter	2	203407041	2	202542318	528333	517648
NM_001204.6(BMPR2):c.1285_1286insGGATT (p.V429Gfs*47)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203407042 - 203407043	2	202542319 - 202542320	425922	414287
NM_001204.6(BMPR2):c.1293_1300delGTACCAGA (p.E431Dfs*14)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203407050 - 203407057	2	202542327 - 202542334	425923	414288
NM_001204.6(BMPR2):c.1296C>G (p.Y432*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203407053	2	202542330	425924	414289
NM_001204.6(BMPR2):c.1297C>T (p.Gln433Ter)	BMPR2	Primary pulmonary hypertension|Pulmonary hypertension, primary, 1, with hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Oct 1, 2008)	no assertion criteria provided	2	203407054	2	202542331	8819	23858
NM_001204.6(BMPR2):c.1302G>A (p.Met434Ile)	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203407059	2	202542336	333643	286684
NM_001204.6(BMPR2):c.1313_1316delCAGA (p.T438Rfs*35)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203407070 - 203407073	2	202542347 - 202542350	425925	414290
NM_001204.6(BMPR2):c.1346T>G (p.Met449Arg)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203407103	2	202542380	425926	414291
NM_001204.6(BMPR2):c.1348C>T (p.Q450*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203407105	2	202542382	425927	414292
NM_001204.6(BMPR2):c.1366delGinsCA (p.Glu456Glnfs)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203407123	2	202542400	425928	414293
NM_001204.6(BMPR2):c.1371dup (p.Gln458Thrfs)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203407128	2	202542405	425930	414295
NM_001204.6(BMPR2):c.1371delA (p.K457Nfs*17)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203407128	2	202542405	425929	414294
NM_001204.6(BMPR2):c.1376_1377delGA (p.R459Tfs*11)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203407133 - 203407134	2	202542410 - 202542411	425931	414296
NM_001204.6(BMPR2):c.1387_1388insA (p.P463Hfs*8)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203407144 - 203407145	2	202542421 - 202542422	425932	414297
NM_001204.6(BMPR2):c.1389dup (p.Glu464Argfs)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203407146	2	202542423	425933	414298
NM_001204.6(BMPR2):c.1392delA (p.A465Pfs*9)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203407149	2	202542426	425934	414299
NM_001204.6(BMPR2):c.1397G>A (p.W466*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203407154	2	202542431	425935	414300
NM_001204.6(BMPR2):c.1398G>A (p.Trp466Ter)	BMPR2	Primary pulmonary hypertension	Pathogenic(Last reviewed: Oct 16, 2016)	criteria provided, single submitter	2	203407155	2	202542432	409813	392288
NM_001204.6(BMPR2):c.1401delA (p.E468Kfs*6)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203407158	2	202542435	425936	414301
NM_001204.6(BMPR2):c.1402G>T (p.E468*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203407159	2	202542436	425937	414302
NM_001204.6(BMPR2):c.1413+1G>A	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203407171	2	202542448	425938	414303
NM_001204.6(BMPR2):c.1413+3A>T	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203407173	2	202542450	425939	414304
NM_001204.6(BMPR2):c.1414-3C>T	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203417436	2	202552713	333644	284798
NM_001204.6(BMPR2):c.1414-2A>T	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203417437	2	202552714	425940	414305
NM_001204.6(BMPR2):c.1424C>A (p.S475*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203417449	2	202552726	425943	414306
NM_001204.6(BMPR2):c.1426_1450del25 (p.Leu476Glyfs)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203417451 - 203417475	2	202552728 - 202552752	212813	209590
NM_001204.6(BMPR2):c.1427delT (p.L476Pfs*30)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203417452	2	202552729	425944	414307
NM_001204.6(BMPR2):c.1441G>T (p.E481*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203417466	2	202552743	425945	414308
NM_001204.6(BMPR2):c.1443_1445delAGA (p.Glu481del)	BMPR2	Primary pulmonary hypertension	Pathogenic(Last reviewed: Jul 11, 2016)	no assertion criteria provided	2	203417468 - 203417470	2	202552745 - 202552747	264652	259247
NM_001204.6(BMPR2):c.1447T>C (p.Cys483Arg)	BMPR2	Pulmonary hypertension, primary, dexfenfluramine-associated	Pathogenic	no assertion criteria provided	2	203417472	2	202552749	425946	414309
NM_001204.6(BMPR2):c.1451G>A (p.W484*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203417476	2	202552753	425947	414310
NM_001204.6(BMPR2):c.1453G>A (p.Asp485Asn)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203417478	2	202552755	425948	414311
NM_001204.6(BMPR2):c.1454A>G (p.Asp485Gly)	BMPR2	Primary pulmonary hypertension	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	2	203417479	2	202552756	8801	23840
NM_001204.6(BMPR2):c.1456C>T (p.Q486*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203417481	2	202552758	425949	414312
NM_001204.6(BMPR2):c.1460A>T (p.Asp487Val)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203417485	2	202552762	425950	414313
NM_001204.6(BMPR2):c.1469C>T (p.Ala490Val)	BMPR2	Primary pulmonary hypertension	Pathogenic(Last reviewed: Jul 11, 2016)	no assertion criteria provided	2	203417494	2	202552771	264653	259248
NM_001204.6(BMPR2):c.1471C>T (p.Arg491Trp)	BMPR2	Primary pulmonary hypertension|not provided	Pathogenic(Last reviewed: Aug 27, 2015)	criteria provided, single submitter	2	203417496	2	202552773	8802	23841
NM_001204.6(BMPR2):c.1472G>A (p.Arg491Gln)	BMPR2	Primary pulmonary hypertension|not specified	Pathogenic(Last reviewed: Oct 24, 2016)	criteria provided, single submitter	2	203417497	2	202552774	8806	23845
NM_001204.6(BMPR2):c.1477dup (p.Thr493Asnfs)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203417502	2	202552779	425951	414314
NM_001204.6(BMPR2):c.1481C>T (p.Ala494Val)	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203417506	2	202552783	333645	286688
NM_001204.6(BMPR2):c.1483C>T (p.Q495*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203417508	2	202552785	425952	414315
NM_001204.6(BMPR2):c.1486T>C (p.Cys496Arg)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203417511	2	202552788	425953	414316
NM_001204.6(BMPR2):c.1487G>A (p.Cys496Tyr)	BMPR2	Primary pulmonary hypertension|not specified	Pathogenic(Last reviewed: Aug 12, 2016)	criteria provided, single submitter	2	203417512	2	202552789	425954	414317
NM_001204.6(BMPR2):c.1509A>C (p.Glu503Asp)	BMPR2	Primary pulmonary hypertension|Pulmonary arterial hypertension associated with congenital heart disease	Uncertain significance(Last reviewed: Jun 27, 2018)	criteria provided, multiple submitters, no conflicts	2	203417534	2	202552811	409828	392291
NM_001204.6(BMPR2):c.1513dup (p.Met505Asnfs)	BMPR2	Primary pulmonary hypertension	Pathogenic(Last reviewed: Feb 20, 2018)	criteria provided, single submitter	2	203417538	2	202552815	568737	557816
NM_001204.6(BMPR2):c.1516A>G (p.Met506Val)	BMPR2	Primary pulmonary hypertension	Uncertain significance	no assertion criteria provided	2	203417541	2	202552818	425955	414318
NM_001204.6(BMPR2):c.1523G>A (p.W508*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203417548	2	202552825	425956	414319
NM_001204.6(BMPR2):c.1525G>T (p.E509*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203417550	2	202552827	425957	414320
NM_001204.6(BMPR2):c.1535A>C (p.Lys512Thr)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203417560	2	202552837	425958	414321
NM_001204.6(BMPR2):c.1557T>A (p.Asn519Lys)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203417582	2	202552859	425959	414322
NM_001204.6(BMPR2):c.1585delC (p.R529Afs*35)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203417610	2	202552887	425960	414323
NM_001204.6(BMPR2):c.1587-7_1587-4delCTTT	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203419968 - 203419971	2	202555245 - 202555248	425961	414324
NM_001204.6(BMPR2):c.1598A>G (p.His533Arg)	BMPR2	Primary pulmonary hypertension	Uncertain significance	no assertion criteria provided	2	203419986	2	202555263	425962	414325
NM_001204.6(BMPR2):c.1629T>G (p.Y543*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203420017	2	202555294	425963	414326
NM_001204.6(BMPR2):c.1687G>A (p.Val563Met)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203420075	2	202555352	425964	414327
NM_001204.6(BMPR2):c.1750C>T (p.R584*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203420138	2	202555415	425965	414328
NM_001204.6(BMPR2):c.1766A>G (p.Tyr589Cys)	BMPR2	Primary pulmonary hypertension	Uncertain significance	no assertion criteria provided	2	203420154	2	202555431	425966	414329
NM_001204.6(BMPR2):c.1771C>T (p.R591*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203420159	2	202555436	425967	414330
NM_001204.6(BMPR2):c.1789C>T (p.Arg597Ter)	BMPR2	Primary pulmonary hypertension|not provided	Pathogenic(Last reviewed: Jun 15, 2016)	criteria provided, single submitter	2	203420177	2	202555454	265619	259717
NM_001204.6(BMPR2):c.1862C>A (p.Thr621Lys)	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203420250	2	202555527	333646	286695
NM_001204.6(BMPR2):c.1914A>G (p.Thr638=)	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jan 18, 2017)	criteria provided, single submitter	2	203420302	2	202555579	458624	450267
NM_001204.6(BMPR2):c.1954_1955dup (p.Val654Leufs)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203420342 - 203420343	2	202555619 - 202555620	425968	414331
NM_001204.6(BMPR2):c.1968dup (p.Gln657Thrfs)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203420356	2	202555633	425969	414332
NM_001204.6(BMPR2):c.1969C>T (p.Q657*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203420357	2	202555634	425970	414333
NM_001204.6(BMPR2):c.1978G>T (p.E660*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203420366	2	202555643	425971	414334
NM_001204.6(BMPR2):c.1981G>T (p.E661*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203420369	2	202555646	425972	414335
NM_001204.6(BMPR2):c.2009delC (p.P670Qfs*30)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203420397	2	202555674	425973	414336
NM_001204.6(BMPR2):c.2124C>G (p.Y708*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203420512	2	202555789	425974	414337
NM_001204.6(BMPR2):c.2128delC (p.L710Sfs*2)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203420516	2	202555793	425975	414338
NM_001204.6(BMPR2):c.2286delC (p.N764Ifs*8)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203420674	2	202555951	425976	414339
NM_001204.6(BMPR2):c.2291dup (p.Asn764Lysfs)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203420679	2	202555956	425977	414340
NM_001204.6(BMPR2):c.2296A>G (p.Thr766Ala)	BMPR2	Primary pulmonary hypertension	Uncertain significance	no assertion criteria provided	2	203420684	2	202555961	425978	414341
NM_001204.6(BMPR2):c.2297delC (p.T766Kfs*6)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203420685	2	202555962	425979	414342
NM_001204.6(BMPR2):c.2303_2309delAGCCCCG (p.E768Gfs*2)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203420691 - 203420697	2	202555968 - 202555974	425980	414343
NM_001204.6(BMPR2):c.2308delC (p.R770Gfs*2)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203420696	2	202555973	425981	414344
NM_001204.6(BMPR2):c.2324G>A (p.Ser775Asn)	BMPR2	Primary pulmonary hypertension|not specified	Benign/Likely benign(Last reviewed: Jul 24, 2017)	criteria provided, multiple submitters, no conflicts	2	203420712	2	202555989	136528	140231
NM_001204.6(BMPR2):c.2352C>T (p.Val784=)	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203420740	2	202556017	333647	284800
NM_001204.6(BMPR2):c.2353G>A (p.Glu785Lys)	BMPR2	Pulmonary arterial hypertension associated with congenital heart disease	Uncertain significance(Last reviewed: Jun 27, 2018)	criteria provided, single submitter	2	203420741	2	202556018	548687	539171
NM_001204.6(BMPR2):c.2379A>C (p.Thr793=)	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203420767	2	202556044	333648	287147
NM_001204.6(BMPR2):c.2386delG (p.A796Qfs*7)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203420774	2	202556051	425982	414345
NM_001204.6(BMPR2):c.2407_2408insTG (p.T803Mfs*5)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203420795 - 203420796	2	202556072 - 202556073	425983	414346
NM_001204.6(BMPR2):c.2410_2413delGTCA (p.V804Pfs*2)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203420798 - 203420801	2	202556075 - 202556078	425984	414347
NM_001204.6(BMPR2):c.2413dup (p.Thr805Asnfs)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203420801	2	202556078	425985	414348
NM_001204.6(BMPR2):c.2442_2443delCA (p.H814Qfs*3)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203420830 - 203420831	2	202556107 - 202556108	425986	414349
NM_001204.6(BMPR2):c.2446_2447dup (p.Asn817Leufs)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203420834 - 203420835	2	202556111 - 202556112	425987	414350
NM_001204.6(BMPR2):c.2484delG (p.T829Qfs*10)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203420872	2	202556149	425988	414351
NM_001204.6(BMPR2):c.2503_2506delACAA (p.T835Pfs*3)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203420891 - 203420894	2	202556168 - 202556171	425990	414352
NM_001204.6(BMPR2):c.2503dup (p.Thr835Asnfs)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203420891	2	202556168	425989	414353
NM_001204.6(BMPR2):c.2504delC (p.T835Kfs*4)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203420892	2	202556169	425991	414354
NM_001204.6(BMPR2):c.2506_2522del17 (p.Thr836Terfs)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203420894 - 203420910	2	202556171 - 202556187	425992	414355
NM_001204.6(BMPR2):c.2521_2522dup (p.Arg842Ilefs)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203420909 - 203420910	2	202556186 - 202556187	425993	414356
NM_001204.6(BMPR2):c.2527delG (p.A843Pfs*16)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203420915	2	202556192	425994	414357
NM_001204.6(BMPR2):c.2533G>T (p.E845*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203420921	2	202556198	425995	414358
NM_001204.6(BMPR2):c.2580delT (p.N861Ifs*11)	BMPR2	Primary pulmonary hypertension	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	2	203420968	2	202556245	425996	414359
NM_001204.6(BMPR2):c.2588G>A (p.Ser863Asn)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203420976	2	202556253	425997	414360
NM_001204.6(BMPR2):c.2609delT (p.L870Yfs*2)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203420997	2	202556274	425998	414361
NM_001204.6(BMPR2):c.2617C>T (p.Arg873Ter)	BMPR2	Primary pulmonary hypertension	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	2	203421005	2	202556282	8805	23844
NM_001204.6(BMPR2):c.2618G>A (p.Arg873Gln)	BMPR2	Primary pulmonary hypertension	Uncertain significance	no assertion criteria provided	2	203421006	2	202556283	425999	414362
NM_001204.6(BMPR2):c.2620G>T (p.E874*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203421008	2	202556285	426000	414363
NM_001204.6(BMPR2):c.2626C>T (p.Q876*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203421014	2	202556291	426001	414364
NM_001204.6(BMPR2):c.2656C>T (p.Arg886Cys)	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Apr 11, 2017)	criteria provided, single submitter	2	203421044	2	202556321	458626	450525
NM_001204.6(BMPR2):c.2668delA (p.R890Gfs*6)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203421056	2	202556333	426002	414365
NM_001204.6(BMPR2):c.2695C>T (p.Arg899Ter)	BMPR2	Primary pulmonary hypertension	Pathogenic(Last reviewed: Aug 11, 2017)	criteria provided, single submitter	2	203421083	2	202556360	8796	23835
NM_001204.6(BMPR2):c.2696G>C (p.Arg899Pro)	BMPR2	Primary pulmonary hypertension	Pathogenic(Last reviewed: Aug 1, 2005)	no assertion criteria provided	2	203421084	2	202556361	8811	23850
NM_001204.6(BMPR2):c.2708A>G (p.Asn903Ser)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203421096	2	202556373	426003	414366
NM_001204.6(BMPR2):c.2730T>A (p.C910*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203421118	2	202556395	426004	414367
NM_001204.6(BMPR2):c.2737C>T (p.Q913*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203421125	2	202556402	426005	414368
NM_001204.6(BMPR2):c.2748T>C (p.Leu916=)	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203421136	2	202556413	333649	287150
NM_001204.6(BMPR2):c.2752C>T (p.Q918*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203421140	2	202556417	426006	414369
NM_001204.6(BMPR2):c.2789C>G (p.S930*)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203421177	2	202556454	426007	414370
NM_001204.6(BMPR2):c.2801G>C (p.Arg934Thr)	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203421189	2	202556466	333650	284804
NM_001204.6(BMPR2):c.2811G>A (p.Arg937=)	BMPR2	Primary pulmonary hypertension|not specified	Benign(Last reviewed: Dec 4, 2016)	criteria provided, multiple submitters, no conflicts	2	203421199	2	202556476	136529	140232
NM_001204.6(BMPR2):c.2887G>T (p.Gly963Cys)	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203424439	2	202559716	333651	284005
NM_001204.6(BMPR2):c.2945A>G (p.Lys982Arg)	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203424497	2	202559774	426008	414371
NM_001204.6(BMPR2):c.2948G>A (p.Arg983Gln)	BMPR2	Primary pulmonary hypertension|Pulmonary arterial hypertension|Mitral valve prolapse|Right ventricular hypertrophy|Pulmonary artery dilatation|Right ventricular dilatation|Elevated right atrial pressure|Increased pulmonary vascular resistance|Right bundle branch block	Likely benign(Last reviewed: Nov 29, 2017)	criteria provided, multiple submitters, no conflicts	2	203424500	2	202559777	333652	287152
NM_001204.6(BMPR2):c.3012C>T (p.Gly1004=)	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: May 14, 2016)	criteria provided, single submitter	2	203424564	2	202559841	415837	392468
NM_001204.6(BMPR2):c.*77A>G	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203424746	2	202560023	333654	284805
NM_001204.6(BMPR2):c.*79delA	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203424748	2	202560025	333653	284806
NM_001204.6(BMPR2):c.*106C>T	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203424775	2	202560052	333655	286698
NM_001204.6(BMPR2):c.*130G>C	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203424799	2	202560076	333656	284814
NM_001204.6(BMPR2):c.*221C>T	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203424890	2	202560167	333657	287153
NM_001204.6(BMPR2):c.*241C>T	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203424910	2	202560187	333658	284007
NM_001204.6(BMPR2):c.*309delA	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203424978	2	202560255	333659	284011
NM_001204.6(BMPR2):c.*378T>G	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203425047	2	202560324	333660	287154
NM_001204.6(BMPR2):c.*454G>A	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203425123	2	202560400	333661	284014
NM_001204.6(BMPR2):c.*686C>G	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203425355	2	202560632	333662	284816
NM_001204.6(BMPR2):c.*700T>C	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203425369	2	202560646	333663	287156
NM_001204.6(BMPR2):c.*806C>T	BMPR2	Primary pulmonary hypertension	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203425475	2	202560752	333664	287159
NM_001204.6(BMPR2):c.*815C>T	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203425484	2	202560761	333665	286709
NM_001204.6(BMPR2):c.*995G>A	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203425664	2	202560941	333666	286710
NM_001204.6(BMPR2):c.*1226C>A	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203425895	2	202561172	333667	284817
NM_001204.6(BMPR2):c.*1236C>A	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203425905	2	202561182	333668	284015
NM_001204.6(BMPR2):c.*1268_*1269delCT	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203425937 - 203425938	2	202561214 - 202561215	333669	287160
NM_001204.6(BMPR2):c.*1306A>C	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203425975	2	202561252	333670	286720
NM_001204.6(BMPR2):c.*1401C>T	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203426070	2	202561347	333671	286722
NM_001204.6(BMPR2):c.*1466T>G	BMPR2	Primary pulmonary hypertension	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203426135	2	202561412	333672	286736
NM_001204.6(BMPR2):c.*1732T>C	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203426401	2	202561678	333673	284022
NM_001204.6(BMPR2):c.*1999T>G	BMPR2	Primary pulmonary hypertension	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203426668	2	202561945	333674	284029
NM_001204.6(BMPR2):c.*2035C>T	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203426704	2	202561981	333675	284031
NM_001204.6(BMPR2):c.*2173A>G	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203426842	2	202562119	333676	284038
NM_001204.6(BMPR2):c.*2491T>C	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203427160	2	202562437	333677	284824
NM_001204.6(BMPR2):c.*2519A>G	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203427188	2	202562465	333678	284828
NM_001204.6(BMPR2):c.*2769T>A	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203427438	2	202562715	333679	286737
NM_001204.6(BMPR2):c.*2833G>A	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203427502	2	202562779	333680	284040
NM_001204.6(BMPR2):c.*2854T>G	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203427523	2	202562800	333681	284041
NM_001204.6(BMPR2):c.*2901A>C	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203427570	2	202562847	333684	287163
NM_001204.6(BMPR2):c.*2901delA	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203427570	2	202562847	333683	284829
NM_001204.6(BMPR2):c.*2901dupA	BMPR2	Primary pulmonary hypertension	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203427570	2	202562847	333682	287174
NM_001204.6(BMPR2):c.*2939A>G	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203427608	2	202562885	333685	286743
NM_001204.6(BMPR2):c.*3061A>G	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203427730	2	202563007	333686	284830
NM_001204.6(BMPR2):c.*3350G>T	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203428019	2	202563296	333687	287175
NM_001204.6(BMPR2):c.*3353T>C	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203428022	2	202563299	333688	284049
NM_001204.6(BMPR2):c.*3354G>T	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203428023	2	202563300	333689	286744
NM_001204.6(BMPR2):c.*3446G>A	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203428115	2	202563392	333690	287181
NM_001204.6(BMPR2):c.*3498dupA	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203428167	2	202563444	333691	284832
NM_001204.6(BMPR2):c.*3554C>T	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203428223	2	202563500	333692	284050
NM_001204.6(BMPR2):c.*3794T>C	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203428463	2	202563740	333693	286745
NM_001204.6(BMPR2):c.*3823_*3825delCAA	BMPR2	Primary pulmonary hypertension	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203428492 - 203428494	2	202563769 - 202563771	333694	284840
NM_001204.6(BMPR2):c.*3907G>C	BMPR2	Primary pulmonary hypertension	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203428576	2	202563853	333695	284054
NM_001204.6(BMPR2):c.*4034_*4037delTTTA	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203428703 - 203428706	2	202563980 - 202563983	333696	287182
NM_001204.6(BMPR2):c.*4364C>T	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203429033	2	202564310	333697	287186
NM_001204.6(BMPR2):c.*4584T>A	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203429253	2	202564530	333698	286746
NM_001204.6(BMPR2):c.*4821G>C	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203429490	2	202564767	333699	284844
NM_001204.6(BMPR2):c.*4905C>A	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203429574	2	202564851	333700	284853
NM_001204.6(BMPR2):c.*5031C>T	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203429700	2	202564977	333701	284059
NM_001204.6(BMPR2):c.*5038T>A	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203429707	2	202564984	333702	286747
NM_001204.6(BMPR2):c.*5044A>G	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203429713	2	202564990	333703	284856
NM_001204.6(BMPR2):c.*5111dupA	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203429780	2	202565057	333704	286753
NM_001204.6(BMPR2):c.*5152A>G	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203429821	2	202565098	333705	284857
NM_001204.6(BMPR2):c.*5154C>T	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203429823	2	202565100	333706	284858
NM_001204.6(BMPR2):c.*5198A>C	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203429867	2	202565144	333707	286762
NM_001204.6(BMPR2):c.*5243T>C	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203429912	2	202565189	333708	287187
NM_001204.6(BMPR2):c.*5246C>T	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203429915	2	202565192	333709	286763
NM_001204.6(BMPR2):c.*5408G>T	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203430077	2	202565354	333710	286764
NM_001204.6(BMPR2):c.*5522C>T	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203430191	2	202565468	333711	286771
NM_001204.6(BMPR2):c.*5624A>G	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203430293	2	202565570	333712	286782
NM_001204.6(BMPR2):c.*5627G>T	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203430296	2	202565573	333713	284861
NM_001204.6(BMPR2):c.*5781A>G	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203430450	2	202565727	333714	284071
NM_001204.6(BMPR2):c.*5787T>G	BMPR2	Primary pulmonary hypertension	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203430456	2	202565733	333715	286792
NM_001204.6(BMPR2):c.*5946C>T	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203430615	2	202565892	333716	286796
NM_001204.6(BMPR2):c.*5998G>A	BMPR2	Primary pulmonary hypertension	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203430667	2	202565944	333717	284077
NM_001204.6(BMPR2):c.*6001T>C	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203430670	2	202565947	333718	286798
NM_001204.6(BMPR2):c.*6108G>T	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203430777	2	202566054	333719	284862
NM_001204.6(BMPR2):c.*6505C>G	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203431174	2	202566451	333720	284863
NM_001204.6(BMPR2):c.*6525G>A	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203431194	2	202566471	333721	284078
NM_001204.6(BMPR2):c.*6695C>T	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203431364	2	202566641	333722	286799
NM_001204.6(BMPR2):c.*6879A>G	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203431548	2	202566825	333723	287189
NM_001204.6(BMPR2):c.*7080G>A	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203431749	2	202567026	333724	284877
NM_001204.6(BMPR2):c.*7135A>G	BMPR2	Primary pulmonary hypertension	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203431804	2	202567081	333725	287192
NM_001204.6(BMPR2):c.*7162delA	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203431831	2	202567108	333726	287193
NM_001204.6(BMPR2):c.*7306A>G	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203431975	2	202567252	333727	287194
NM_001204.6(BMPR2):c.*7496T>C	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203432165	2	202567442	333728	284083
NM_001204.6(BMPR2):c.*7505T>G	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203432174	2	202567451	333729	284093
NM_001204.6(BMPR2):c.*7750G>T	BMPR2	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203432419	2	202567696	333730	284094
NM_001204.6(BMPR2):c.*7776C>T	BMPR2	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	203432445	2	202567722	333731	284097
NM_001875.4(CPS1):c.209_216dup (p.Phe73Lysfs)	CPS1	Congenital hyperammonemia, type I|Pulmonary hypertension, neonatal, susceptibility to	Likely pathogenic(Last reviewed: Jun 21, 2016)	no assertion criteria provided	2	211438104 - 211438111	2	210573380 - 210573387	417895	404756
NM_001875.4(CPS1):c.637G>A (p.Gly213Ser)	CPS1	Congenital hyperammonemia, type I	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	211452797	2	210588073	334015	287384
NM_001875.4(CPS1):c.1571G>T (p.Gly524Val)	CPS1	Variant of unknown significance	Uncertain significance(Last reviewed: Sep 1, 2011)	no assertion criteria provided	2	211465300	2	210600576	60771	75313
NM_001875.4(CPS1):c.4196A>C (p.Asn1399Thr)	CPS1	Venoocclusive disease after bone marrow transplantation, susceptibility to|Pulmonary hypertension, neonatal, susceptibility to	risk factor(Last reviewed: Oct 19, 2018)	no assertion criteria provided	2	211540486	2	210675762	2423	17462
NM_212482.2(FN1):c.5773T>A (p.Trp1925Arg)	FN1	Glomerulopathy with fibronectin deposits 2	Pathogenic(Last reviewed: Feb 19, 2008)	no assertion criteria provided	2	216241335	2	215376612	16323	31362
NM_000092.4(COL4A4):c.4394G>A (p.Gly1465Asp)	COL4A4	Alport syndrome, autosomal recessive|Hearing impairment|Hypertension|Myopia|Proteinuria|Hematuria|Hypertension	Conflicting interpretations of pathogenicity(Last reviewed: Apr 2, 2018)	criteria provided, conflicting interpretations	2	227875157	2	227010441	523324	513923
NM_000092.4(COL4A4):c.4217-15T>C	COL4A4	Alport syndrome|not specified|Stage 5 chronic kidney disease|Hyperkalemia|Hypertension|Thrombocytopenia|Hypertension	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	227877028	2	227012312	255039	250588
NM_000092.4(COL4A4):c.3055G>C (p.Glu1019Gln)	COL4A4	Stage 5 chronic kidney disease|Hyperkalemia|Hypertension|Thrombocytopenia|Hypertension	Uncertain significance(Last reviewed: Jun 16, 2015)	criteria provided, single submitter	2	227915788	2	227051072	374041	360836
NM_000092.4(COL4A4):c.2320G>C	COL4A4	Alport syndrome, autosomal recessive|Hearing impairment|Hypertension|Myopia|Proteinuria|Hematuria|Hypertension	Likely pathogenic(Last reviewed: Mar 17, 2017)	criteria provided, multiple submitters, no conflicts	2	227924184	2	227059468	242442	223747
NM_000092.4(COL4A4):c.[1320_1369+2del];[2320G>C]	COL4A4	Alport syndrome, autosomal recessive	Pathogenic(Last reviewed: Feb 2, 2016)	criteria provided, single submitter	2|2	227958838 - 227958889	2|2	227094122 - 227094173	424759	223748|223747
NM_000091.4(COL4A3):c.1184G>A (p.Gly395Glu)	COL4A3|LOC654841	not provided	Likely pathogenic(Last reviewed: Nov 16, 2015)	criteria provided, single submitter	2	228128529	2	227263813	430020	421365
NM_004544.3(NDUFA10):c.881T>C (p.Leu294Pro)	NDUFA10	Mitochondrial complex I deficiency	Pathogenic(Last reviewed: Dec 2, 2016)	no assertion criteria provided	2	240944636	2	240005219	372194	359099
NC_000002.12:g.(?_202513699)_(202542467_?)del	BMPR2	Primary pulmonary hypertension	Pathogenic(Last reviewed: Apr 17, 2018)	criteria provided, single submitter	2	203378422 - 203407190	2	202513699 - 202542467	583625	558078
NM_001204.6(BMPR2):c.(?_-63)_(76_?)+61del	BMPR2	Idiopathic and/or familial pulmonary arterial hypertension	Pathogenic(Last reviewed: Oct 2, 2017)	criteria provided, single submitter	2	203242135 - 203242334	2	202377412 - 202377611	517622	496630
NC_000002.12:g.(?_202467499)_(202514999_?)del	BMPR2	Primary pulmonary hypertension	Pathogenic(Last reviewed: Feb 20, 2017)	criteria provided, single submitter	2	203332222 - 203379722	2	202467499 - 202514999	458622	448566
NM_001204.6(BMPR2):c.(1413+1_1414-1)_(*1_?)del	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203407171 - 203424670	2	202542448 - 202559947	425942	414038
NM_001204.6(BMPR2):c.(418+1_419-1)_(*1_?)del	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203332413 - 203424670	2	202467690 - 202559947	425789	414037
NM_001204.6(BMPR2):c.(76+1_77-1)_(*1_?)del	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203242274 - 203424670	2	202377551 - 202559947	425698	414036
NM_001204.6(BMPR2):c.(?_-1)_(*1_?)del	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203242197 - 203424670	2	202377474 - 202559947	425675	414045
NM_001204.6(BMPR2):c.(?_-1)_(1128+1_1129-1)del	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203242197 - 203397307	2	202377474 - 202532584	425674	414044
NM_001204.6(BMPR2):c.(?_-1)_(529+1_530-1)del	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203242197 - 203379610	2	202377474 - 202514887	425673	414043
NM_001204.6(BMPR2):c.(?_-1)_(418+1_419-1)del	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203242197 - 203378441	2	202377474 - 202513718	425672	414042
NM_001204.6(BMPR2):c.(?_-1)_(76+1_77-1)del	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203242197 - 203329531	2	202377474 - 202464808	425671	414041
NM_001204.6(BMPR2):c.(?_-540)_(*1_?)del	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203241658 - 203424670	2	202376935 - 202559947	425670	414040
NM_001204.6(BMPR2):c.(?_-540)_(76+1_77-1)del	BMPR2	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	2	203241658 - 203329531	2	202376935 - 202464808	425669	414039
NM_001204.6(BMPR2):c.77-?_418+?del	BMPR2	Primary pulmonary hypertension	Pathogenic(Last reviewed: Jul 26, 2016)	criteria provided, single submitter	2	203329532 - 203332412	2	202464809 - 202467689	417478	391465
NM_001204.6(BMPR2):c.248-329_418+6029del	BMPR2	Primary pulmonary hypertension	Likely pathogenic(Last reviewed: Jul 11, 2016)	no assertion criteria provided	2	203331913 - 203338445	2	202467190 - 202473722	264654	259243
GRCh38/hg38 2p16.3(chr2:50827235-50953482)x1	NRXN1	See cases	Pathogenic(Last reviewed: Jul 18, 2014)	no assertion criteria provided	2	51054373 - 51180620	2	50827235 - 50953482	152099	161850
NM_001204.6(BMPR2):c.77-?_247+?del (p.A26_Q82del)	BMPR2	Primary pulmonary hypertension|Pulmonary venoocclusive disease 1	Pathogenic(Last reviewed: Feb 1, 2006)	no assertion criteria provided	2	203329532 - 203329702	2	202464809 - 202464979	8816	23855
NM_001031717.3(CRELD1):c.985C>T (p.Arg329Cys)	CRELD1	Atrioventricular septal defect 2|not provided	Likely benign(Last reviewed: Mar 31, 2018)	criteria provided, multiple submitters, no conflicts	3	9985136	3	9943452	3427	18466
NM_000551.3(VHL):c.376G>A (p.Asp126Asn)	VHL|LOC107303340	Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 29, 2018)	criteria provided, conflicting interpretations	3	10188233	3	10146549	141044	150758
NM_000551.3(VHL):c.548C>T (p.Ser183Leu)	VHL|LOC107303340	Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome	Uncertain significance(Last reviewed: Dec 12, 2017)	criteria provided, single submitter	3	10191555	3	10149871	411985	393224
NM_015869.4(PPARG):c.-22C>T	PPARG	Obesity|Diabetes Mellitus, Noninsulin-Dependent, with Acanthosis Nigricans and Hypertension|Familial partial lipodystrophy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	3	12393070	3	12351571	342919	292190
NM_015869.4(PPARG):c.34C>G (p.Pro12Ala)	PPARG	Obesity|Diabetes Mellitus, Noninsulin-Dependent, with Acanthosis Nigricans and Hypertension|not specified|Familial partial lipodystrophy	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	3	12393125	3	12351626	130019	135465
NM_138712.3(PPARG):c.34C>G (p.Pro12Ala)	PPARG	Diabetes mellitus, noninsulin-dependent, modifier of|Obesity, modifier of|Body mass index, modifier of|Intimal medial thickness of internal carotid artery, modifier of	risk factor(Last reviewed: Jun 1, 2007)	no assertion criteria provided	3	12421238	3	12379739	8131	23170
NM_015869.4(PPARG):c.240C>T (p.Asp80=)	PPARG	Obesity|Diabetes Mellitus, Noninsulin-Dependent, with Acanthosis Nigricans and Hypertension|Familial partial lipodystrophy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	3	12421360	3	12379861	342920	288404
NM_015869.4(PPARG):c.288C>T (p.Asp96=)	PPARG	Obesity|Diabetes Mellitus, Noninsulin-Dependent, with Acanthosis Nigricans and Hypertension|Familial partial lipodystrophy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	3	12421408	3	12379909	342921	288413
NM_015869.4(PPARG):c.438T>C (p.Ala146=)	PPARG	Obesity|Diabetes Mellitus, Noninsulin-Dependent, with Acanthosis Nigricans and Hypertension|not specified|Familial partial lipodystrophy	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	3	12422948	3	12381449	342922	292296
NM_015869.4(PPARG):c.481-3C>T	PPARG	Obesity|Diabetes Mellitus, Noninsulin-Dependent, with Acanthosis Nigricans and Hypertension|Familial partial lipodystrophy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	3	12434110	3	12392611	342923	289177
NM_015869.4(PPARG):c.507G>A (p.Leu169=)	PPARG	Obesity|Diabetes Mellitus, Noninsulin-Dependent, with Acanthosis Nigricans and Hypertension|Familial partial lipodystrophy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	3	12434139	3	12392640	342924	288431
NM_015869.4(PPARG):c.891C>G (p.Pro297=)	PPARG	Obesity|Diabetes Mellitus, Noninsulin-Dependent, with Acanthosis Nigricans and Hypertension|Familial partial lipodystrophy	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	3	12458274	3	12416775	343047	292303
NM_138712.3(PPARG):c.868G>A (p.Val290Met)	PPARG	Familial partial lipodystrophy 3	Pathogenic(Last reviewed: Apr 1, 2003)	no assertion criteria provided	3	12458335	3	12416836	8137	23176
NM_015869.4(PPARG):c.1206C>A (p.Phe402Leu)	PPARG	Obesity|Diabetes Mellitus, Noninsulin-Dependent, with Acanthosis Nigricans and Hypertension|Familial partial lipodystrophy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	3	12458589	3	12417090	343048	288432
NM_015869.4(PPARG):c.1371A>G (p.Ser457=)	PPARG	Obesity|Diabetes Mellitus, Noninsulin-Dependent, with Acanthosis Nigricans and Hypertension|Familial partial lipodystrophy	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	3	12475497	3	12433998	343049	292305
NM_015869.4(PPARG):c.1431C>T (p.His477=)	PPARG	Glioma susceptibility 1|Obesity|Diabetes Mellitus, Noninsulin-Dependent, with Acanthosis Nigricans and Hypertension|not specified|Familial partial lipodystrophy	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	3	12475557	3	12434058	8139	23178
NM_015869.4(PPARG):c.1452C>T (p.Ile484=)	PPARG	Obesity|Diabetes Mellitus, Noninsulin-Dependent, with Acanthosis Nigricans and Hypertension|Familial partial lipodystrophy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	3	12475578	3	12434079	343050	292306
NM_015869.4(PPARG):c.1484C>T (p.Pro495Leu)	PPARG	Familial partial lipodystrophy 3|Obesity|Diabetes Mellitus, Noninsulin-Dependent, with Acanthosis Nigricans and Hypertension|Familial partial lipodystrophy	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	3	12475610	3	12434111	8136	23175
NM_015869.4(PPARG):c.1509C>T (p.Asp503=)	PPARG	Obesity|Diabetes Mellitus, Noninsulin-Dependent, with Acanthosis Nigricans and Hypertension|Familial partial lipodystrophy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	3	12475635	3	12434136	343051	292310
NM_001317040.1(GLB1):c.985C>T (p.His329Tyr)	GLB1	GM1 gangliosidosis type 2|Gangliosidosis GM1 type 3|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 23, 2017)	criteria provided, multiple submitters, no conflicts	3	33093448	3	33051956	372371	359418
NM_006371.4(CRTAP):c.826C>T (p.Gln276Ter)	CRTAP	Osteogenesis imperfecta type 7	Pathogenic(Last reviewed: Oct 1, 2012)	no assertion criteria provided	3	33171463	3	33129971	4950	19989
NM_198056.2(SCN5A):c.5476C>T (p.Arg1826Cys)	SCN5A	Atrial fibrillation|Brugada syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 10, 2017)	criteria provided, conflicting interpretations	3	38592387	3	38550896	67994	78886
NM_198056.2(SCN5A):c.1993G>T (p.Ala665Ser)	SCN5A	Brugada syndrome|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 21, 2017)	criteria provided, conflicting interpretations	3	38640439	3	38598948	201467	196957
NM_198056.2(SCN5A):c.1073T>C (p.Phe358Ser)	SCN5A	not specified	Uncertain significance(Last reviewed: Feb 25, 2011)	no assertion criteria provided	3	38648227	3	38606736	235057	236760
NM_006514.3(SCN10A):c.368C>G (p.Ala123Gly)	SCN10A	SCN10A-Related Disorder	not provided	no assertion provided	3	38833562	3	38792071	440986	434585
NM_015340.3(LARS2):c.1565C>A (p.Thr522Asn)	LARS2|LARS2-AS1	not provided|Perrault syndrome 4|Hydrops, lactic acidosis, and sideroblastic anemia|Perrault syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 19, 2017)	criteria provided, multiple submitters, no conflicts	3	45537808	3	45496316	55871	70522
NM_000258.2(MYL3):c.530A>G (p.Glu177Gly)	MYL3	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Apr 17, 2018)	criteria provided, conflicting interpretations	3	46899903	3	46858413	36648	45310
NM_000258.2(MYL3):c.427G>A (p.Glu143Lys)	MYL3	Familial hypertrophic cardiomyopathy 8|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jun 2, 2018)	criteria provided, conflicting interpretations	3	46901019	3	46859529	14063	29102
NM_003280.2(TNNC1):c.435C>A (p.Asp145Glu)	TNNC1	Dilated cardiomyopathy 1Z|Dilated cardiomyopathy 1S|Familial hypertrophic cardiomyopathy 13|not specified|Cardiovascular phenotype	Uncertain significance(Last reviewed: Aug 24, 2017)	criteria provided, multiple submitters, no conflicts	3	52485426	3	52451410	12445	27484
NM_031850.3(AGTR1):c.*86A>C	AGTR1	Hypertension, essential, susceptibility to|Renal dysplasia	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	3	148459988	3	148742201	18065	33104
NM_004366.5(CLCN2):c.2593A>C (p.Ser865Arg)	CLCN2	Hyperaldosteronism, familial, type II	Pathogenic(Last reviewed: Sep 25, 2017)	no assertion criteria provided	3	184064498	3	184346710	441168	434792
NM_004366.5(CLCN2):c.1084A>T (p.Lys362del)	CLCN2	Hyperaldosteronism, familial, type II	Pathogenic(Last reviewed: Sep 25, 2017)	no assertion criteria provided	3	184074782	3	184356994	441167	434793
NM_004366.5(CLCN2):c.515G>A (p.Arg172Gln)	CLCN2	Hyperaldosteronism, familial, type II	Pathogenic(Last reviewed: Sep 25, 2017)	no assertion criteria provided	3	184075850	3	184358062	441164	434794
NM_004366.5(CLCN2):c.76T>A (p.Tyr26Asn)	CLCN2	Hyperaldosteronism, familial, type II	Pathogenic(Last reviewed: Sep 25, 2017)	no assertion criteria provided	3	184076907	3	184359119	441166	434795
NM_004366.5(CLCN2):c.65T>A (p.Met22Lys)	CLCN2	Hyperaldosteronism, familial, type II	Pathogenic(Last reviewed: Sep 25, 2017)	no assertion criteria provided	3	184076918	3	184359130	441165	434796
NM_176801.2(ADD1):c.1378G>T (p.Gly460Trp)	ADD1	Hypertension, salt-sensitive essential, susceptibility to|furosemide and spironolactone response - Efficacy	drug response(Last reviewed: Oct 14, 2015)	reviewed by expert panel	4	2906707	4	2904980	18274	33313
NM_001145853.1(WFS1):c.1079G>A (p.Cys360Tyr)	WFS1	Diabetes mellitus AND insipidus with optic atrophy AND deafness|WFS1-Related Disorders|not specified	Uncertain significance(Last reviewed: Aug 7, 2018)	criteria provided, multiple submitters, no conflicts	4	6302601	4	6300874	374398	361179
NM_001080522.2(CC2D2A):c.3145C>T (p.Arg1049Ter)	CC2D2A	COACH syndrome|Joubert syndrome|Meckel-Gruber syndrome|Joubert syndrome 9/15, digenic|not provided	Pathogenic(Last reviewed: Jan 8, 2018)	criteria provided, multiple submitters, no conflicts	4	15565108	4	15563485	747	15786
NM_003924.3(PHOX2B):c.385G>A (p.Glu129Lys)	PHOX2B	Congenital central hypoventilation	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	4	41749410	4	41747393	561080	552081
NM_006587.3(CORIN):c.1615C>T (p.Arg539Cys)	CORIN	Variant of unknown significance|not provided	Uncertain significance(Last reviewed: Jan 31, 2017)	criteria provided, single submitter	4	47663848	4	47661831	41463	49899
NM_058172.5(ANTXR2):c.1073dupC (p.Ala359Cysfs)	ANTXR2	Hyaline fibromatosis syndrome	Pathogenic(Last reviewed: Jun 3, 2016)	no assertion criteria provided	4	80905986	4	79984832	2604	17643
NM_001025616.2(ARHGAP24):c.473A>G (p.Gln158Arg)	ARHGAP24	not specified|not provided	Uncertain significance(Last reviewed: Mar 10, 2017)	criteria provided, single submitter	4	86863300	4	85942147	224509	226249
NM_000297.3(PKD2):c.357_364delCCCGGGCAinsTAGGACG (p.Pro120Argfs)	PKD2	Polycystic kidney dysplasia|Hypertension|Chronic kidney disease|Hypertension	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	4	88929242 - 88929249	4	88008090 - 88008097	373955	360862
NM_001256792.1(BMPR1B):c.80C>G (p.Pro27Arg)	BMPR1B	Primary pulmonary hypertension 3	Uncertain significance(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	4	96025655	4	95104504	522761	513274
NM_001256792.1(BMPR1B):c.547T>C (p.Ser183Pro)	BMPR1B	Pulmonary arterial hypertension associated with congenital heart disease	Uncertain significance(Last reviewed: Jun 27, 2018)	criteria provided, single submitter	4	96046234	4	95125083	548684	539172
NM_000204.4(CFI):c.1571A>T (p.Asp524Val)	CFI	Atypical hemolytic-uremic syndrome 3	risk factor(Last reviewed: Jun 1, 2004)	no assertion criteria provided	4	110662230	4	109741074	12122	27161
NM_005900.2(SMAD1):c.8T>C (p.Val3Ala)	SMAD1|SMAD1-AS1	Primary pulmonary hypertension|Variant of unknown significance	Uncertain significance(Last reviewed: Dec 1, 2011)	no assertion criteria provided	4	146435773	4	145514621	60478	75073
NM_000901.4(NR3C2):c.2429C>T (p.Ser810Leu)	NR3C2	Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy	Pathogenic(Last reviewed: Jul 7, 2000)	no assertion criteria provided	4	149073701	4	148152550	8557	23596
NM_005141.4(FGB):c.794C>T (p.Pro265Leu)	FGB	Afibrinogenemia, congenital|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2017)	criteria provided, conflicting interpretations	4	155489608	4	154568456	517313	496315
NM_000508.4(FGA):c.1634A>T (p.Glu545Val)	FGA	Familial visceral amyloidosis, Ostertag type	Pathogenic(Last reviewed: Dec 25, 2008)	no assertion criteria provided	4	155506947	4	154585795	16410	31449
NM_000508.4(FGA):c.1622delT (p.Val541Alafs)	FGA	Familial visceral amyloidosis, Ostertag type	Pathogenic(Last reviewed: Dec 15, 1997)	no assertion criteria provided	4	155506959	4	154585807	16409	31448
NM_000508.3(FGA):c.1438A>T (p.Lys480Ter)	FGA	FIBRINOGEN MARBURG	other(Last reviewed: Nov 7, 2018)	no assertion criteria provided	4	155507143	4	154585991	16407	31446
NM_000856.5(GUCY1A1):c.1550G>A (p.Cys517Tyr)	GUCY1A1	Moyamoya disease 6 with achalasia	Pathogenic(Last reviewed: Aug 16, 2018)	no assertion criteria provided	4	156634713	4	155713561	559597	550318
NM_004168.3(SDHA):c.91C>T (p.Arg31Ter)	SDHA	Carney triad|Mitochondrial complex II deficiency|Pilocytic astrocytoma, somatic|Pilocytic astrocytoma|Paragangliomas 5|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 29, 2018)	criteria provided, multiple submitters, no conflicts	5	223624	5	223509	142601	152315
NM_001165899.1(PDE4D):c.490C>A (p.Pro164Thr)	PDE4D	Acrodysostosis 2, with or without hormone resistance	Pathogenic(Last reviewed: Apr 6, 2012)	no assertion criteria provided	5	58489337	5	59193511	30035	38990
NM_001165899.1(PDE4D):c.385T>G (p.Ser129Ala)	PDE4D	Acrodysostosis 2, with or without hormone resistance	Pathogenic(Last reviewed: Apr 6, 2012)	no assertion criteria provided	5	58511682	5	59215856	30037	38992
NM_022132.4(MCCC2):c.1015G>A (p.Val339Met)	MCCC2	3-methylcrotonyl CoA carboxylase 2 deficiency|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 27, 2018)	criteria provided, conflicting interpretations	5	70936845	5	71641018	203805	200099
NM_000521.3(HEXB):c.272G>C (p.Cys91Ser)	HEXB	Sandhoff disease	Uncertain significance(Last reviewed: Jan 15, 2015)	no assertion criteria provided	5	73981357	5	74685532	374340	361184
NM_003719.3(PDE8B):c.914A>C (p.His305Pro)	PDE8B	Pigmented nodular adrenocortical disease, primary, 3	Pathogenic(Last reviewed: Feb 14, 2008)	no assertion criteria provided	5	76645281	5	77349456	6390	21429
NM_003060.3(SLC22A5):c.34G>A (p.Gly12Ser)	SLC22A5	Renal carnitine transport defect	Uncertain significance(Last reviewed: Jun 29, 2018)	criteria provided, single submitter	5	131705698	5	132370006	25349	36683
NM_017415.2(KLHL3):c.1583G>A (p.Arg528His)	KLHL3	Pseudohypoaldosteronism, type 2|Pseudohypoaldosteronism type 2D	Pathogenic(Last reviewed: Oct 1, 2014)	no assertion criteria provided	5	136963994	5	137628305	30518	39475
NM_017415.2(KLHL3):c.1582C>T (p.Arg528Cys)	KLHL3	Pseudohypoaldosteronism, type 2|Pseudohypoaldosteronism type 2D	Pathogenic(Last reviewed: Mar 11, 2012)	no assertion criteria provided	5	136963995	5	137628306	30522	39479
NM_017415.2(KLHL3):c.1277C>T (p.Pro426Leu)	KLHL3	Pseudohypoaldosteronism type 2D	Pathogenic(Last reviewed: Mar 11, 2012)	no assertion criteria provided	5	136973027	5	137637338	31546	40224
NM_017415.2(KLHL3):c.1229C>T (p.Ser410Leu)	KLHL3	Pseudohypoaldosteronism, type 2|Pseudohypoaldosteronism type 2D	Pathogenic(Last reviewed: Mar 11, 2012)	no assertion criteria provided	5	136973075	5	137637386	30517	39474
NM_017415.2(KLHL3):c.1193C>T (p.Ala398Val)	KLHL3	Pseudohypoaldosteronism type 2D	Pathogenic(Last reviewed: Mar 11, 2012)	no assertion criteria provided	5	136974668	5	137638979	31544	40222
NM_001018077.1(NR3C1):c.2318T>C (p.Leu773Pro)	NR3C1	Glucocorticoid resistance, generalized	Pathogenic(Last reviewed: Jun 1, 2005)	no assertion criteria provided	5	142661470	5	143281905	16155	31194
NM_001018077.1(NR3C1):c.1676T>A (p.Ile559Asn)	NR3C1	Glucocorticoid resistance, generalized	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	5	142680121	5	143300556	16151	31190
NM_004137.3(KCNMB1):c.193G>A (p.Glu65Lys)	KCNMB1|KCNIP1	Hypertension, diastolic, resistance to	protective(Last reviewed: Jan 1, 2005)	no assertion criteria provided	5	169810796	5	170383792	5941	20980
NM_000505.3(F12):c.983C>G (p.Thr328Arg)	F12|SLC34A1	Hereditary angioneurotic edema with normal C1 esterase inhibitor activity|Hyperbilirubinemia|Hypertension|Urticaria|Angioedema|Hypertension|Urticaria	Pathogenic(Last reviewed: Jan 6, 2015)	criteria provided, single submitter	5	176831232	5	177404231	1170	16209
NM_000843.3(GRM6):c.2213_2219delCCAGAGG (p.Ala738Glyfs)	GRM6|LOC100130798	Congenital stationary night blindness	not provided	no assertion provided	5	178410128 - 178410134	5	178983127 - 178983133	441099	434600
NM_004415.3(DSP):c.943C>T (p.Arg315Cys)	DSP	Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Skin fragility woolly hair syndrome|Arrhythmogenic right ventricular cardiomyopathy|not specified|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Oct 31, 2017)	criteria provided, conflicting interpretations	6	7566613	6	7566380	44982	54149
NM_004415.3(DSP):c.4901G>A (p.Arg1634Gln)	DSP	Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Arrhythmogenic right ventricular cardiomyopathy|not specified	Uncertain significance(Last reviewed: May 7, 2018)	criteria provided, multiple submitters, no conflicts	6	7581324	6	7581091	199887	197078
NM_000410.3(HFE):c.187C>G (p.His63Asp)	HFE|LOC108783645	Microvascular complications of diabetes 7|Hemochromatosis type 1|not provided|Hereditary hemochromatosis	Pathogenic, other, risk factor(Last reviewed: Jul 10, 2018)	criteria provided, multiple submitters, no conflicts	6	26091179	6	26090951	10	15049
NM_000410.3(HFE):c.845G>A (p.Cys282Tyr)	HFE	Microvascular complications of diabetes 7|Hemochromatosis type 1|Porphyria cutanea tarda, susceptibility to|Porphyria variegata, susceptibility to|Hemochromatosis, juvenile, digenic|Alzheimer disease, susceptibility to|Transferrin serum level quantitative trait locus 2|not provided|Hereditary cancer-predisposing syndrome|Cutaneous photosensitivity|Porphyrinuria|Hereditary hemochromatosis	Conflicting interpretations of pathogenicity, association, other, risk factor(Last reviewed: Jul 10, 2018)	criteria provided, conflicting interpretations	6	26093141	6	26092913	9	15048
NM_080680.2(COL11A2):c.1615C>T (p.Arg539Trp)	COL11A2	Weissenbacher-Zweymuller syndrome|Fibrochondrogenesis|Otospondylomegaepiphyseal dysplasia|not specified|not provided|Nonsyndromic Hearing Loss, Dominant|Stickler Syndrome, Dominant|Connective tissue disorder	Conflicting interpretations of pathogenicity(Last reviewed: May 31, 2017)	criteria provided, conflicting interpretations	6	33146747	6	33178970	46556	55721
NM_001168357.1(PLA2G7):c.1136T>C (p.Val379Ala)	PLA2G7	Asthma and atopy, susceptibility to|not provided	risk factor(Last reviewed: Jul 1, 2004)	no assertion criteria provided	6	46672943	6	46705206	7916	22955
NM_001168357.1(PLA2G7):c.275G>A (p.Arg92His)	PLA2G7	not provided	not provided	no assertion provided	6	46684222	6	46716485	56163	70802
NM_138694.3(PKHD1):c.5221G>A (p.Val1741Met)	PKHD1	Autosomal recessive polycystic kidney disease|not specified	Uncertain significance(Last reviewed: Aug 2, 2017)	criteria provided, multiple submitters, no conflicts	6	51889387	6	52024589	4111	19150
NM_002290.4(LAMA4):c.1454T>A (p.Leu485His)	LAMA4	not specified|not provided|Dilated cardiomyopathy 1JJ|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Sep 29, 2017)	criteria provided, conflicting interpretations	6	112493889	6	112172687	44347	53514
NM_000045.3(ARG1):c.62G>A (p.Arg21Gln)	ARG1|MED23	Arginase deficiency|not specified	Likely benign(Last reviewed: Feb 5, 2018)	criteria provided, single submitter	6	131897807	6	131576667	517018	501451
NM_006208.3(ENPP1):c.517A>C (p.Lys173Gln)	ENPP1	Arterial calcification of infancy|Diabetes mellitus type 2|Obesity|Insulin resistance, susceptibility to|not specified|Hypophosphatemic Rickets, Recessive	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	132172368	6	131851228	13589	28628
NM_006208.3(ENPP1):c.1025G>T (p.Gly342Val)	ENPP1	Arterial calcification of infancy	Pathogenic(Last reviewed: Jul 15, 2005)	no assertion criteria provided	6	132182844	6	131861704	13591	28630
NM_006208.3(ENPP1):c.1652A>G (p.Tyr551Cys)	ENPP1	Arterial calcification of infancy	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	6	132196932	6	131875792	561004	552092
NM_006208.3(ENPP1):c.2330A>G (p.His777Arg)	ENPP1	Arterial calcification of infancy	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	6	132206089	6	131884949	561005	552093
NCBI36/hg18 6p25.3-22.3(chr6:97634-15840373)x3		See cases	Pathogenic(Last reviewed: Mar 9, 2012)	no assertion criteria provided					443607	437269
GRCh38/hg38 6q26(chr6:162579229-163529838)x3	PRKN|QKI|PACRG|PACRG-AS1|DKFZp451B082|PACRG-AS3|CAHM|PACRG-AS2|LOC110121075	See cases	Uncertain significance(Last reviewed: Dec 17, 2012)	no assertion criteria provided	6	163000261 - 163950870	6	162579229 - 163529838	152216	161967
GRCh38/hg38 6q22.1(chr6:115890731-116427566)x3	COL10A1|FRK|TSPYL1|TSPYL4|DSE|NT5DC1|LOC100287467	See cases	Uncertain significance(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	6	116211895 - 116748729	6	115890731 - 116427566	59526	74121
NM_015570.3(AUTS2):c.1603C>T (p.His535Tyr)	AUTS2	Mental retardation, autosomal dominant 26	Likely pathogenic(Last reviewed: Mar 1, 2018)	criteria provided, single submitter	7	70231234	7	70766248	584456	575490
NM_001540.4(HSPB1):c.184G>A (p.Ala62Thr)	HSPB1	not specified|HSPB1-Related Disorder	Uncertain significance(Last reviewed: Feb 20, 2017)	criteria provided, single submitter	7	75932213	7	76302896	423730	407259
NM_001001547.2(CD36):c.268C>T (p.Pro90Ser)	CD36	Platelet glycoprotein IV deficiency	Pathogenic(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	80286003	7	80656687	13535	28574
NM_000777.5(CYP3A5):c.1165C>T (p.Pro389Ser)	CYP3A5|ZSCAN25	Essential hypertension	not provided	no assertion provided	7	99250264	7	99652641	585032	576126
NM_001753.4(CAV1):c.156C>T (p.Val52=)	CAV1	not specified|Primary pulmonary hypertension 3	Benign(Last reviewed: Apr 25, 2017)	criteria provided, multiple submitters, no conflicts	7	116166704	7	116526650	128610	134059
NM_001753.4(CAV1):c.192C>T (p.Val64=)	CAV1	Primary pulmonary hypertension 3	Likely benign(Last reviewed: May 9, 2017)	criteria provided, single submitter	7	116166740	7	116526686	474315	455981
NM_001172896.1(CAV1):c.145A>G (p.Ser49Gly)	CAV1	Pulmonary arterial hypertension associated with congenital heart disease	Uncertain significance(Last reviewed: Jun 27, 2018)	criteria provided, single submitter	7	116199042	7	116558988	548689	539173
NM_001753.4(CAV1):c.401_402delTTinsA (p.Ile134Lysfs)	CAV1	Primary pulmonary hypertension 3	Pathogenic(Last reviewed: Sep 5, 2013)	criteria provided, single submitter	7	116199205 - 116199206	7	116559151 - 116559152	128609	134058
NM_001753.4(CAV1):c.448A>G (p.Ile150Val)	CAV1	Primary pulmonary hypertension 3	Uncertain significance(Last reviewed: Mar 14, 2018)	criteria provided, single submitter	7	116199252	7	116559198	566670	561181
NM_001753.4(CAV1):c.473delC (p.Pro158Hisfs)	CAV1	Primary pulmonary hypertension 3	Pathogenic(Last reviewed: Jun 1, 2012)	no assertion criteria provided	7	116199277	7	116559223	56968	71563
NM_001753.4(CAV1):c.474delA (p.Leu159Serfs)	CAV1	Primary pulmonary hypertension 3	Pathogenic(Last reviewed: Jun 1, 2012)	no assertion criteria provided	7	116199278	7	116559224	56967	71562
NM_001753.4(CAV1):c.479_480delTT (p.Phe160Terfs)	CAV1	Lipodystrophy, congenital generalized, type 3|Primary pulmonary hypertension 3|Inborn genetic diseases	Pathogenic	criteria provided, single submitter	7	116199283 - 116199284	7	116559229 - 116559230	208669	205252
NM_001753.4(CAV1):c.500T>C (p.Phe167Ser)	CAV1	Primary pulmonary hypertension 3	Likely benign(Last reviewed: Sep 15, 2017)	criteria provided, single submitter	7	116199304	7	116559250	541324	522709
NM_000492.3(CFTR):c.1766+1G>A	CFTR	Cystic fibrosis	Pathogenic(Last reviewed: Mar 3, 2004)	practice guideline	7	117230494	7	117590440	7168	22207
NM_004333.5(BRAF):c.622A>G (p.Ile208Val)	BRAF	not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 27, 2017)	criteria provided, conflicting interpretations	7	140507849	7	140808049	178963	174180
NM_018238.3(AGK):c.975+1G>T	AGK	Cataract and cardiomyopathy	Pathogenic(Last reviewed: Jan 25, 2012)	no assertion criteria provided	7	141341709	7	141641909	30825	39782
NM_000238.3(KCNH2):c.1128G>A (p.Gln376=)	KCNH2	Long QT syndrome|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Mar 24, 2018)	criteria provided, multiple submitters, no conflicts	7	150654379	7	150957291	200323	197299
NM_000238.3(KCNH2):c.442C>T (p.Arg148Trp)	KCNH2	Long QT syndrome|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Dec 22, 2017)	criteria provided, conflicting interpretations	7	150656690	7	150959602	67505	78401
NM_000603.4(NOS3):c.[774T>C;894T>G]	NOS3	Metabolic syndrome, susceptibility to	risk factor(Last reviewed: Jun 1, 2017)	criteria provided, single submitter	7|7	150696111	7|7	150999023	496809	29054|389810
NM_000603.4(NOS3):c.894T>G (p.Asp298Glu)	NOS3	Ischemic stroke, susceptibility to|Alzheimer disease, late-onset, susceptibility to|Coronary artery spasm 1, susceptibility to|Hypertension, pregnancy-induced, susceptibility to|Hypertension resistant to conventional therapy|Ischemic heart disease, susceptibility to|not specified	Benign(Last reviewed: Mar 28, 2016)	criteria provided, single submitter	7	150696111	7	150999023	14015	29054
NM_016203.3(PRKAG2):c.590C>G (p.Pro197Arg)	PRKAG2	Stroke|Webbed neck|Hypertension|Coronary artery disease|Left ventricular hypertrophy|Ventricular tachycardia|Ventricular tachycardia|Hypertension|Stroke	Uncertain significance(Last reviewed: Sep 5, 2014)	criteria provided, single submitter	7	151372600	7	151675514	374128	360891
NM_000930.4(PLAT):c.102_103delCA (p.Arg35Ilefs)	PLAT	not provided	Uncertain significance(Last reviewed: Nov 10, 2016)	no assertion criteria provided	8	42048902 - 42048903	8	42191384 - 42191385	268128	263654
NM_012082.3(ZFPM2):c.2209A>G (p.Lys737Glu)	ZFPM2|ZFPM2-AS1	Double outlet right ventricle	Pathogenic(Last reviewed: Nov 1, 2012)	no assertion criteria provided	8	106814519	8	105802291	39519	48118
NM_000497.3(CYP11B1):c.1121G>A (p.Arg374Gln)	CYP11B1|LOC106799833	Deficiency of steroid 11-beta-monooxygenase	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	8	143957128	8	142875712	1174	16213
NM_000497.3(CYP11B1):c.953C>T (p.Thr318Met)	CYP11B1|LOC106799833	Deficiency of steroid 11-beta-monooxygenase	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	8	143957658	8	142876242	1173	16212
NM_000498.3(CYP11B2):c.-344T=	CYP11B2|LOC110673971	Aldosterone to renin ratio, increased	association(Last reviewed: Sep 18, 2013)	no assertion criteria provided	8	143999600	8	142918184	16883	31922
GRCh38/hg38 8p23.3-23.2(chr8:226452-4316172)x1	CLN8|MYOM2|DLGAP2|ARHGEF10|KBTBD11|FBXO25|CSMD1|FAM87A|TDRP|ERICH1|ZNF596|LOC286083|LOC401442|ERICH1-AS1|MIR596|MIR3674|DLGAP2-AS1|LOC101927752|LOC101927815|LOC101928058|MIR7160|KBTBD11-OT1|LOC106783493|LOC107522030	See cases	Uncertain significance(Last reviewed: Aug 13, 2012)	no assertion criteria provided	8	176452 - 4173694	8	226452 - 4316172	154744	164498
GRCh38/hg38 8q22.3-24.3(chr8:103306336-145068712)x3	ADCY8|ANGPT1|ANXA13|ADGRB1|CYC1|CYP11B1|CYP11B2|DPYS|EEF1D|EXT1|GLI4|GML|GPR20|GPT|GRINA|HAS2|HSF1|EIF3E|KCNQ3|LY6E|LY6H|MYC|NDUFB9|TONSL|CCN3|TNFRSF11B|ENPP2|PLEC|POU5F1B|PTK2|PVT1|RAD21|RPL8|ST3GAL1|SLA|SNTB1|SQLE|TAF2|TG|TRHR|TRPS1|TSTA3|COL14A1|ZNF7|ZNF16|PSCA|FZD6|LY6D|JRK|EIF3H|DGAT1|GPAA1|CCN4|FOXH1|EBAG9|RECQL4|LRRC14|EMC2|RIMS2|MTSS1|ZNF623|WASHC5|HHLA1|TRIB1|NDRG1|COLEC10|KHDRBS3|PTP4A3|RNF139|ZHX1|PUF60|ZHX2|DENND3|ZC3H3|EFR3A|ARC|BOP1|ZFPM2|SCRIB|LRRC6|DCAF13|FBXL6|OPLAH|KCNV1|MTBP|AGO2|COMMD5|MRPL13|ATAD2|ASAP1-IT1|CPSF1|LRP12|CYHR1|ASAP1|FAM135B|PHF20L1|VPS28|HGH1|KCNK9|THEM6|FAM49B|CHRAC1|EXOSC4|LY6K|TRMT12|OXR1|WDYHV1|SLC39A4|SYBU|GSDMC|ENY2|SLURP1|SLC45A4|ZFAT|ZNF250|DEPTOR|PYCR3|C8orf33|LYNX1|RHPN1-AS1|DSCC1|DERL1|SLC52A2|GSDMD|ZNF696|ARHGAP39|ZNF34|SLC25A32|DCSTAMP|SHARPIN|EPPK1|SCRT1|TRAPPC9|TATDN1|MAF1|UTP23|PARP10|C8orf76|TIGD5|NUDCD1|FAM83A|PPP1R16A|MED30|ZNF251|KIFC2|PKHD1L1|NAPRT|TBC1D31|HPYR1|MFSD3|MAL2|CSMD3|RHPN1|FBXO32|CTHRC1|TOP1MT|CCDC26|ZNF572|ABRA|LYPD2|TMEM71|FER1L6-AS2|TMEM65|LINC00964|FAM84B|TMEM74|FAM91A1|SLC30A8|COL22A1|ADCK5|TSNARE1|MAPK15|NSMCE2|ZNF707|BREA2|FAM83H|LINC01591|ZNF252P-AS1|C8orf31|ZFP41|GPIHBP1|KLHL38|NRBP2|ZNF517|WDR97|TMEM249|RSPO2|PEG13|SPATC1|MROH5|MAFA|SAMD12|LOC401478|MIR30B|MIR30D|C8orf82|SLURP2|FER1L6-AS1|AARD|LRRC24|MIR151A|NCRNA00250|SAMD12-AS1|ZFAT-AS1|HAS2-AS1|LINC00051|TMEM75|MROH6|IQANK1|SCX|RAD21-AS1|FER1L6|MIR548A3|MIR548D1|MIR661|CASC8|MROH1|LINC00977|OC90|LINC01300|MIR937|MIR939|FAM83H-AS1|LOC100130027|LINC00861|LOC100130232|CCDC166|FAM83A-AS1|LOC100132813|LY6E-DT|TRM-CAT1-1|CASC11|TONSL-AS1|LNCOC1|MIR1302-7|MIR1205|MIR1206|MIR1207|MIR1204|MIR1234|MIR2053|MIR1208|PTCSC1|LOC100310756|MIR3686|MIR548AA1|MIR3610|CCAT1|ASAP1-IT2|C8orf17|MINCR|ZHX1-C8orf76|MIR4662A|MIR4662B|MIR4663|MIR4472-1|MIR4664|PCAT1|MIR5194|LINC00536|CCAT2|PRNCR1|LINC01608|LINC01609|LOC101927513|LOC101927543|LOC101927588|RNF139-AS1|LOC101927657|LINC00824|LOC101927798|LOC101927822|LOC101927845|LOC101927915|LOC101928087|LY6L|LOC101928160|LOC101928902|MIR6846|MIR6847|MIR6848|MIR7112|MIR6850|MIR548AZ|MIR6844|MIR6893|MIR6845|MIR6849|MIR7848|ZFPM2-AS1|CASC21|CASC19|PCAT2|LINC01151|MAFA-AS1|LOC105375690|LINC02237|LOC105375713|MAL2-AS1|SMILR|LOC105375744|LOC105375773|LOC105375787|LINC00976|LOC106799833|LOC106799834|LOC106867047|LOC107403242|LINC02055|LOC108228207|LOC108254690|LOC108281119|LOC108353813|LOC108491824|SNORD168|SNORD173|SNORD149|LOC110120608|LOC110120802|LOC110121123|LOC110121191|LOC110121208|LOC110121217|LOC110121218|LOC110599578|LOC110673971|LOC110673972|LYNX1-SLURP2|LOC111365157|LOC111365183|LOC111556135|LOC111589211	See cases	Pathogenic(Last reviewed: Aug 13, 2012)	no assertion criteria provided	8	104318564 - 146294098	8	103306336 - 145068712	154743	164497
GRCh38/hg38 8p23.1(chr8:7411297-8222398)x1	DEFB4A|SPAG11B|DEFB103B|DEFB104A|DEFB105A|DEFB106A|DEFB107A|USP17L8|DEFB103A|DEFB107B|DEFB104B|DEFB106B|DEFB105B|USP17L3|SPAG11A|PRR23D1|FAM66E|ZNF705B|PRR23D2|DEFB4B|MIR548I3|FAM85B	See cases	Benign(Last reviewed: Oct 22, 2013)	no assertion criteria provided	8	7268819 - 8079920	8	7411297 - 8222398	32007	40672
NM_001114753.2(ENG):c.1853G>T (p.Arg618Leu)	ENG	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	9	130578085	9	127815806	426047	414374
NM_001114753.2(ENG):c.1804delA (p.I602Sfs*38)	ENG	Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic	no assertion criteria provided	9	130578270	9	127815991	426046	414375
NM_000118.3(ENG):c.1742-15G>A	ENG|LOC102723566	not specified	Uncertain significance(Last reviewed: Sep 29, 2017)	criteria provided, single submitter	9	130578347	9	127816068	504728	496503
NM_001114753.2(ENG):c.1742-22T>C (p.C582_R618del)	ENG|LOC102723566	Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic	no assertion criteria provided	9	130578354	9	127816075	426045	414376
NM_000118.3(ENG):c.1633G>A (p.Gly545Ser)	ENG|LOC102723566	Primary pulmonary hypertension|Osler hemorrhagic telangiectasia syndrome|not specified|Pulmonary arterial hypertension associated with congenital heart disease	Conflicting interpretations of pathogenicity(Last reviewed: Jun 27, 2018)	criteria provided, conflicting interpretations	9	130580452	9	127818173	237022	240451
NM_001114753.2(ENG):c.1410delG (p.Q471Sfs*20)	ENG|LOC102723566	Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic	no assertion criteria provided	9	130581013	9	127818734	426044	414377
NM_001114753.2(ENG):c.1334delT (p.M445Rfs*46)	ENG|LOC102723566	Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic	no assertion criteria provided	9	130581089	9	127818810	426043	414378
NM_001114753.2(ENG):c.788T>A (p.Ile263Asn)	ENG	Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic	no assertion criteria provided	9	130587538	9	127825259	426042	414379
NM_001114753.2(ENG):c.682_686delTCGGC (p.S228Rfs*104)	ENG	Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic	no assertion criteria provided	9	130587977 - 130587981	9	127825698 - 127825702	426041	414380
NM_000118.3(ENG):c.640G>A (p.Gly214Ser)	ENG	Primary pulmonary hypertension|Osler hemorrhagic telangiectasia syndrome|Haemorrhagic telangiectasia 1	Uncertain significance(Last reviewed: Mar 4, 2018)	criteria provided, single submitter	9	130588023	9	127825744	161233	171112
NM_000093.4(COL5A1):c.983G>A (p.Gly328Glu)	COL5A1	Ehlers-Danlos syndrome, type 2|Ehlers-Danlos syndrome, classic type	Uncertain significance(Last reviewed: Nov 18, 2017)	criteria provided, single submitter	9	137622140	9	134730294	529272	524287
NM_017617.5(NOTCH1):c.4487G>A (p.Cys1496Tyr)	NOTCH1	Adams-Oliver syndrome 5	Pathogenic	criteria provided, single submitter	9	139399861	9	136505409	156007	165811
NM_017617.5(NOTCH1):c.1285T>C (p.Cys429Arg)	NOTCH1	Adams-Oliver syndrome 5	Pathogenic/Likely pathogenic(Last reviewed: Sep 4, 2014)	no assertion criteria provided	9	139412360	9	136517908	156214	166011
NM_016204.3(GDF2):c.76C>T (p.Gln26Ter)	GDF2	Telangiectasia, hereditary hemorrhagic, type 5	Uncertain significance(Last reviewed: Jan 26, 2018)	criteria provided, single submitter	10	48416618	10	47322744	541541	525348
NM_001080512.2(BICC1):c.259C>T (p.Gln87Ter)	BICC1	Renal dysplasia diffuse cystic	risk factor(Last reviewed: Jan 1, 2012)	no assertion criteria provided	10	60461855	10	58702095	31153	40110
NM_001130161.2(STOX1):c.1824A>C (p.Glu608Asp)	STOX1	Preeclampsia/eclampsia 4	Pathogenic(Last reviewed: May 1, 2005)	no assertion criteria provided	10	70645376	10	68885620	1720	16759
NM_004329.2(BMPR1A):c.1498A>G (p.Met500Val)	BMPR1A	Juvenile polyposis syndrome|not provided|Hereditary cancer-predisposing syndrome|Juvenile Polyposis|Pulmonary arterial hypertension associated with congenital heart disease	Uncertain significance(Last reviewed: Jun 27, 2018)	criteria provided, multiple submitters, no conflicts	10	88683375	10	86923618	301353	311450
NM_001613.2(ACTA2):c.536G>A (p.Arg179His)	ACTA2	Aortic aneurysm, familial thoracic 6|Multisystemic smooth muscle dysfunction syndrome|Moyamoya disease 5|Thoracic aortic aneurysm and aortic dissection|not provided|Cardiovascular phenotype|alterations of great arteries and veins|Connective tissue disorder	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	10	90701066	10	88941309	29598	38552
NM_001613.2(ACTA2):c.535C>T (p.Arg179Cys)	ACTA2	Aortic aneurysm, familial thoracic 6|not provided	Pathogenic(Last reviewed: Jun 20, 2018)	criteria provided, multiple submitters, no conflicts	10	90701067	10	88941310	265026	259943
NM_016341.3(PLCE1):c.961C>T (p.Arg321Ter)	PLCE1	Nephrotic syndrome, type 3	Pathogenic(Last reviewed: Jul 1, 2010)	no assertion criteria provided	10	95791764	10	94032007	18423	33462
NM_016341.3(PLCE1):c.1477C>T (p.Arg493Ter)	PLCE1	Nephrotic syndrome, type 3	Pathogenic(Last reviewed: Dec 1, 2006)	no assertion criteria provided	10	95892201	10	94132444	2345	17384
NM_003990.4(PAX2):c.76dupG (p.Val26Glyfs)	PAX2	Renal coloboma syndrome|not provided|Focal segmental glomerulosclerosis 7	Pathogenic(Last reviewed: Jun 26, 2017)	criteria provided, multiple submitters, no conflicts	10	102509535	10	100749778	156297	166077
NM_003990.4(PAX2):c.130_151del22 (p.Leu44Profs)	PAX2	Renal coloboma syndrome	Pathogenic(Last reviewed: Mar 1, 2012)	no assertion criteria provided	10	102509589 - 102509610	10	100749832 - 100749853	13797	28836
NM_033163.3(FGF8):c.686C>T (p.Thr229Met)	FGF8	Kallmann syndrome 6	Uncertain significance(Last reviewed: Jan 1, 2010)	no assertion criteria provided	10	103530135	10	101770378	9126	24165
NM_030912.2(TRIM8):c.1375C>T (p.Gln459Ter)	TRIM8	TRIM8-related epileptic encephalopathy	Likely pathogenic(Last reviewed: May 14, 2018)	criteria provided, single submitter	10	104416830	10	102657073	584442	575492
NM_000102.3(CYP17A1):c.1358T>C (p.Phe453Ser)	CYP17A1	Combined partial 17-alpha-hydroxylase/17,20-lyase deficiency	Pathogenic(Last reviewed: Sep 1, 2006)	no assertion criteria provided	10	104590628	10	102830871	1806	16845
NM_000102.3(CYP17A1):c.1039C>T (p.Arg347Cys)	CYP17A1	Combined partial 17-alpha-hydroxylase/17,20-lyase deficiency	Pathogenic(Last reviewed: Dec 1, 2002)	no assertion criteria provided	10	104592368	10	102832611	1794	16833
NM_000102.3(CYP17A1):c.316T>C (p.Ser106Pro)	CYP17A1	Complete combined 17-alpha-hydroxylase/17,20-lyase deficiency|not provided	Pathogenic(Last reviewed: Oct 13, 2016)	criteria provided, single submitter	10	104595131	10	102835374	1780	16819
NM_000102.3(CYP17A1):c.157_159delTTC (p.Phe54del)	CYP17A1	Combined partial 17-alpha-hydroxylase/17,20-lyase deficiency	Pathogenic(Last reviewed: Oct 1, 1996)	no assertion criteria provided	10	104596960 - 104596962	10	102837203 - 102837205	1778	16817
NM_000102.3(CYP17A1):c.62G>A (p.Arg21Lys)	CYP17A1	Congenital adrenal hyperplasia|not specified	Uncertain significance(Last reviewed: Apr 13, 2017)	criteria provided, multiple submitters, no conflicts	10	104597057	10	102837300	298626	319911
NM_000102.3(CYP17A1):c.51G>A (p.Trp17Ter)	CYP17A1	Complete combined 17-alpha-hydroxylase/17,20-lyase deficiency	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	10	104597068	10	102837311	1789	16828
NM_001134363.2(RBM20):c.448G>A (p.Ala150Thr)	RBM20	Dilated cardiomyopathy 1DD|not specified|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	Conflicting interpretations of pathogenicity(Last reviewed: Jan 16, 2018)	criteria provided, conflicting interpretations	10	112540815	10	110781057	44018	53186
NM_002775.4(HTRA1):c.517G>C (p.Ala173Pro)	HTRA1	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2	Pathogenic(Last reviewed: Sep 21, 2016)	no assertion criteria provided	10	124248462	10	122488946	221229	222927
NM_002775.4(HTRA1):c.852C>A (p.Ser284Arg)	HTRA1	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2	Pathogenic(Last reviewed: Sep 21, 2016)	no assertion criteria provided	10	124266281	10	122506765	221230	222928
NM_002775.4(HTRA1):c.973_1005del33	HTRA1	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2	Pathogenic(Last reviewed: Sep 21, 2016)	no assertion criteria provided	10	124266885	10	122507369	221231	222929
GRCh38/hg38 10q21.2-21.3(chr10:60977777-62913465)x3	EGR2|RHOBTB1|ZNF365|ARID5B|ADO|CABCOCO1|TMEM26|RTKN2|LOC283045|LINC00845|TMEM26-AS1|LOC111946249	See cases	Uncertain significance(Last reviewed: Mar 11, 2013)	no assertion criteria provided	10	62737535 - 64673225	10	60977777 - 62913465	155221	164975
NM_000218.2(KCNQ1):c.484G>A (p.Val162Met)	KCNQ1	Long QT syndrome|not specified|Congenital long QT syndrome	Uncertain significance(Last reviewed: Jan 3, 2017)	criteria provided, multiple submitters, no conflicts	11	2591864	11	2570634	67077	77973
NM_000218.2(KCNQ1):c.521G>A (p.Arg174His)	KCNQ1	not provided|Long QT syndrome, LQT1 subtype|Congenital long QT syndrome	Pathogenic(Last reviewed: Sep 29, 2017)	criteria provided, single submitter	11	2591901	11	2570671	53059	67727
NM_000218.2(KCNQ1):c.565G>A (p.Gly189Arg)	KCNQ1	Long QT syndrome 1|not provided|Congenital long QT syndrome	Likely pathogenic(Last reviewed: May 2, 2017)	criteria provided, single submitter	11	2591945	11	2570715	3114	18153
NM_000218.2(KCNQ1):c.1105C>G (p.Pro369Ala)	KCNQ1	not specified	Uncertain significance(Last reviewed: May 18, 2014)	criteria provided, single submitter	11	2606514	11	2585284	200840	197472
NM_000218.2(KCNQ1):c.1121T>A (p.Leu374His)	KCNQ1	Long QT syndrome|not specified|not provided|Congenital long QT syndrome|Cardiovascular phenotype	Uncertain significance(Last reviewed: Aug 8, 2017)	criteria provided, multiple submitters, no conflicts	11	2606530	11	2585300	52961	67629
NM_000518.5(HBB):c.425T>G (p.Leu142Arg)	HBB|LOC107133510|LOC110006319	HEMOGLOBIN OLMSTED	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	11	5246847	11	5225617	15298	30337
NM_000518.5(HBB):c.363A>C (p.Lys121Asn)	HBB|LOC107133510|LOC110006319	not specified|not provided	Uncertain significance(Last reviewed: Sep 28, 2016)	criteria provided, single submitter	11	5246909	11	5225679	15329	30368
NM_000518.4(HBB):c.34G>T (p.Val12Phe)	HBB|LOC106099062|LOC107133510	HEMOGLOBIN WASHTENAW	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	11	5248218	11	5226988	15535	30574
NM_024426.4(WT1):c.1378T>C (p.Phe460Leu)	WT1	Frasier syndrome	Pathogenic(Last reviewed: Jan 1, 1999)	no assertion criteria provided	11	32413572	11	32392026	3504	18543
NM_000506.3(F2):c.1785C>G (p.Asp595Glu)	F2	Hereditary factor II deficiency disease	Pathogenic(Last reviewed: Mar 1, 2006)	no assertion criteria provided	11	46760874	11	46739324	13314	28353
NM_000506.4(F2):c.*97G>A	F2	VENOUS THROMBOSIS|Ischemic stroke, susceptibility to|Prothrombin deficiency, congenital|Pregnancy loss, recurrent, susceptibility to, 2|Venous thrombosis	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, multiple submitters, no conflicts	11	46761055	11	46739505	13310	28349
NM_000256.3(MYBPC3):c.3682C>T (p.Arg1228Cys)	MYBPC3	Primary dilated cardiomyopathy|Familial hypertrophic cardiomyopathy 4|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2018)	criteria provided, conflicting interpretations	11	47353755	11	47332204	161306	171133
NM_000256.3(MYBPC3):c.3584G>T (p.Gly1195Val)	MYBPC3	not specified|not provided	Likely pathogenic(Last reviewed: May 14, 2014)	criteria provided, single submitter	11	47354160	11	47332609	181013	179186
NM_000256.3(MYBPC3):c.2882C>T (p.Pro961Leu)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified	Uncertain significance(Last reviewed: Aug 11, 2017)	criteria provided, multiple submitters, no conflicts	11	47356616	11	47335065	42665	51835
NM_000256.3(MYBPC3):c.2870C>G (p.Thr957Ser)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Left ventricular noncompaction 10|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Apr 16, 2018)	criteria provided, conflicting interpretations	11	47356628	11	47335077	36607	45269
NM_000256.3(MYBPC3):c.2374T>C (p.Trp792Arg)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Apr 19, 2018)	criteria provided, multiple submitters, no conflicts	11	47359280	11	47337729	36605	45267
NM_000256.3(MYBPC3):c.2210C>T (p.Thr737Met)	MYBPC3	not specified|not provided|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jan 11, 2018)	criteria provided, multiple submitters, no conflicts	11	47360169	11	47338618	42608	51778
NM_000256.3(MYBPC3):c.1624G>C (p.Glu542Gln)	MYBPC3	Familial hypertrophic cardiomyopathy 1|Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Left ventricular noncompaction 10|Hypertrophic cardiomyopathy|Familial dilated cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, multiple submitters, no conflicts	11	47364129	11	47342578	8608	23647
NM_000256.3(MYBPC3):c.1484G>A (p.Arg495Gln)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|MYBPC3-Related Disorders	Pathogenic/Likely pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, multiple submitters, no conflicts	11	47364269	11	47342718	164113	174776
NM_000256.3(MYBPC3):c.1321G>A (p.Glu441Lys)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Wolff-Parkinson-White pattern|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Uncertain significance(Last reviewed: Apr 27, 2018)	criteria provided, multiple submitters, no conflicts	11	47364602	11	47343051	36601	45263
NM_000256.3(MYBPC3):c.713G>A (p.Arg238His)	MYBPC3	Familial hypertrophic cardiomyopathy 4|not specified|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Aug 17, 2017)	criteria provided, multiple submitters, no conflicts	11	47370034	11	47348483	177910	175203
NM_000256.3(MYBPC3):c.624G>C (p.Gln208His)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Oct 13, 2017)	criteria provided, multiple submitters, no conflicts	11	47371355	11	47349804	42775	51945
NM_032667.6(BSCL2):c.565G>T (p.Glu189Ter)	BSCL2|HNRNPUL2-BSCL2	Congenital generalized lipodystrophy type 2|Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Apr 24, 2015)	criteria provided, single submitter	11	62460143	11	62692671	4546	19585
NM_000244.3(MEN1):c.669+1delG	MEN1	Gastrointestinal stroma tumor|Parathyroid adenoma|Thyroid adenoma|Hypertension|Diabetes mellitus|Thyroid adenoma|Chronic diarrhea|Parathyroid adenoma|Gastrointestinal stroma tumor|Diabetes mellitus|Hypertension	Pathogenic(Last reviewed: Jan 20, 2015)	criteria provided, single submitter	11	64575362	11	64807890	374107	360931
NM_007103.3(NDUFV1):c.491A>G (p.Asn164Ser)	NDUFV1	Mitochondrial complex I deficiency	not provided	no assertion provided	11	67377087	11	67609616	585028	576145
NM_005472.4(KCNE3):c.248G>A (p.Arg83His)	KCNE3	Brugada syndrome 6|not specified|Syncope|not provided|Ventricular fibrillation|Ventricular fibrillation|Periodic paralysis|Cardiovascular phenotype|Periodic paralysis	Conflicting interpretations of pathogenicity(Last reviewed: May 11, 2018)	criteria provided, conflicting interpretations	11	74168361	11	74457316	5541	20580
NM_004588.4(SCN2B):c.82C>T (p.Arg28Trp)	SCN2B	not specified|Atrial fibrillation, familial, 14	Uncertain significance(Last reviewed: Feb 6, 2017)	criteria provided, single submitter	11	118039455	11	118168740	60769	75311
NM_000190.3:c.1078_1132delGCCCATTAACTGGTTTGTGGGGCACAGATGCCTGGGTTGCTGCTGTCCAGTGCCT	HMBS	Acute intermittent porphyria	Pathogenic(Last reviewed: May 20, 2017)	criteria provided, single submitter	11	118963985 - 118964039	11	119093275 - 119093329	549662	540142
NM_005188.3(CBL):c.1186T>C (p.Cys396Arg)	CBL	Noonan syndrome-like disorder with juvenile myelomonocytic leukemia|not provided	Pathogenic(Last reviewed: Feb 19, 2014)	criteria provided, single submitter	11	119148966	11	119278256	29823	38778
GRCh38/hg38 11p14.3-14.1(chr11:23024064-27978597)x1	BDNF|BBOX1|LIN7C|LGR4|ANO3|CCDC34|MUC15|SLC5A12|LUZP2|FIBIN|BDNF-AS|LINC00678|MIR8054|MIR8087|BBOX1-AS1|LOC105376599|LOC105376671|LOC108178983|LOC108178984	See cases	Likely pathogenic(Last reviewed: Aug 29, 2011)	no assertion criteria provided	11	23045610 - 28000144	11	23024064 - 27978597	148655	158406
GRCh38/hg38 11q25(chr11:131212028-135075271)x1	OPCML|IGSF9B|NCAPD3|ACAD8|B3GAT1|THYN1|NTM|JAM3|GLB1L2|VPS26B|GLB1L3|SPATA19|MIR4697HG|LOC283177|LOC646522|LOC729305|LOC100128239|LOC100507548|MIR4697|NTM-IT|NTM-AS1|LOC101929653|SNORD153|LOC110120853	See cases	Pathogenic(Last reviewed: Jun 5, 2011)	no assertion criteria provided	11	131081923 - 134945165	11	131212028 - 135075271	148509	158260
GRCh38/hg38 11q23.2-25(chr11:112864326-131189315)x3	ACRV1|APLP2|APOA1|APOA4|APOC3|ARCN1|FXYD2|CXCR5|CBL|CD3D|CD3E|CD3G|CHEK1|DDX6|DPAGT1|DRD2|ETS1|FLI1|SLC37A4|GRIK4|H2AFX|HMBS|HSPA8|HTR3A|IL10RA|STT3A|KCNJ1|KCNJ5|VWA5A|MCAM|KMT2A|NCAM1|NFRKB|NNMT|NRGN|PAFAH1B2|NECTIN1|RPS25|SC5D|SCN2B|SCN4B|ST3GAL4|SORL1|SRPRA|ST14|TAGLN|TECTA|THY1|UPK2|ZBTB16|ZNF202|BARX2|ZPR1|USP2|PCSK7|HTR3B|ZW10|UBE4A|EI24|FEZ1|ARHGAP32|C2CD2L|RBM7|MPZL2|HYOU1|ATP5MG|ADAMTS8|TREH|CEP164|PHLDB1|ARHGEF12|SIK3|VSIG2|BACE1|TRIM29|CADM1|POU2F3|HINFP|REXO2|OR8G2P|OR8B8|OR8G1|OR10D3|OR8B2|DCPS|ZBTB44|DDX25|CDON|SIDT2|TRAPPC4|SPA17|FXYD6|SIAE|C11orf71|ROBO4|NXPE4|TTC12|FOXRED1|SCN3B|VPS11|CRTAM|TMPRSS4|IFT46|PRDM10|DSCAML1|GRAMD1B|USP28|PKNOX2|TP53AIP1|ABCG4|ROBO3|RNF26|OR10G6|FAM118B|NLRX1|MSANTD2|CLMP|PDZD3|JHY|CCDC15|TMPRSS5|PUS3|MFRP|TMPRSS13|KIRREL3|BUD13|TMEM25|RPUSD4|TBRG1|UBASH3B|SNORD14C|SNORD14D|SNORD14E|ESAM|TIRAP|C1QTNF5|PANX3|APOA5|TMEM45B|NXPE1|NXPE2|JAML|TTC36|PATE1|ADAMTS15|MPZL3|C11orf45|HYLS1|TMEM218|SLC37A2|OR8B12|OR8G5|OR10G8|OR10G9|OR10S1|OR6T1|OR4D5|TBCEL|TMEM136|HEPACAM|OAF|ANKK1|RNF214|LINC00900|BCL9L|FOXR1|CCDC153|OR8D1|OR8D2|OR8B4|KIRREL3-AS3|C11orf44|CCDC84|TMEM225|OR8D4|VSIG10L2|BSX|OR6X1|OR6M1|OR10G4|OR10G7|OR8B3|OR8A1|MIR100HG|PATE2|PATE4|GSEC|LOC399975|SNX19|LOC403312|MIRLET7A2|MIR100|MIR125B1|BLID|LINC00167|HEPN1|CLDN25|LOC646383|LOC649133|LOC100128242|LOC100131626|PATE3|TRK-TTT2-1|NCAM1-AS1|BACE1-AS|MIR4301|MIR3167|USP2-AS1|MIR3656|LOC100507283|SENCR|LINC02551|SMIM35|FXYD6-FXYD2|MIR4493|MIR4492|LOC100652768|KIRREL3-AS2|LOC101928847|LOC101928940|LOC101928985|LOC101929011|LOC101929089|LOC101929208|LOC101929227|LOC101929340|LOC101929427|LOC101929473|LOC101929497|ETS1-AS1|LOC101929538|LINC01395|MIR6756|MIR6090|MIR6716|MIR8052|LOC102724301|LOC103611081|PKNOX2-AS1|APOA1-AS|LOC105369507|LOC105369509|LOC105369532|STT3A-AS1|LINC02098|LOC107984399|LOC108165612|LOC108165613|LOC108281156|LOC108353823|LOC108491825|LOC109280160|SNORD150|LOC110120944|LOC110121415|LOC110121418|LOC110121460|LOC111365219|LOC111413012|LOC111429625|LOC111464985|LOC111465015|LOC111718489	See cases	Pathogenic(Last reviewed: Jun 5, 2011)	no assertion criteria provided	11	112832130 - 131059210	11	112864326 - 131189315	148508	158259
NM_213655.4(WNK1):c.2999del (p.Arg1000Asnfs)	WNK1	Hereditary sensory and autonomic neuropathy type IIA	Pathogenic(Last reviewed: Jul 1, 2008)	no assertion criteria provided	12	977636	12	868470	5170	20209
NM_002234.3(KCNA5):c.544G>A (p.Gly182Arg)	KCNA5	Atrial fibrillation, familial, 7	Uncertain significance(Last reviewed: Apr 16, 2018)	criteria provided, single submitter	12	5153857	12	5044691	469594	463145
NM_002234.3(KCNA5):c.633G>C (p.Glu211Asp)	KCNA5	Atrial fibrillation, familial, 7|Primary pulmonary hypertension|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Aug 24, 2017)	criteria provided, conflicting interpretations	12	5153946	12	5044780	191459	189348
NM_001038.5(SCNN1A):c.1435T>C (p.Cys479Arg)	SCNN1A	LIDDLE SYNDROME 3	Pathogenic(Last reviewed: Sep 17, 2018)	no assertion criteria provided	12	6458497	12	6349331	561216	552354
NM_002336.2(LRP6):c.1831C>T (p.Arg611Cys)	LRP6	Coronary artery disease, autosomal dominant 2	Pathogenic(Last reviewed: Mar 2, 2007)	no assertion criteria provided	12	12317428	12	12164494	6267	21306
NM_002336.2(LRP6):c.1418G>A (p.Arg473Gln)	LRP6	Coronary artery disease, autosomal dominant 2	Pathogenic(Last reviewed: Sep 1, 2013)	no assertion criteria provided	12	12332871	12	12179937	66055	76960
NM_002336.2(LRP6):c.1298A>G (p.Asn433Ser)	LRP6	Coronary artery disease, autosomal dominant 2	Pathogenic(Last reviewed: Sep 1, 2013)	no assertion criteria provided	12	12334052	12	12181118	66054	76959
NM_002336.2(LRP6):c.1079G>A (p.Arg360His)	LRP6	Coronary artery disease, autosomal dominant 2	Pathogenic(Last reviewed: Sep 1, 2013)	no assertion criteria provided	12	12334271	12	12181337	66056	76961
NM_000921.4(PDE3A):c.1333A>G (p.Thr445Ala)	PDE3A	Brachydactyly with hypertension	Pathogenic(Last reviewed: Jun 1, 2015)	no assertion criteria provided	12	20769227	12	20616293	193021	190182
NM_000921.4(PDE3A):c.1334C>G (p.Thr445Ser)	PDE3A	Brachydactyly with hypertension	Pathogenic(Last reviewed: Jun 1, 2015)	no assertion criteria provided	12	20769228	12	20616294	193022	190183
NM_000921.4(PDE3A):c.1334C>A (p.Thr445Asn)	PDE3A	Brachydactyly with hypertension	Pathogenic(Last reviewed: Jun 1, 2015)	no assertion criteria provided	12	20769228	12	20616294	193020	190181
NM_000921.4(PDE3A):c.1339G>A (p.Ala447Thr)	PDE3A	Brachydactyly with hypertension	Pathogenic(Last reviewed: Jun 1, 2015)	no assertion criteria provided	12	20769233	12	20616299	193023	190184
NM_000921.4(PDE3A):c.1340C>T (p.Ala447Val)	PDE3A	Brachydactyly with hypertension	Pathogenic(Last reviewed: Jun 1, 2015)	no assertion criteria provided	12	20769234	12	20616300	193024	190185
NM_000921.4(PDE3A):c.1346G>T (p.Gly449Val)	PDE3A	Brachydactyly with hypertension	Pathogenic(Last reviewed: Jun 1, 2015)	no assertion criteria provided	12	20769240	12	20616306	193025	190186
NM_005691.3(ABCC9):c.3347G>A (p.Arg1116His)	ABCC9	Hypertrichotic osteochondrodysplasia	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	12	21995374	12	21842440	35533	44204
NM_004572.3(PKP2):c.2578-8T>G	PKP2	Arrhythmogenic right ventricular cardiomyopathy, type 9|not specified	Uncertain significance(Last reviewed: Jul 31, 2017)	criteria provided, multiple submitters, no conflicts	12	32945434	12	32792500	201969	198384
NM_004572.3(PKP2):c.2197_2202delCACACCinsG (p.His733Alafs)	PKP2	Arrhythmogenic right ventricular cardiomyopathy, type 9|Arrhythmogenic right ventricular cardiomyopathy|not provided|Arrhythmogenic right ventricular dysplasia/cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, multiple submitters, no conflicts	12	32955434 - 32955439	12	32802500 - 32802505	45063	54230
NM_000020.2(ACVRL1):c.37delC (p.L13Cfs*2)	ACVRL1	Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic	no assertion criteria provided	12	52306295	12	51912511	426009	414381
NM_000020.2(ACVRL1):c.199C>T (p.Arg67Trp)	ACVRL1	Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic	no assertion criteria provided	12	52307020	12	51913236	426010	414382
NM_000020.2(ACVRL1):c.293A>G (p.Asn98Ser)	ACVRL1	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	12	52307114	12	51913330	426011	414383
NM_000020.2(ACVRL1):c.430C>T (p.Arg144Ter)	ACVRL1	Primary pulmonary hypertension|Hereditary hemorrhagic telangiectasia type 2	Pathogenic(Last reviewed: May 18, 2018)	criteria provided, single submitter	12	52307459	12	51913675	212804	210228
NM_000020.2(ACVRL1):c.536A>C (p.Asp179Ala)	ACVRL1	Primary pulmonary hypertension|Hereditary hemorrhagic telangiectasia type 2	Likely benign(Last reviewed: Jun 23, 2017)	criteria provided, single submitter	12	52307768	12	51913984	426012	414384
NM_000020.2(ACVRL1):c.593T>A (p.Val198Glu)	ACVRL1	Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic	no assertion criteria provided	12	52307825	12	51914041	426013	414385
NM_000020.2(ACVRL1):c.602A>G (p.Gln201Arg)	ACVRL1	Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic	no assertion criteria provided	12	52307834	12	51914050	426014	414386
NM_000020.2(ACVRL1):c.632G>A (p.Gly211Asp)	ACVRL1	Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Dec 1, 2003)	no assertion criteria provided	12	52308229	12	51914445	8253	23292
NM_000020.2(ACVRL1):c.653_654invGG (p.Arg218Pro)	ACVRL1	Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic	no assertion criteria provided	12	52308250 - 52308251	12	51914466 - 51914467	426015	414433
NM_000020.2(ACVRL1):c.760_762delGAC (p.Asp254del)	ACVRL1	Hereditary hemorrhagic telangiectasia type 2|Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Aug 2, 2001)	no assertion criteria provided	12	52308357 - 52308359	12	51914573 - 51914575	8250	23289
NM_000020.2(ACVRL1):c.788A>G (p.Asp263Gly)	ACVRL1	Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic	no assertion criteria provided	12	52309024	12	51915240	426016	414387
NM_000020.2(ACVRL1):c.818T>C (p.Leu273Pro)	ACVRL1	Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic	no assertion criteria provided	12	52309054	12	51915270	426017	414388
NM_000020.2(ACVRL1):c.853C>T (p.Leu285Phe)	ACVRL1	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	12	52309089	12	51915305	426018	414389
NM_000020.2(ACVRL1):c.854T>C (p.Leu285Pro)	ACVRL1	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	12	52309090	12	51915306	426019	414390
NM_000020.2(ACVRL1):c.936C>G (p.His312Gln)	ACVRL1	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	12	52309172	12	51915388	426020	414391
NM_000020.2(ACVRL1):c.950T>C (p.Ile317Thr)	ACVRL1	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	12	52309186	12	51915402	426021	414392
NM_000020.2(ACVRL1):c.955G>C (p.Gly319Arg)	ACVRL1	Primary pulmonary hypertension|Hereditary hemorrhagic telangiectasia type 2	Likely pathogenic(Last reviewed: Sep 15, 2017)	criteria provided, single submitter	12	52309191	12	51915407	426022	414393
NM_000020.2(ACVRL1):c.1031G>A (p.Cys344Tyr)	ACVRL1	Hereditary hemorrhagic telangiectasia type 2|Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|not specified	Pathogenic(Last reviewed: May 12, 2018)	criteria provided, multiple submitters, no conflicts	12	52309267	12	51915483	8254	23293
NM_000020.2(ACVRL1):c.1055C>A (p.Ala352Asp)	ACVRL1	Hereditary hemorrhagic telangiectasia type 2|Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|not specified	Pathogenic/Likely pathogenic(Last reviewed: Jun 19, 2017)	criteria provided, multiple submitters, no conflicts	12	52309826	12	51916042	426023	414394
NM_000020.2(ACVRL1):c.1120C>T (p.Arg374Trp)	ACVRL1	Hereditary hemorrhagic telangiectasia type 2|Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|not specified|not provided	Pathogenic(Last reviewed: Apr 17, 2018)	criteria provided, multiple submitters, no conflicts	12	52309891	12	51916107	8249	23288
NM_000020.2(ACVRL1):c.1121G>A (p.Arg374Gln)	ACVRL1	Hereditary hemorrhagic telangiectasia type 2|Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|not specified	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, multiple submitters, no conflicts	12	52309892	12	51916108	411314	399783
NM_000020.2(ACVRL1):c.1124A>G (p.Tyr375Cys)	ACVRL1	Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic	no assertion criteria provided	12	52309895	12	51916111	426024	414395
NM_000020.2(ACVRL1):c.1142T>C (p.Leu381Pro)	ACVRL1	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	12	52309913	12	51916129	426025	414396
NM_000020.2(ACVRL1):c.1195T>C (p.Trp399Arg)	ACVRL1	Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic	no assertion criteria provided	12	52309966	12	51916182	426026	414397
NM_000020.2(ACVRL1):c.1196G>T (p.Trp399Leu)	ACVRL1	Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic	no assertion criteria provided	12	52309967	12	51916183	426027	414398
NM_000020.2(ACVRL1):c.1196G>C (p.Trp399Ser)	ACVRL1	Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Dec 1, 2003)	no assertion criteria provided	12	52309967	12	51916183	8255	23294
NM_000020.2(ACVRL1):c.1231C>T (p.Arg411Trp)	ACVRL1	Hereditary hemorrhagic telangiectasia type 2|Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|not provided	Pathogenic(Last reviewed: Mar 27, 2018)	criteria provided, multiple submitters, no conflicts	12	52310002	12	51916218	8251	23290
NM_000020.2(ACVRL1):c.1232G>A (p.Arg411Gln)	ACVRL1	Hereditary hemorrhagic telangiectasia type 2|Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|not specified|not provided	Pathogenic(Last reviewed: Jun 9, 2018)	criteria provided, multiple submitters, no conflicts	12	52310003	12	51916219	8243	23282
NM_000020.2(ACVRL1):c.1270C>A (p.Pro424Thr)	ACVRL1	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	12	52312792	12	51919008	426028	414399
NM_000020.2(ACVRL1):c.1280A>T (p.Asp427Val)	ACVRL1	Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic	no assertion criteria provided	12	52312802	12	51919018	426029	414400
NM_000020.2(ACVRL1):c.1324G>A (p.Val442Met)	ACVRL1	Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic	no assertion criteria provided	12	52312846	12	51919062	426030	414401
NM_000020.2(ACVRL1):c.1385C>G (p.S462*)	ACVRL1	Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic	no assertion criteria provided	12	52314550	12	51920766	426031	414402
NM_000020.2(ACVRL1):c.1388delG (p.G463Afs*2)	ACVRL1	Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic	no assertion criteria provided	12	52314553	12	51920769	426032	414403
NM_000020.2(ACVRL1):c.1390delC (p.L464*)	ACVRL1	Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic	no assertion criteria provided	12	52314555	12	51920771	426033	414404
NM_000020.2(ACVRL1):c.1433C>A (p.Ala478Asp)	ACVRL1	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	12	52314598	12	51920814	426034	414405
NM_000020.2(ACVRL1):c.1435C>T (p.Arg479Ter)	ACVRL1	Hereditary hemorrhagic telangiectasia type 2|Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|Osler hemorrhagic telangiectasia syndrome|not specified|not provided	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, multiple submitters, no conflicts	12	52314600	12	51920816	372722	360048
NM_000020.2(ACVRL1):c.1436G>C (p.Arg479Pro)	ACVRL1	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	12	52314601	12	51920817	426036	414407
NM_000020.2(ACVRL1):c.1436G>A (p.Arg479Gln)	ACVRL1	Primary pulmonary hypertension|Hereditary hemorrhagic telangiectasia type 2|not specified	Pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, multiple submitters, no conflicts	12	52314601	12	51920817	426035	414406
NM_000020.2(ACVRL1):c.1450delCinsTG (p.Arg484Trpfs)	ACVRL1	Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic	no assertion criteria provided	12	52314615	12	51920831	426038	414409
NM_000020.2(ACVRL1):c.1450C>G (p.Arg484Gly)	ACVRL1	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	12	52314615	12	51920831	426037	414408
NM_000020.2(ACVRL1):c.1450C>T (p.Arg484Trp)	ACVRL1	Hereditary hemorrhagic telangiectasia type 2|Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|not specified	Pathogenic(Last reviewed: Dec 8, 2016)	criteria provided, single submitter	12	52314615	12	51920831	8252	23291
NM_000020.2(ACVRL1):c.1451G>A (p.Arg484Gln)	ACVRL1	Hereditary hemorrhagic telangiectasia type 2|Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|not specified|Pulmonary arterial hypertension|Epistaxis|not provided	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, multiple submitters, no conflicts	12	52314616	12	51920832	212796	210238
NM_000020.2(ACVRL1):c.1460A>C (p.Lys487Thr)	ACVRL1	Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic	no assertion criteria provided	12	52314625	12	51920841	426039	414410
NM_000020.2(ACVRL1):c.1468C>T (p.Q490*)	ACVRL1	Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic	no assertion criteria provided	12	52314633	12	51920849	426040	414411
NC_000012.12:g.69430244C>T	YEATS4	hydrochlorothiazide response - Efficacy	drug response(Last reviewed: Jul 11, 2016)	reviewed by expert panel	12	69824024	12	69430244	226017	227776
NM_003276.2(TMPO):c.1277C>T (p.Pro426Leu)	TMPO	Primary dilated cardiomyopathy|Loeys-Dietz syndrome 2|Dilated cardiomyopathy 1T|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Dec 6, 2017)	criteria provided, conflicting interpretations	12	98927312	12	98533534	192133	189921
NM_000432.3(MYL2):c.64G>A (p.Glu22Lys)	MYL2	Familial hypertrophic cardiomyopathy 10|Primary familial hypertrophic cardiomyopathy|not provided|Death in early adulthood	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2017)	criteria provided, multiple submitters, no conflicts	12	111356937	12	110919133	14065	29104
NM_000432.3(MYL2):c.37G>A (p.Ala13Thr)	MYL2	Familial hypertrophic cardiomyopathy 10|Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Apr 5, 2018)	criteria provided, conflicting interpretations	12	111356964	12	110919160	14064	29103
NM_002834.4(PTPN11):c.922A>G (p.Asn308Asp)	PTPN11	Noonan syndrome 1|Juvenile myelomonocytic leukemia|Metachondromatosis|LEOPARD syndrome 1|Noonan syndrome|not specified|not provided|Rasopathy|Inborn genetic diseases|Cardiovascular phenotype	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	12	112915523	12	112477719	13326	28365
NM_014365.2(HSPB8):c.520_533delTACTCAACATTTGG (p.Tyr174Argfs)	HSPB8	Distal myopathy|Motor neuropathy	Likely pathogenic(Last reviewed: Oct 30, 2017)	criteria provided, single submitter	12	119631592 - 119631605	12	119193787 - 119193800	584450	575496
NM_005505.4(SCARB1):c.523A>G (p.Thr175Ala)	SCARB1	High density lipoprotein cholesterol level quantitative trait locus 6	association(Last reviewed: Jun 1, 2011)	no assertion criteria provided	12	125298855	12	124814309	39738	48337
GRCh37/hg19 12p12.1(chr12:24687132-25353987)x3	BCAT1|LRMP|SOX5|CASC1|ETFRF1|C12orf77	See cases	Likely benign(Last reviewed: Dec 16, 2014)	no assertion criteria provided	12	24687132 - 25353987			442329	435991
NC_000013.11:g.23799617_23835311del35695	MIPEP	Combined oxidative phosphorylation deficiency 31	Likely pathogenic(Last reviewed: Jan 4, 2018)	criteria provided, single submitter	13	24373720 - 24409414	13	23799617 - 23835311	584455	575516
NM_005932.3(MIPEP):c.358G>A (p.Asp120Asn)	MIPEP	Combined oxidative phosphorylation deficiency 31	Likely pathogenic(Last reviewed: Jan 4, 2018)	criteria provided, single submitter	13	24460477	13	23886338	584454	575498
NC_000013.9:g.31818484_31977333del158850		Breast-ovarian cancer, familial 2	Pathogenic(Last reviewed: Apr 12, 2018)	criteria provided, single submitter					559474	550198
NM_001127217.2(SMAD9):c.*3835C>A	SMAD9	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37418978	13	36844841	311807	328048
NM_001127217.2(SMAD9):c.*3778C>A	SMAD9	Primary pulmonary hypertension	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37419035	13	36844898	311809	319497
NM_001127217.2(SMAD9):c.*3778C>T	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37419035	13	36844898	311808	334367
NM_001127217.2(SMAD9):c.*3768_*3770delAAC	SMAD9	Primary pulmonary hypertension	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37419043 - 37419045	13	36844906 - 36844908	311810	319502
NM_001127217.2(SMAD9):c.*3756_*3759delTTCT	SMAD9	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37419054 - 37419057	13	36844917 - 36844920	311811	336080
NM_001127217.2(SMAD9):c.*3751A>G	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37419062	13	36844925	311812	334371
NM_001127217.2(SMAD9):c.*3713T>C	SMAD9	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37419100	13	36844963	311813	336085
NM_001127217.2(SMAD9):c.*3599A>T	SMAD9	Primary pulmonary hypertension	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37419214	13	36845077	311814	319515
NM_001127217.2(SMAD9):c.*3590delA	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37419223	13	36845086	311815	334372
NM_001127217.2(SMAD9):c.*3572_*3575delCACA	SMAD9	Primary pulmonary hypertension	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37419238 - 37419241	13	36845101 - 36845104	311817	336095
NM_001127217.2(SMAD9):c.*3574_*3575delCA	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37419238 - 37419239	13	36845101 - 36845102	311816	334373
NM_001127217.2(SMAD9):c.*3560_*3565delTACACA	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37419248 - 37419253	13	36845111 - 36845116	311818	334377
NM_001127217.2(SMAD9):c.*3564C>T	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37419249	13	36845112	311820	334392
NM_001127217.2(SMAD9):c.*3558_*3563delTATACA	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37419250 - 37419255	13	36845113 - 36845118	311819	319518
NM_001127217.2(SMAD9):c.*3562C>T	SMAD9	Primary pulmonary hypertension	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37419251	13	36845114	311821	336101
NM_001127217.2(SMAD9):c.*3558_*3561delTATA	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37419252 - 37419255	13	36845115 - 36845118	311824	334398
NM_001127217.2(SMAD9):c.*3560_*3561delTA	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37419252 - 37419253	13	36845115 - 36845116	311823	319519
NM_001127217.2(SMAD9):c.*3560_*3561dupTA	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37419252 - 37419253	13	36845115 - 36845116	311822	319520
NM_001127217.2(SMAD9):c.*3560T>C	SMAD9	Primary pulmonary hypertension	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37419253	13	36845116	311825	319526
NM_001127217.2(SMAD9):c.*3543A>G	SMAD9	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37419270	13	36845133	311826	334410
NM_001127217.2(SMAD9):c.*3423T>C	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37419390	13	36845253	311827	336113
NM_001127217.2(SMAD9):c.*3354_*3358delGTTTT	SMAD9	Primary pulmonary hypertension	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37419455 - 37419459	13	36845318 - 36845322	311828	334417
NM_001127217.2(SMAD9):c.*3263T>G	SMAD9	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37419550	13	36845413	311829	336115
NM_001127217.2(SMAD9):c.*3262T>C	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37419551	13	36845414	311830	334418
NM_001127217.2(SMAD9):c.*3188A>C	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37419625	13	36845488	311831	334422
NM_001127217.2(SMAD9):c.*3171_*3176delAACATT	SMAD9	Primary pulmonary hypertension	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37419637 - 37419642	13	36845500 - 36845505	311832	336116
NM_001127217.2(SMAD9):c.*2905T>C	SMAD9	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37419908	13	36845771	311833	319527
NM_001127217.2(SMAD9):c.*2684G>C	SMAD9	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37420129	13	36845992	311834	336117
NM_001127217.2(SMAD9):c.*2653C>T	SMAD9	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37420160	13	36846023	311835	328049
NM_001127217.2(SMAD9):c.*2636C>T	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37420177	13	36846040	311836	334424
NM_001127217.2(SMAD9):c.*2546A>C	SMAD9	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37420267	13	36846130	311837	336120
NM_001127217.2(SMAD9):c.*2506_*2511delTAATCT	SMAD9	Primary pulmonary hypertension	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37420302 - 37420307	13	36846165 - 36846170	311838	319534
NM_001127217.2(SMAD9):c.*2465T>C	SMAD9	Primary pulmonary hypertension	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37420348	13	36846211	311839	334428
NM_001127217.2(SMAD9):c.*2418C>T	SMAD9	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37420395	13	36846258	311840	334432
NM_001127217.2(SMAD9):c.*2387A>G	SMAD9	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37420426	13	36846289	311841	336125
NM_001127217.2(SMAD9):c.*2333A>G	SMAD9	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37420480	13	36846343	311842	328050
NM_001127217.2(SMAD9):c.*2276C>T	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37420537	13	36846400	311843	328052
NM_001127217.2(SMAD9):c.*2216G>A	SMAD9	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37420597	13	36846460	311844	319535
NM_001127217.2(SMAD9):c.*2202delT	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37420611	13	36846474	311846	319539
NM_001127217.2(SMAD9):c.*2201_*2202delTT	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37420611 - 37420612	13	36846474 - 36846475	311845	336133
NM_001127217.2(SMAD9):c.*2179_*2181delCTT	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37420632 - 37420634	13	36846495 - 36846497	311847	336134
NM_001127217.2(SMAD9):c.*2179_*2180delCT	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37420633 - 37420634	13	36846496 - 36846497	311848	328053
NM_001127217.2(SMAD9):c.*2179delC	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37420634	13	36846497	311849	334433
NM_001127217.2(SMAD9):c.*2138C>T	SMAD9	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37420675	13	36846538	311850	319541
NM_001127217.2(SMAD9):c.*2036C>A	SMAD9	Primary pulmonary hypertension	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37420777	13	36846640	311851	334438
NM_001127217.2(SMAD9):c.*1960G>T	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37420853	13	36846716	311852	319543
NM_001127217.2(SMAD9):c.*1921C>T	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37420892	13	36846755	311853	328060
NM_001127217.2(SMAD9):c.*1696G>A	SMAD9	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37421117	13	36846980	311854	336139
NM_001127217.2(SMAD9):c.*1667A>G	SMAD9	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37421146	13	36847009	311855	319544
NM_001127217.2(SMAD9):c.*1647T>A	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37421166	13	36847029	311856	319545
NM_001127217.2(SMAD9):c.*1430A>T	SMAD9	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37421383	13	36847246	311857	328061
NM_001127217.2(SMAD9):c.*1379G>T	SMAD9	Primary pulmonary hypertension	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37421434	13	36847297	311858	336151
NM_001127217.2(SMAD9):c.*1322G>A	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37421491	13	36847354	311859	328062
NM_001127217.2(SMAD9):c.*1224A>G	SMAD9	Primary pulmonary hypertension	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37421589	13	36847452	311860	336172
NM_001127217.2(SMAD9):c.*1066G>C	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37421747	13	36847610	311861	328065
NM_001127217.2(SMAD9):c.*1038G>C	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37421775	13	36847638	311862	334449
NM_001127217.2(SMAD9):c.*1031C>T	SMAD9	Primary pulmonary hypertension	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37421782	13	36847645	311863	334452
NM_001127217.2(SMAD9):c.*997C>T	SMAD9	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37421816	13	36847679	311864	319547
NM_001127217.2(SMAD9):c.*992G>A	SMAD9	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37421821	13	36847684	311865	336188
NM_001127217.2(SMAD9):c.*991C>T	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37421822	13	36847685	311866	319548
NM_001127217.2(SMAD9):c.*970G>A	SMAD9	Primary pulmonary hypertension	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37421843	13	36847706	311867	334453
NM_001127217.2(SMAD9):c.*948A>G	SMAD9	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37421865	13	36847728	311868	336189
NM_001127217.2(SMAD9):c.*870T>C	SMAD9	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37421943	13	36847806	311869	328067
NM_001127217.2(SMAD9):c.*850C>T	SMAD9	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37421963	13	36847826	311870	319549
NM_001127217.2(SMAD9):c.*805C>T	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37422008	13	36847871	311871	319553
NM_001127217.2(SMAD9):c.*793C>G	SMAD9	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37422020	13	36847883	311872	336190
NM_001127217.2(SMAD9):c.*733G>A	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37422080	13	36847943	311873	319555
NM_001127217.2(SMAD9):c.*669_*670delAG	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37422143 - 37422144	13	36848006 - 36848007	311874	319556
NM_001127217.2(SMAD9):c.*666_*667delCA	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37422146 - 37422147	13	36848009 - 36848010	311875	334456
NM_001127217.2(SMAD9):c.*637C>T	SMAD9	Primary pulmonary hypertension	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37422176	13	36848039	311876	328084
NM_001127217.2(SMAD9):c.*624T>G	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37422189	13	36848052	311877	328086
NM_001127217.2(SMAD9):c.*615A>G	SMAD9	Primary pulmonary hypertension	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37422198	13	36848061	311878	328094
NM_001127217.2(SMAD9):c.*590T>A	SMAD9	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37422223	13	36848086	311879	334460
NM_001127217.2(SMAD9):c.*573T>C	SMAD9	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37422240	13	36848103	311880	334462
NM_001127217.2(SMAD9):c.*557T>C	SMAD9	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37422256	13	36848119	311881	334465
NM_001127217.2(SMAD9):c.*448_*452delGATGT	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37422361 - 37422365	13	36848224 - 36848228	311882	334467
NM_001127217.2(SMAD9):c.*435delC	SMAD9	Primary pulmonary hypertension	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37422378	13	36848241	311883	334468
NM_001127217.2(SMAD9):c.*396A>G	SMAD9	Primary pulmonary hypertension	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37422417	13	36848280	311884	334478
NM_001127217.2(SMAD9):c.*382dupT	SMAD9	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37422431	13	36848294	311885	328096
NM_001127217.2(SMAD9):c.*364T>C	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37422449	13	36848312	311886	319560
NM_001127217.2(SMAD9):c.*298_*301delACAG	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37422512 - 37422515	13	36848375 - 36848378	311887	319565
NM_001127217.2(SMAD9):c.*298A>G	SMAD9	Primary pulmonary hypertension	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37422515	13	36848378	311888	334480
NM_001127217.2(SMAD9):c.*200A>C	SMAD9	Primary pulmonary hypertension	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37422613	13	36848476	311889	319569
NM_001127217.2(SMAD9):c.*118C>T	SMAD9	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37422695	13	36848558	311890	319570
NM_001127217.2(SMAD9):c.*94_*95delAT	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37422718 - 37422719	13	36848581 - 36848582	311891	319575
NM_001127217.2(SMAD9):c.*47G>A	SMAD9	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37422766	13	36848629	311892	319576
NM_001127217.2(SMAD9):c.*3G>C	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37422810	13	36848673	311893	319577
NM_005905.5(SMAD9):c.1045A>G (p.Asn349Asp)	SMAD9	Pulmonary arterial hypertension associated with congenital heart disease	Uncertain significance(Last reviewed: Jun 27, 2018)	criteria provided, single submitter	13	37427660	13	36853523	548691	539174
NM_001127217.2(SMAD9):c.1117G>A (p.Val373Ile)	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37427699	13	36853562	311894	336192
NM_001127217.2(SMAD9):c.1088A>G (p.Asn363Ser)	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37427728	13	36853591	311895	328098
NM_001127217.2(SMAD9):c.1042G>A (p.Glu348Lys)	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37427774	13	36853637	311896	319581
NM_001127217.2(SMAD9):c.1035G>A (p.Val345=)	SMAD9	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37427781	13	36853644	311897	334487
NM_001127217.2(SMAD9):c.1011C>G (p.His337Gln)	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37427805	13	36853668	311898	336196
NM_001127217.2(SMAD9):c.971C>T (p.Thr324Met)	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37439706	13	36865569	311899	336204
NM_001127217.2(SMAD9):c.907G>A (p.Asp303Asn)	SMAD9	not specified	Uncertain significance(Last reviewed: Sep 19, 2017)	criteria provided, single submitter	13	37439770	13	36865633	452036	445150
NM_001127217.2(SMAD9):c.880C>T (p.Arg294Ter)	SMAD9	not provided|Primary pulmonary hypertension 2	Pathogenic(Last reviewed: Jan 23, 2017)	criteria provided, single submitter	13	37439797	13	36865660	56970	71565
NM_001127217.2(SMAD9):c.830C>G (p.Ala277Gly)	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37439847	13	36865710	311900	319586
NM_001127217.2(SMAD9):c.828C>T (p.Val276=)	SMAD9	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37439849	13	36865712	311901	336215
NM_001127217.2(SMAD9):c.788G>A (p.Arg263Gln)	SMAD9	Primary pulmonary hypertension|not specified|Primary pulmonary hypertension 2	Conflicting interpretations of pathogenicity(Last reviewed: Dec 19, 2017)	criteria provided, conflicting interpretations	13	37439889	13	36865752	213812	210240
NM_001127217.2(SMAD9):c.781+2T>A	SMAD9	Primary pulmonary hypertension 2	Uncertain significance(Last reviewed: Sep 13, 2017)	criteria provided, single submitter	13	37441408	13	36867271	541761	528081
NM_001127217.2(SMAD9):c.756T>C (p.His252=)	SMAD9	Primary pulmonary hypertension|not specified|Primary pulmonary hypertension 2	Benign/Likely benign(Last reviewed: May 3, 2017)	criteria provided, multiple submitters, no conflicts	13	37441435	13	36867298	227077	230444
NM_001127217.2(SMAD9):c.743C>A (p.Thr248Lys)	SMAD9	Primary pulmonary hypertension|not specified|Primary pulmonary hypertension 2	Benign/Likely benign(Last reviewed: Aug 7, 2017)	criteria provided, multiple submitters, no conflicts	13	37441448	13	36867311	311902	319588
NM_001127217.2(SMAD9):c.606C>A (p.Cys202Ter)	SMAD9	Primary pulmonary hypertension 2	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	13	37446859	13	36872722	6515	21554
NM_001127217.2(SMAD9):c.603G>T (p.Pro201=)	SMAD9	Primary pulmonary hypertension 2	Likely benign(Last reviewed: Feb 13, 2017)	criteria provided, single submitter	13	37446862	13	36872725	474935	463630
NM_001127217.2(SMAD9):c.487G>A (p.Ala163Thr)	SMAD9	Primary pulmonary hypertension|not specified	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	13	37446978	13	36872841	213810	210241
NM_001127217.2(SMAD9):c.486C>T (p.Ser162=)	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37446979	13	36872842	311903	336217
NM_001127217.2(SMAD9):c.434C>A (p.Pro145Gln)	SMAD9	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37447031	13	36872894	311904	334491
NM_001127217.2(SMAD9):c.348A>G (p.Pro116=)	SMAD9	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37453479	13	36879342	311905	336227
NM_001127217.2(SMAD9):c.327G>A (p.Pro109=)	SMAD9	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37453500	13	36879363	311906	319591
NM_001127217.2(SMAD9):c.204C>A (p.Cys68Ter)	SMAD9	Pulmonary arterial hypertension associated with congenital heart disease	Likely pathogenic(Last reviewed: Jun 27, 2018)	criteria provided, single submitter	13	37453623	13	36879486	548690	539175
NM_001127217.2(SMAD9):c.127A>G (p.Lys43Glu)	SMAD9	Primary pulmonary hypertension 2	Pathogenic(Last reviewed: Dec 1, 2011)	no assertion criteria provided	13	37453700	13	36879563	56969	71564
NM_001127217.2(SMAD9):c.65T>C (p.Leu22Pro)	SMAD9	Primary pulmonary hypertension|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Mar 6, 2017)	criteria provided, conflicting interpretations	13	37453762	13	36879625	213811	210242
NM_001127217.2(SMAD9):c.48C>T (p.Pro16=)	SMAD9	Primary pulmonary hypertension|not specified	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	13	37453779	13	36879642	227954	230445
NM_001127217.2(SMAD9):c.15C>G (p.Thr5=)	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37453812	13	36879675	311907	336231
NM_001127217.2(SMAD9):c.12C>T (p.Thr4=)	SMAD9	Primary pulmonary hypertension|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	13	37453815	13	36879678	227076	230446
NM_001127217.2(SMAD9):c.-37C>T	SMAD9	Primary pulmonary hypertension|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	13	37453863	13	36879726	213809	210243
NM_001127217.2(SMAD9):c.-50G>A	SMAD9	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37453876	13	36879739	311908	319593
NM_001127217.2(SMAD9):c.-110A>C	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37453936	13	36879799	311909	319594
NM_001127217.2(SMAD9):c.-141C>T	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37453967	13	36879830	311910	319595
NM_001127217.2(SMAD9):c.-223_-221dupCCG	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37494287 - 37494289	13	36920150 - 36920152	311911	319597
NM_001127217.2(SMAD9):c.-230G>A	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37494296	13	36920159	311912	334504
NM_001127217.2(SMAD9):c.-255_-253delTGC	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37494319 - 37494321	13	36920182 - 36920184	311913	328099
NM_001127217.2(SMAD9):c.-256_-255insAGCCGC	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37494321 - 37494322	13	36920184 - 36920185	311916	328106
NM_001127217.2(SMAD9):c.-256_-255insCGC	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37494321 - 37494322	13	36920184 - 36920185	311915	328105
NM_001127217.2(SMAD9):c.-264_-255delCGCCGCTGCTinsTGCA	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37494321 - 37494330	13	36920184 - 36920193	311914	328110
NM_001127217.2(SMAD9):c.-261_-256delCGCTGC	SMAD9	Primary pulmonary hypertension	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37494322 - 37494327	13	36920185 - 36920190	311917	334505
NM_001127217.2(SMAD9):c.-258T>C	SMAD9	Primary pulmonary hypertension	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37494324	13	36920187	311919	334511
NM_001127217.2(SMAD9):c.-264_-259delCGCCGC	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37494325 - 37494330	13	36920188 - 36920193	311920	336234
NM_001127217.2(SMAD9):c.-261_-259dupCGC	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37494325 - 37494327	13	36920188 - 36920190	311918	336232
NM_001127217.2(SMAD9):c.-264C>G	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37494330	13	36920193	311922	336235
NM_001127217.2(SMAD9):c.-264C>T	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37494330	13	36920193	311921	334512
NM_001127217.2(SMAD9):c.-268C>G	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37494334	13	36920197	311923	328118
NM_001127217.2(SMAD9):c.-282C>T	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37494348	13	36920211	311924	336244
NM_001127217.2(SMAD9):c.-328G>T	SMAD9	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	37494394	13	36920257	311925	319600
NM_020751.2(COG6):c.851C>G (p.Ala284Gly)	COG6	Congenital disorder of glycosylation type 2L	not provided	no assertion provided	13	40261702	13	39687565	585029	576160
NM_001845.5(COL4A1):c.3104G>T (p.Gly1035Val)	COL4A1	SCHIZENCEPHALY	Pathogenic(Last reviewed: Oct 2, 2017)	no assertion criteria provided	13	110827659	13	110175312	440782	434400
NM_001845.5(COL4A1):c.1612C>G (p.Arg538Gly)	COL4A1	Hemorrhage, intracerebral, susceptibility to	risk factor(Last reviewed: Apr 1, 2012)	no assertion criteria provided	13	110839601	13	110187254	39864	48463
NM_001846.3(COL4A2):c.3368A>G (p.Glu1123Gly)	COL4A2	Porencephalic cyst|Hemorrhage, intracerebral, susceptibility to|not provided	Benign/Likely benign, risk factor(Last reviewed: Jan 9, 2017)	criteria provided, multiple submitters, no conflicts	13	111143601	13	110491254	29629	38583
NM_001846.3(COL4A2):c.3448C>A (p.Gln1150Lys)	COL4A2	Porencephalic cyst|Hemorrhage, intracerebral, susceptibility to	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	111143681	13	110491334	29630	38584
GRCh37/hg19 13q14.11(chr13:42149812-42734566)x3	VWA8|DGKH	See cases	Uncertain significance(Last reviewed: Jul 15, 2014)	no assertion criteria provided	13	42149812 - 42734566			443133	436795
NM_000257.3(MYH7):c.5452C>T (p.Arg1818Trp)	MYH7	Familial hypertrophic cardiomyopathy 1|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 18, 2016)	criteria provided, conflicting interpretations	14	23884311	14	23415102	217826	214496
NM_000257.3(MYH7):c.5283+2dup	MYH7	not provided	not provided	no assertion provided	14	23884588	14	23415379	585162	576163
NM_000257.3(MYH7):c.4078G>A (p.Val1360Ile)	MYH7	not specified	Uncertain significance(Last reviewed: Jan 31, 2014)	no assertion criteria provided	14	23887510	14	23418301	42991	52161
NM_000257.3(MYH7):c.3982G>A (p.Ala1328Thr)	MYH7	not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Uncertain significance(Last reviewed: Mar 27, 2018)	criteria provided, multiple submitters, no conflicts	14	23887606	14	23418397	42985	52155
NM_000257.3(MYH7):c.2945T>C (p.Met982Thr)	MYH7	Myosin storage myopathy|Myopathy, distal, 1|not specified|Hypertrophic cardiomyopathy|Scapuloperoneal myopathy|Left ventricular noncompaction cardiomyopathy|Increased left ventricular wall thickness|Inborn genetic diseases|Dilated Cardiomyopathy, Dominant	Benign(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23892910	14	23423701	42941	52111
NM_000257.3(MYH7):c.2389G>A (p.Ala797Thr)	MYH7	Familial hypertrophic cardiomyopathy 1|Myopathy, myosin storage, autosomal recessive|Myosin storage myopathy|Congenital myopathy with fiber type disproportion|Wolff-Parkinson-White pattern|Dilated cardiomyopathy 1S|Primary familial hypertrophic cardiomyopathy|Myopathy, distal, 1|Scapuloperoneal myopathy, MYH7-related|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Sep 16, 2018)	criteria provided, multiple submitters, no conflicts	14	23894525	14	23425316	42901	52071
NM_000257.3(MYH7):c.1988G>A (p.Arg663His)	MYH7	Familial hypertrophic cardiomyopathy 1|Myopathy, myosin storage, autosomal recessive|Myosin storage myopathy|Dilated cardiomyopathy 1S|Primary familial hypertrophic cardiomyopathy|Myopathy, distal, 1|Scapuloperoneal myopathy, MYH7-related|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23896042	14	23426833	42875	52045
NM_000257.3(MYH7):c.958G>A (p.Val320Met)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Jun 28, 2018)	criteria provided, conflicting interpretations	14	23899810	14	23430601	161328	171165
NM_000257.3(MYH7):c.773T>C (p.Leu258Ser)	MYH7	not specified	Uncertain significance(Last reviewed: May 23, 2017)	criteria provided, single submitter	14	23900650	14	23431441	235037	236807
NM_001099274.2(TINF2):c.811C>T (p.Gln271Ter)	TINF2	Dyskeratosis congenita, autosomal dominant, 3	Pathogenic(Last reviewed: May 1, 2012)	no assertion criteria provided	14	24709875	14	24240669	31543	40215
NM_025152.2(NUBPL):c.545T>C (p.Val182Ala)	NUBPL	Mitochondrial complex I deficiency|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 31, 2017)	criteria provided, conflicting interpretations	14	32257017	14	31787811	214874	211675
NM_001756.3(SERPINA6):c.344T>A (p.Leu115His)	SERPINA6	Corticosteroid-binding globulin deficiency|not specified	Uncertain significance(Last reviewed: Mar 8, 2016)	criteria provided, single submitter	14	94780642	14	94314305	16974	32013
NM_001127701.1(SERPINA1):c.1096G>A (p.Glu366Lys)	SERPINA1	FRAXE|PI Z|PI Z(AUGSBURG)|PI Z(TUN)|Alpha-1-antitrypsin deficiency|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Jul 4, 2018)	criteria provided, multiple submitters, no conflicts	14	94844947	14	94378610	17967	33006
NM_022489.3(INF2):c.658G>A (p.Glu220Lys)	INF2	not provided|Hypertension|Proteinuria|Renal insufficiency|Focal segmental glomerulosclerosis|Hypertension	Pathogenic/Likely pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, multiple submitters, no conflicts	14	105169782	14	104703445	523533	514037
GRCh38/hg38 14q22.3-23.1(chr14:57121531-58028799)x1	EXOC5|CCDC198|AP5M1|NAA30|ARMH4|SLC35F4	See cases	Uncertain significance(Last reviewed: Mar 24, 2014)	no assertion criteria provided	14	57588249 - 58495517	14	57121531 - 58028799	155334	165088
NM_000275.2(OCA2):c.1103C>T (p.Ala368Val)	OCA2	Tyrosinase-positive oculocutaneous albinism|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 7, 2016)	criteria provided, conflicting interpretations	15	28235735	15	27990589	193574	190737
NM_019074.4(DLL4):c.1168T>C (p.Cys390Arg)	DLL4	Adams-Oliver syndrome|Adams-Oliver syndrome 6	Pathogenic	criteria provided, single submitter	15	41227243	15	40935045	204372	200766
NM_019074.4(DLL4):c.1672C>T (p.Arg558Ter)	DLL4	Adams-Oliver syndrome|Adams-Oliver syndrome 6	Pathogenic	criteria provided, single submitter	15	41228857	15	40936659	204369	200770
NM_000138.4(FBN1):c.5087A>G (p.Tyr1696Cys)	FBN1	Geleophysic dysplasia 2	Pathogenic(Last reviewed: Jan 4, 2018)	no assertion criteria provided	15	48755416	15	48463219	29699	38654
NM_000138.4(FBN1):c.4253_4259delGCCAGTG (p.Gly1418Alafs)	FBN1	Marfan syndrome	Pathogenic(Last reviewed: Feb 1, 2010)	no assertion criteria provided	15	48764825 - 48764831	15	48472628 - 48472634	41409	49841
NM_000138.4(FBN1):c.871G>T (p.Glu291Ter)	FBN1	Marfan syndrome	Pathogenic(Last reviewed: May 30, 2016)	criteria provided, single submitter	15	48818444	15	48526247	453293	446890
NM_005154.4(USP8):c.3130C>G (p.Pro1044Ala)	USP8	not provided	not provided	no assertion provided	15	50790884	15	50498687	441073	434647
NM_001018005.1(TPM1):c.712C>T (p.Arg238Trp)	TPM1	Cardiomyopathy|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jul 15, 2014)	criteria provided, conflicting interpretations	15	63354784	15	63062585	43436	52606
GRCh37/hg19 15q13.1(chr15:28262885-28265761)x1	OCA2	Tyrosinase-positive oculocutaneous albinism	not provided	no assertion provided	15	28262839 - 28265960			585229	576279
GRCh37/hg19 15q11.2(chr15:22765628-23300287)	CYFIP1|NIPA2|TUBGCP5|NIPA1	Obesity|Epistaxis|Hypertension|Abnormal facial shape|Obesity|Numerous pigmented freckles|Abnormal platelet function|Abnormal platelet morphology|Increased mean platelet volume|Abnormal platelet shape|Thrombocytopenia|Hypertension	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	15	22765628 - 23300287			523249	514165
GRCh38/hg38 15q11.2(chr15:22658112-23102647)x1	CYFIP1|NIPA2|TUBGCP5|NIPA1|LOC283683	See cases	Uncertain significance(Last reviewed: Aug 15, 2014)	no assertion criteria provided	15	22770421 - 23214984	15	22658112 - 23102647	151197	160948
NM_021098.2(CACNA1H):c.4645A>G (p.Met1549Val)	CACNA1H	Primary hyperaldosteronism|Hyperaldosteronism, familial, type IV	Pathogenic(Last reviewed: Apr 24, 2015)	no assertion criteria provided	16	1262024	16	1212024	189779	187648
NM_005262.2(GFER):c.586C>T (p.Arg196Cys)	GFER	Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay|Mitochondrial diseases	Pathogenic(Last reviewed: Apr 7, 2017)	no assertion criteria provided	16	2035997	16	1985996	426097	414710
NM_001009944.2(PKD1):c.12499delA (p.Arg4167Glyfs)	PKD1	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Dec 30, 2016)	no assertion criteria provided	16	2140141	16	2090140	488184	481143
NM_001009944.2(PKD1):c.11524T>C (p.Trp3842Arg)	PKD1|LOC105371049	Polycystic kidney dysplasia|Hypertension|Hypertension	Likely pathogenic(Last reviewed: Jun 18, 2014)	criteria provided, single submitter	16	2141795	16	2091794	374187	360987
NM_001009944.2(PKD1):c.10487delT (p.Leu3496Argfs)	PKD1	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Dec 30, 2017)	no assertion criteria provided	16	2147161	16	2097160	488344	481173
NM_000296.3(PKD1):c.9185T>A (p.Val3062Asp)	PKD1	Hypertension|Renal cyst|Hepatic cysts|Pancreatic cysts|Renovascular hypertension|Hypertension	Likely pathogenic(Last reviewed: Oct 5, 2015)	criteria provided, single submitter	16	2152398	16	2102397	374044	360988
NM_000296.3(PKD1):c.8311G>A (p.Glu2771Lys)	PKD1	not provided|Hypertension|Multiple renal cysts|Hypertension	Pathogenic(Last reviewed: Sep 29, 2016)	criteria provided, multiple submitters, no conflicts	16	2153747	16	2103746	374097	360989
NM_001009944.2(PKD1):c.7226C>T (p.Thr2409Met)	PKD1	Polycystic kidney disease, adult type	Uncertain significance(Last reviewed: Oct 16, 2017)	criteria provided, single submitter	16	2156662	16	2106661	584459	575501
NM_000296.3(PKD1):c.3520C>T (p.Gln1174Ter)	PKD1	Polycystic kidney dysplasia|Hypertension|Hypertension	Pathogenic(Last reviewed: Jun 11, 2015)	criteria provided, single submitter	16	2161648	16	2111647	374102	360993
NM_001089.2(ABCA3):c.2125C>T (p.Arg709Trp)	ABCA3	not specified	Uncertain significance(Last reviewed: Jun 21, 2016)	criteria provided, single submitter	16	2347468	16	2297467	162674	176003
NM_001089.2(ABCA3):c.1502C>A (p.Ala501Glu)	ABCA3	not specified	Conflicting interpretations of pathogenicity(Last reviewed: Dec 11, 2015)	criteria provided, conflicting interpretations	16	2350115	16	2300114	178700	176147
NM_001089.2(ABCA3):c.977T>C (p.Leu326Pro)	ABCA3	Surfactant metabolism dysfunction, pulmonary, 3|not specified	Uncertain significance(Last reviewed: Oct 10, 2017)	criteria provided, single submitter	16	2367662	16	2317661	8017	23056
NM_002474.2(MYH11):c.2297G>A (p.Ser766Asn)	MYH11	not specified|Familial thoracic aortic aneurysm	Uncertain significance(Last reviewed: Jun 13, 2016)	criteria provided, single submitter	16	15841541	16	15747684	372955	360231
NM_003361.3(UMOD):c.743G>C (p.Cys248Ser)	UMOD	Familial juvenile gout	Pathogenic(Last reviewed: May 15, 2010)	no assertion criteria provided	16	20359880	16	20348558	64644	75598
NM_003361.3(UMOD):c.376T>C (p.Cys126Arg)	UMOD	Familial juvenile gout	Pathogenic(Last reviewed: Jan 6, 2012)	no assertion criteria provided	16	20360247	16	20348925	12259	27298
NM_003361.3(UMOD):c.-1746T>C	UMOD	Essential hypertension	association(Last reviewed: Jul 1, 2015)	no assertion criteria provided	16	20365654	16	20354332	219224	217245
NM_001039.3(SCNN1G):c.1749_1753del (p.Glu583Aspfs)	SCNN1G	LIDDLE SYNDROME 2	Pathogenic(Last reviewed: Sep 27, 2018)	no assertion criteria provided	16	23226589 - 23226593	16	23215268 - 23215272	565277	556461
NM_000336.2(SCNN1B):c.1688G>A (p.Arg563Gln)	SCNN1B	Low renin, low aldosterone hypertension	Likely pathogenic(Last reviewed: Mar 10, 2018)	criteria provided, single submitter	16	23391887	16	23380566	561264	552409
NM_000336.2(SCNN1B):c.1696C>T (p.Arg566Ter)	SCNN1B	Pseudoprimary hyperaldosteronism|not provided	Pathogenic(Last reviewed: Aug 14, 2017)	criteria provided, multiple submitters, no conflicts	16	23391895	16	23380574	8830	23869
NM_000336.2(SCNN1B):c.1858T>C (p.Tyr620His)	SCNN1B	Pseudoprimary hyperaldosteronism	Pathogenic(Last reviewed: Apr 1, 1996)	no assertion criteria provided	16	23392057	16	23380736	8833	23872
NM_022162.2(NOD2):c.1001G>A (p.Arg334Gln)	NOD2	Sarcoidosis, early-onset|Blau syndrome|Inflammatory bowel disease 1|not provided	Pathogenic(Last reviewed: May 29, 2018)	criteria provided, multiple submitters, no conflicts	16	50744823	16	50710912	4694	19733
NM_000078.2(CETP):c.1264G>A (p.Val422Ile)	CETP	Hyperalphalipoproteinemia 1|High density lipoprotein cholesterol level quantitative trait locus 10	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	16	57016092	16	56982180	17525	32564
NM_000196.3(HSD11B2):c.343_348delGAGTTG (p.Glu115_Leu116del)	HSD11B2	Apparent mineralocorticoid excess, mild	Pathogenic(Last reviewed: Mar 1, 2001)	no assertion criteria provided	16	67469608 - 67469613	16	67435705 - 67435710	12100	27139
NM_000196.3(HSD11B2):c.667G>A (p.Asp223Asn)	HSD11B2	Apparent mineralocorticoid excess	Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	16	67470154	16	67436251	12101	27140
NM_000196.3(HSD11B2):c.680C>T (p.Pro227Leu)	HSD11B2	Apparent mineralocorticoid excess, mild	Pathogenic(Last reviewed: Oct 26, 1999)	no assertion criteria provided	16	67470167	16	67436264	12099	27138
NM_000196.3(HSD11B2):c.835C>T (p.Arg279Cys)	HSD11B2	Apparent mineralocorticoid excess	Pathogenic(Last reviewed: Aug 1, 1998)	no assertion criteria provided	16	67470523	16	67436620	12098	27137
NM_000196.3(HSD11B2):c.895_897delTAC (p.Tyr299del)	HSD11B2	Apparent mineralocorticoid excess	Pathogenic(Last reviewed: May 1, 2004)	no assertion criteria provided	16	67470583 - 67470585	16	67436680 - 67436682	12102	27141
NM_000196.3(HSD11B2):c.1012T>C (p.Tyr338His)	HSD11B2	Apparent mineralocorticoid excess	Pathogenic(Last reviewed: Apr 1, 2007)	no assertion criteria provided	16	67470700	16	67436797	31131	40088
NM_024306.4(FA2H):c.133G>T (p.Gly45Trp)	FA2H	Spastic paraplegia 35	Likely pathogenic(Last reviewed: Sep 29, 2017)	criteria provided, single submitter	16	74808521	16	74774623	584457	575502
NM_013275.5(ANKRD11):c.2408_2412delAAAAA (p.Lys803Argfs)	ANKRD11	KBG syndrome|not provided	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, multiple submitters, no conflicts	16	89350538 - 89350542	16	89284130 - 89284134	266033	260852
NM_001451.2(FOXF1):c.(?_15)_(*58_?)del	FOXF1	Primary pulmonary hypertension	Pathogenic(Last reviewed: Oct 26, 2015)	criteria provided, single submitter	16	86544190 - 86546749	16	86510584 - 86513143	228348	230608
NM_003673.3(TCAP):c.458G>A (p.Arg153His)	TCAP	Dilated cardiomyopathy 1N|Primary familial hypertrophic cardiomyopathy|not specified	Uncertain significance(Last reviewed: Jan 24, 2017)	criteria provided, multiple submitters, no conflicts	17	37822316	17	39666063	44710	53877
NM_032387.4(WNK4):c.1693C>G (p.Gln565Glu)	WNK4	Pseudohypoaldosteronism type 2B	Pathogenic(Last reviewed: Feb 16, 2017)	no assertion criteria provided	17	40939512	17	42787494	7660	22699
NM_138387.3(G6PC3):c.346A>G (p.Met116Val)	G6PC3	Dursun syndrome	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	17	42152068	17	44074700	1042	16081
NM_000088.3(COL1A1):c.1777G>A (p.Gly593Ser)	COL1A1	Hypertelorism|Osteogenesis imperfecta, recessive perinatal lethal|Skeletal dysplasia|Cranial asymmetry|Pathologic fracture|Abnormality of the pinna|Anteverted nares|Blue sclerae|Broad forehead|Depressed nasal bridge|Downslanted palpebral fissures|Flat occiput|Premature birth|Triangular face|Wide anterior fontanel|Low-set, posteriorly rotated ears|Osteopenia|Generalized hypotonia|Bowing of limbs due to multiple fractures|Fractures of the long bones|Craniofacial disproportion|Decreased calvarial ossification|Crumpled long bones|Maternal hypertension|Rhizomelia|Neonatal short-limb short stature|Wide cranial sutures|Neonatal asphyxia	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	17	48270399	17	50193038	17326	32365
NM_000250.1(MPO):c.2031-2A>C	MPO	Myeloperoxidase deficiency|not provided	Pathogenic(Last reviewed: Aug 4, 2017)	criteria provided, multiple submitters, no conflicts	17	56348226	17	58270865	3632	18671
NM_000250.1(MPO):c.1705C>T (p.Arg569Trp)	MPO|LOC106694316	Myeloperoxidase deficiency|not provided	Pathogenic(Last reviewed: Aug 18, 2016)	criteria provided, single submitter	17	56350196	17	58272835	3626	18665
NM_018488.3(TBX4):c.293C>G (p.Pro98Arg)	TBX4	Pulmonary arterial hypertension associated with congenital heart disease	Likely pathogenic(Last reviewed: Jun 27, 2018)	criteria provided, single submitter	17	59543191	17	61465830	548692	539176
NM_018488.3(TBX4):c.538_547delCCCTTTGGCC (p.Pro180Ilefs)	TBX4	Pulmonary arterial hypertension associated with congenital heart disease	Likely pathogenic(Last reviewed: Jun 27, 2018)	criteria provided, single submitter	17	59545007 - 59545016	17	61467646 - 61467655	548695	539177
NM_018488.3(TBX4):c.557T>G (p.Leu186Arg)	TBX4	Primary pulmonary hypertension	Uncertain significance(Last reviewed: Sep 30, 2016)	criteria provided, single submitter	17	59555995	17	61478634	279597	263862
NM_018488.3(TBX4):c.670_672delTTC (p.Phe224del)	TBX4	Pulmonary arterial hypertension associated with congenital heart disease	Likely pathogenic(Last reviewed: Jun 27, 2018)	criteria provided, single submitter	17	59556108 - 59556110	17	61478747 - 61478749	548697	539178
NM_001321120.2(TBX4):c.702+1G>A	TBX4	not provided|Pulmonary arterial hypertension associated with congenital heart disease	Conflicting interpretations of pathogenicity(Last reviewed: Jun 27, 2018)	criteria provided, conflicting interpretations	17	59556141	17	61478780	547941	538468
NM_018488.3(TBX4):c.749G>A (p.Arg250Gln)	TBX4	Pulmonary arterial hypertension associated with congenital heart disease	Uncertain significance(Last reviewed: Jun 27, 2018)	criteria provided, single submitter	17	59557288	17	61479927	548696	539179
NM_018488.3(TBX4):c.1074delC (p.Ser359Leufs)	TBX4	Pulmonary arterial hypertension associated with congenital heart disease	Uncertain significance(Last reviewed: Jun 27, 2018)	criteria provided, single submitter	17	59560313	17	61482952	548693	539180
NM_018488.3(TBX4):c.1112delC (p.Pro371Leufs)	TBX4	Pulmonary arterial hypertension associated with congenital heart disease	Uncertain significance(Last reviewed: Jun 27, 2018)	criteria provided, single submitter	17	59560351	17	61482990	548694	539181
NM_000789.3(ACE):c.2306-117_2306-116insAF118569.1:g.14094_14382	ACE	Microvascular complications of diabetes 3|Ischemic stroke, susceptibility to|Myocardial infarction|ANGIOTENSIN I-CONVERTING ENZYME INSERTION/DELETION POLYMORPHISM|Stroke, hemorrhagic, susceptibility to|Severe acute respiratory syndrome, progression of|Susceptibility to progression to renal failure in IgA nephropathy	Conflicting interpretations of pathogenicity, risk factor(Last reviewed: Feb 17, 2009)	no assertion criteria provided	17	61565892 - 61565893	17	63488531 - 63488532	18061	33100
NM_000789.3(ACE):c.3683C>T (p.Pro1228Leu)	ACE	Angiotensin i-converting enzyme, benign serum increase	Pathogenic(Last reviewed: Dec 23, 2003)	no assertion criteria provided	17	61574338	17	63496977	18062	33101
NM_002737.2(PRKCA):c.1854+3730G>A	PRKCA	hydrochlorothiazide response - Efficacy	drug response(Last reviewed: Jul 11, 2016)	reviewed by expert panel	17	64788827	17	66792709	225956	227794
NM_000160.4(GCGR):c.118G>A (p.Gly40Ser)	GCGR	Diabetes mellitus type 2	Pathogenic(Last reviewed: Feb 1, 1996)	no assertion criteria provided	17	79767715	17	81809839	16159	31198
NM_006796.2(AFG3L2):c.2011G>A (p.Gly671Arg)	AFG3L2	Spinocerebellar ataxia 28	Pathogenic(Last reviewed: Jul 18, 2017)	criteria provided, single submitter	18	12337504	18	12337505	30425	39382
NM_000529.2(MC2R):c.221G>T (p.Ser74Ile)	MC2R	ACTH resistance|Glucocorticoid Deficiency	Pathogenic(Last reviewed: Jan 23, 2009)	no assertion criteria provided	18	13885297	18	13885298	3258	18297
NM_005257.5(GATA6):c.551G>A (p.Ser184Asn)	GATA6	Tetralogy of Fallot|Atrial septal defect 9	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	18	19751656	18	22171695	30210	39166
NM_001943.4(DSG2):c.437G>T (p.Arg146Leu)	DSG2	Arrhythmogenic right ventricular cardiomyopathy, type 10|Arrhythmogenic right ventricular cardiomyopathy|not specified|not provided|Cardiac arrest|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	Conflicting interpretations of pathogenicity(Last reviewed: Jun 12, 2018)	criteria provided, conflicting interpretations	18	29101120	18	31521157	44317	53484
NM_001943.4(DSG2):c.1885C>T (p.Pro629Ser)	DSG2	Arrhythmogenic right ventricular cardiomyopathy, type 10|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 27, 2018)	criteria provided, conflicting interpretations	18	29121161	18	31541198	199813	197990
NM_005359.5(SMAD4):c.38A>G (p.Asn13Ser)	SMAD4	Juvenile polyposis syndrome|Primary pulmonary hypertension|not specified|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 23, 2017)	criteria provided, multiple submitters, no conflicts	18	48573454	18	51047084	68788	79680
NM_005359.5(SMAD4):c.692dupG (p.Ser232Glnfs)	SMAD4	Juvenile polyposis syndrome|Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	18	48584519	18	51058149	24811	36152
NM_005359.5(SMAD4):c.1448-6T>C	SMAD4	Primary pulmonary hypertension	Uncertain significance	no assertion criteria provided	18	48604620	18	51078250	426048	414427
NM_001144968.1(NEDD4L):c.24G>A (p.Gln8=)	NEDD4L	diuretics response - Efficacy|hydrochlorothiazide response - Efficacy	drug response(Last reviewed: Apr 7, 2016)	reviewed by expert panel	18	55816791	18	58149559	225996	227795
GRCh38/hg38 18p11.32(chr18:967505-1652748)x3	LINC00470	See cases	Uncertain significance(Last reviewed: Feb 14, 2012)	no assertion criteria provided	18	967506 - 1652749	18	967505 - 1652748	149122	158873
NM_000455.4(STK11):c.1294C>T (p.Gln432Ter)	STK11	Peutz-Jeghers syndrome|not specified	Uncertain significance(Last reviewed: Aug 18, 2016)	criteria provided, single submitter	19	1226638	19	1226639	388557	377158
NM_032737.3(LMNB2):c.1279G>A (p.Ala427Thr)	LMNB2	Acquired partial lipodystrophy|not provided	risk factor(Last reviewed: Aug 1, 2006)	no assertion criteria provided	19	2434027	19	2434029	14475	29514
NM_032737.3(LMNB2):c.704G>A (p.Arg235Gln)	LMNB2	Acquired partial lipodystrophy|not specified|not provided|Epilepsy, progressive myoclonic, 9|Lipodystrophy, partial, acquired, susceptibility to	Benign(Last reviewed: Aug 11, 2017)	criteria provided, single submitter	19	2435150	19	2435152	14474	29513
NM_001130823.2(DNMT1):c.2791G>A (p.Glu931Lys)	DNMT1	DNMT1-Related Disorder	not provided	no assertion provided	19	10257130	19	10146454	440984	434670
NM_000121.3(EPOR):c.1299_1305delCCAGCTC (p.Gln434Cysfs)	EPOR	Familial erythrocytosis, 1	Affects(Last reviewed: Sep 1, 1997)	no assertion criteria provided	19	11488882 - 11488888	19	11378206 - 11378212	16599	31638
NM_000435.2(NOTCH3):c.3058G>C (p.Ala1020Pro)	NOTCH3	Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy|not specified	Benign(Last reviewed: Jul 12, 2017)	criteria provided, multiple submitters, no conflicts	19	15291576	19	15180765	9227	24266
NM_004646.3(NPHS1):c.1481delC (p.Ser494Cysfs)	NPHS1	Finnish congenital nephrotic syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 1999)	no assertion criteria provided	19	36337056	19	35846154	56441	71080
NM_000540.2(RYR1):c.3095G>A (p.Arg1032His)	RYR1	Malignant hyperthermia, susceptibility to, 1|not provided|RYR1-Related Disorders|RYR1-Related Disorder	Uncertain significance(Last reviewed: Mar 22, 2018)	criteria provided, multiple submitters, no conflicts	19	38956955	19	38466315	374974	361886
NM_017827.3(SARS2):c.*341G>C	SARS2	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	39405905	19	38915265	329205	343501
NM_017827.3(SARS2):c.*140C>T	SARS2	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	39406106	19	38915466	329206	348832
NM_017827.3(SARS2):c.*79G>C	SARS2	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	39406167	19	38915527	329207	349792
NM_017827.3(SARS2):c.*22C>A	SARS2	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	39406224	19	38915584	329209	333468
NM_017827.3(SARS2):c.*22C>T	SARS2	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	39406224	19	38915584	329208	343507
NM_017827.3(SARS2):c.1347+10G>A	SARS2	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Mar 12, 2018)	criteria provided, conflicting interpretations	19	39406667	19	38916027	329210	348833
NM_017827.3(SARS2):c.1321G>A (p.Ala441Thr)	SARS2	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	39406703	19	38916063	329211	333469
NM_001145901.1(SARS2):c.1175A>G (p.Asp392Gly)	SARS2	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	Pathogenic(Last reviewed: Feb 11, 2011)	no assertion criteria provided	19	39406946	19	38916306	30982	39939
NM_017827.3(SARS2):c.1160+4T>C	SARS2	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis|not provided	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	39408360	19	38917720	329212	348834
NM_001145901.1(SARS2):c.1048T>C (p.Phe350Leu)	SARS2	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	Pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	19	39408569	19	38917929	242874	243995
NM_017827.3(SARS2):c.963-10T>C	SARS2	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	39408658	19	38918018	329213	333470
NM_017827.3(SARS2):c.917-4C>T	SARS2	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	39408783	19	38918143	329214	333476
NM_017827.3(SARS2):c.916+14_916+15delTG	SARS2	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis|not specified	Benign/Likely benign(Last reviewed: Feb 8, 2018)	criteria provided, multiple submitters, no conflicts	19	39409047 - 39409048	19	38918407 - 38918408	329215	349794
NM_017827.3(SARS2):c.888G>A (p.Leu296=)	SARS2	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	39409090	19	38918450	329216	348836
NM_017827.3(SARS2):c.758G>A (p.Arg253Gln)	SARS2	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	39410403	19	38919763	329217	333477
NM_017827.3(SARS2):c.694C>T (p.Arg232Cys)	SARS2	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis|not provided	Likely pathogenic(Last reviewed: Jun 13, 2017)	criteria provided, single submitter	19	39410467	19	38919827	432690	426310
NM_017827.3(SARS2):c.654-11C>G	SARS2	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Feb 16, 2018)	criteria provided, conflicting interpretations	19	39410518	19	38919878	329218	333479
NM_017827.3(SARS2):c.590-5T>A	SARS2	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 6, 2017)	criteria provided, conflicting interpretations	19	39410794	19	38920154	138958	142661
NM_017827.3(SARS2):c.589+4G>A	SARS2	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	39412028	19	38921388	329219	349796
NM_017827.3(SARS2):c.535-15G>C	SARS2	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	39412101	19	38921461	329220	343512
NM_017827.3(SARS2):c.534+10G>A	SARS2	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	39412157	19	38921517	329221	348837
NM_017827.3(SARS2):c.501G>A (p.Ala167=)	SARS2	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	19	39412200	19	38921560	215109	211878
NM_017827.3(SARS2):c.394-5C>G	SARS2	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	39412312	19	38921672	329222	349801
NM_017827.3(SARS2):c.364-7C>A	SARS2	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jun 20, 2017)	criteria provided, conflicting interpretations	19	39412914	19	38922274	215106	211881
NM_017827.3(SARS2):c.353G>A (p.Arg118Gln)	SARS2	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	39416855	19	38926215	329223	348838
NM_017827.3(SARS2):c.321G>A (p.Glu107=)	SARS2	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis|not provided	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	39416887	19	38926247	329224	343513
NM_017827.3(SARS2):c.310C>T (p.Arg104Trp)	SARS2	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	19	39416898	19	38926258	215102	211882
NM_017827.3(SARS2):c.248C>T (p.Ser83Leu)	SARS2	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	19	39421129	19	38930489	138961	142664
NM_017827.3(SARS2):c.175G>C (p.Asp59His)	SARS2	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	39421202	19	38930562	329225	349802
NM_017827.3(SARS2):c.103A>G (p.Thr35Ala)	SARS2	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis|not specified|not provided	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	39421274	19	38930634	138960	142663
NM_017827.3(SARS2):c.44G>C (p.Arg15Pro)	SARS2	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	39421333	19	38930693	329226	349805
NM_017827.3(SARS2):c.30G>A (p.Trp10Ter)	SARS2	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis|not provided	Pathogenic(Last reviewed: Jun 13, 2017)	criteria provided, single submitter	19	39421347	19	38930707	215114	211885
NM_017827.3(SARS2):c.-12T>C	MRPS12|SARS2	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	39421388	19	38930748	329227	348839
NM_017827.3(SARS2):c.-19G>T	MRPS12|SARS2	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	39421395	19	38930755	329228	343520
NM_017827.3(SARS2):c.-106A>T	MRPS12|SARS2	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	39421482	19	38930842	329229	349812
NM_003573.2(LTBP4):c.4129C>T (p.Arg1377Ter)	LTBP4	Cutis laxa with severe pulmonary, gastrointestinal, and urinary abnormalities	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	19	41132933	19	40627028	40004	48517
NM_025136.3(OPA3):c.55G>A (p.Val19Ile)	OPA3	3-Methylglutaconic aciduria type 3|Optic atrophy and cataract, autosomal dominant	not provided	no assertion provided	19	46087968	19	45584710	585025	576185
NM_144687.3(NLRP12):c.1027C>T (p.Arg343Trp)	NLRP12	Periodic fever syndrome	not provided	no assertion provided	19	54313886	19	53810632	440985	434676
NM_000214.2(JAG1):c.1339T>C (p.Cys447Arg)	JAG1	not specified|not provided	Likely pathogenic(Last reviewed: May 29, 2015)	criteria provided, single submitter	20	10630179	20	10649531	213532	210327
NM_024120.4(NDUFAF5):c.836T>G (p.Met279Arg)	NDUFAF5	Mitochondrial complex I deficiency|Inborn genetic diseases	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2017)	criteria provided, conflicting interpretations	20	13797166	20	13816520	225036	226977
NM_022095.3(ZNF335):c.2744_2747del (p.Ser915Thrfs)	ZNF335	not provided|Primary autosomal recessive microcephaly 10	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	20	44581304 - 44581307	20	45952665 - 45952668	375393	362164
NM_022095.3(ZNF335):c.724_726del (p.Val242del)	ZNF335	Primary autosomal recessive microcephaly 10	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	20	44596460 - 44596463	20	45967822 - 45967824	561147	552224
NM_001077490.2(GNAS):c.1235C>T (p.Pro412Leu)	GNAS	Pseudopseudohypoparathyroidism	Uncertain significance(Last reviewed: Jun 28, 2017)	criteria provided, single submitter	20	57429742	20	58854687	584449	575506
GRCh37/hg19 20p12.2(chr20:10639152-10639516)x1	JAG1	See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	20	10639152 - 10639516			253515	247963
NM_172201.1(KCNE2):c.29C>T (p.Thr10Met)	KCNE2	Long QT syndrome 6|Long QT syndrome|not specified|Congenital long QT syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Apr 5, 2018)	criteria provided, conflicting interpretations	21	35742806	21	34370507	67619	78515
NM_080647.1(TBX1):c.928G>A (p.Gly310Ser)	TBX1	DiGeorge sequence|Cardiovascular phenotype	Benign(Last reviewed: Nov 10, 2017)	criteria provided, multiple submitters, no conflicts	22	19753444	22	19765921	7564	22603
NM_032608.6(MYO18B):c.6496G>T (p.Glu2166Ter)	MYO18B	Klippel-feil syndrome 4, autosomal recessive, with nemaline myopathy and facial dysmorphism	Pathogenic(Last reviewed: Jun 1, 2015)	no assertion criteria provided	22	26422436	22	26026470	224413	226149
NM_021076.3(NEFH):c.1054C>A (p.Arg352Ser)	NEFH	not provided	not provided	no assertion provided	22	29879534	22	29483545	66725	77622
NM_002473.5(MYH9):c.4271A>G (p.Asp1424Gly)	MYH9	Obesity|Epistaxis|Hypertension|Abnormal facial shape|Obesity|Numerous pigmented freckles|Abnormal platelet function|Abnormal platelet morphology|Increased mean platelet volume|Abnormal platelet shape|Thrombocytopenia|Hypertension	Likely pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	22	36688105	22	36292059	523453	514108
NM_022098.3(XPNPEP3):c.1357G>T (p.Gly453Cys)	XPNPEP3	Nephronophthisis-like nephropathy 1	Pathogenic(Last reviewed: Mar 1, 2010)	no assertion criteria provided	22	41320486	22	40924482	51	15090
GRCh37/hg19 22q12.3-13.1(chr22:35674826-39466442)x3	CSF2RB|CSNK1E|H1F0|HMOX1|IL2RB|KCNJ4|LGALS1|LGALS2|MB|MCM5|MFNG|MPST|MYH9|NCF4|POLR2F|PVALB|RAC2|SOX10|SSTR3|TST|PLA2G6|GALR3|APOL1|EIF3D|PICK1|GTPBP1|APOBEC3B|JOSD1|HMGXB4|TOM1|DNAL4|CACNG2|DDX17|KDELR3|IFT27|TRIOBP|CDC42EP1|DMC1|GCAT|CBX6|NPTXR|SLC16A8|RBFOX2|RASD2|SH3BP1|MAFF|APOL2|CBY1|SUN2|TXN2|TMEM184B|GGA1|CYTH4|APOBEC3C|CARD10|EIF3L|TOMM22|PDXP|NOL12|KCTD17|FOXRED2|BAIAP2L2|APOL6|APOL5|APOL4|APOL3|C22orf23|MICALL1|ELFN2|C1QTNF6|ANKRD54|APOBEC3D|TMPRSS6|APOBEC3A|APOBEC3F|TEX33|FAM227A|MIR659	See cases	Likely pathogenic(Last reviewed: Sep 9, 2015)	no assertion criteria provided	22	35674826 - 39466442			443342	437004
GRCh37/hg19 22q12.1-12.3(chr22:28349854-33013062)x3	AP1B1|EWSR1|LIF|LIMK2|DRG1|NEFH|NF2|OSM|RFPL1|SLC5A1|SMTN|SLC5A4|TCN2|XBP1|YWHAH|SYN3|NIPSNAP1|THOC5|MTMR3|GAL3ST1|DEPDC5|SFI1|SF3A1|RASL10A|GAS2L1|RFPL3S|RFPL3|RFPL2|RFPL1S|CHEK2|MORC2|TTC28|PES1|SEC14L2|PATZ1|PISD|OSBP2|C22orf31|C22orf24|FBXO7|RHBDD3|INPP5J|UQCR10|PLA2G3|RTCB|MTFP1|TUG1|ZMAT5|EIF4ENIF1|TBC1D10A|KREMEN1|ZNRF3|ASCC2|RNF185|PIK3IP1|EMID1|SELENOM|HSCB|CCDC117|HORMAD2|DUSP18|C22orf42|CABP7|RNF215|PRR14L|BPIFC|SEC14L3|SEC14L4|SLC35E4|CCDC157|CASTOR1|SEC14L6	See cases	Likely pathogenic(Last reviewed: Sep 9, 2015)	no assertion criteria provided	22	28349854 - 33013062			442415	436077
GRCh37/hg19 22q13.31(chr22:44382852-45007914)x1	SAMM50|PARVB|PARVG|RTL6|SHISAL1	See cases	Uncertain significance(Last reviewed: Sep 9, 2015)	no assertion criteria provided	22	44382852 - 45007914			441741	435403
NM_015884.3(MBTPS2):c.1286G>A (p.Arg429His)	MBTPS2	IFAP syndrome with or without BRESHECK syndrome|not provided	Pathogenic(Last reviewed: Jan 24, 2017)	criteria provided, multiple submitters, no conflicts	X	21899039	X	21880921	11404	26443
NM_004006.2(DMD):c.3028G>C (p.Ala1010Pro)	DMD	not specified	Uncertain significance(Last reviewed: Jul 3, 2014)	criteria provided, single submitter	X	32486749	X	32468632	201746	198584
NM_001127899.3(CLCN5):c.1676G>A (p.Trp559Ter)	CLCN5	Dent disease 1	Pathogenic(Last reviewed: Oct 28, 2013)	no assertion criteria provided	X	49853473	X	50088816	438798	432424
NM_033380.2(COL4A5):c.1690G>C (p.Gly564Arg)	COL4A5	Alport syndrome, X-linked recessive	Likely pathogenic(Last reviewed: Jun 4, 2015)	criteria provided, single submitter	X	107840709	X	108597479	242342	243893
NM_000495.4(COL4A5):c.1871G>A (p.Gly624Asp)	COL4A5	Alport syndrome, X-linked recessive|not provided|Hypertension|Mild proteinuria|Glomerulopathy|Hypertension	Pathogenic(Last reviewed: Sep 16, 2018)	criteria provided, multiple submitters, no conflicts	X	107842023	X	108598793	24455	35796
NM_001015877.1(PHF6):c.956G>C (p.Arg319Pro)	PHF6	Pulmonary arterial hypertension|Bilateral cryptorchidism|Rib fusion|Horseshoe kidney|Macrocephalus|Abnormality of neuronal migration|Enlarged cisterna magna|Hypoplasia of penis	Uncertain significance(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	X	133551320	X	134417290	523390	514120
NM_001159702.2(FHL1):c.625T>C (p.Cys209Arg)	FHL1	Emery-Dreifuss muscular dystrophy 6	Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	X	135290737	X	136208578	11557	26596
NM_005629.3(SLC6A8):c.1601T>C (p.Ile534Thr)	SLC6A8	Creatine deficiency, X-linked|not specified	Likely benign(Last reviewed: Jun 8, 2014)	criteria provided, single submitter	X	152960178	X	153694723	212211	208923
NM_001110556.1(FLNA):c.5182G>T (p.Gly1728Cys)	FLNA	Otopalatodigital spectrum disorder	Pathogenic(Last reviewed: May 15, 2006)	no assertion criteria provided	X	153583228	X	154354860	11768	26807
GRCh38/hg38 Xq12(chrX:67033673-67862682)x2	AR|LOC109504725	See cases	Uncertain significance(Last reviewed: Mar 26, 2013)	no assertion criteria provided	X	66253515 - 67082524	X	67033673 - 67862682	155090	164844
GRCh38/hg38 Xq26.2-26.3(chrX:133532321-137519462)x2	BRS3|CD40LG|FHL1|GPC3|HPRT1|ZNF75D|RTL8C|ARHGEF6|SLC9A6|PLAC1|RTL8A|SNORD61|RBMX|HTATSF1|VGLL1|CT55|SAGE1|MOSPD1|MAP7D3|GPR101|PHF6|MIR503HG|MMGT1|ADGRG4|FAM122B|FAM122C|INTS6L|ZNF449|LINC02243|CCDC160|SMIM10L2A|MIR106A|MIR19B2|MIR92A2|RTL8B|CT45A3|CT45A5|MIR424|CT45A6|CT45A1|MIR450A1|MIR363|MIR20B|MIR18B|MIR450A2|MIR503|SMIM10|SMIM10L2B|MIR542|CT45A2|MIR450B|MIR934|LINC00892|ETDB|SMIM10L2B-AS1|LINC00629|LOC100506790|INTS6L-AS1|CT45A7|ETDA|CT45A10|CT45A9|CT45A8|LOC107032760|LOC110120761|ETDC|GPC3-AS1	See cases	Likely pathogenic(Last reviewed: Dec 17, 2012)	no assertion criteria provided	X	132666349 - 136601621	X	133532321 - 137519462	152215	161966
NC_012920.1:m.4277T>C	MT-TI	not specified	Uncertain significance(Last reviewed: Nov 9, 2011)	no assertion criteria provided	MT	4277	MT	4277	235012	236830
m.4291T>C	MT-TI	Hypertension, hypercholesterolemia, and hypomagnesemia, mitochondrial	Pathogenic(Last reviewed: Nov 12, 2004)	no assertion criteria provided	MT	4291	MT	4291	9607	24646
NC_012920.1:m.7041G>A	MT-CO1	Mitochondrial DNA-related disorder	not provided	no assertion provided	MT	7041	MT	7041	440983	434700
